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Abstract 
Engineering of the PETNR active site to accommodate novel α/β substituted 
enone substrates. 
Experiments facilitating the engineering of the PETNR active site to accommodate a 
range of non natural enone substrates with substituents localised on the α and β 
carbons of the unsaturated bond are described. In order to facilitate the high 
throughput purification of PETNR libraries poly histidine (PETNRHis) and biotin 
(PETNRBio) tagged PETNR variants were generated. High throughput protocols were 
developed for the automated generation, purification and screening of libraries in a 
96 well format. Protocols were optimised and trialled using blocks consisting of 
PETNRHis WT only and characterised in terms of intra block variation. A range of 
single site saturation mutagenic libraries were generated at positions in the active 
site consisting of T26, Y68, W102, H181, H184, Y186, Q241 and Y351. Sequencing 
results indicated randomised libraries with the occasional instance of bias evident. 
Expression and purification in a 96 well format was monitored by SDS PAGE and 
protein quantitation. Library activity was quantified and demonstrated to retain 
varying degrees of activity with the model substrate 2-cyclohexenone. Following 
this verification of the experimental protocol libraries were screened against a 
range of substrates analogous to substrates demonstrated to be active with 
PETNRWT but incorporating substituents at the α and β carbons. ‘Hits’ generated 
from these screening reactions were studied further by the determination of the 
specific activity and quantitation of substrate / product from biotransformation 
reactions. From these screening experiments totalling 3,600 individual reactions, 35 
were identified as potential hits, of these 8 proved to be genuinely improved 
variants. Substituents at the β carbon were demonstrated to compromise the 
activity of the WT enzyme most severely. Positions 68, 102, and 351 were 
demonstrated to play an important role in the accommodation of substituents at 
the α carbon whilst residues 26 and 351 are important for the β carbon. The best 
variants demonstrated up to 9 fold improvements in poor substrates which 
represented rates in excess of those observed for model substrates.  
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1 Introduction 
1.1 Overview 
The aim of the work described in this thesis is to develop a robotic high throughput 
method for the generation of tailored biocatalysts, specifically to enable an 
extension in the substrate specificity of the flavoprotein oxidoreductase 
pentaerythritol tetranitrate reductase (PETNR).  
This chapter will discuss the known properties of the Old Yellow Enzyme (OYE) 
family of oxidoreductases to which PETNR belongs. This discussion will focus on the; 
i) diversity of OYE family members, including a brief history of the family, ii) 
mechanistic similarities within the family, iii) properties of PETNR specifically, iv) 
reaction mechanisms of OYEs with a number of substrate classes, v) structure-
function relationships within the family, to enable the identification of suitable 
targets for mutagenesis, vi) the experimental techniques used to generate and 
screen libraries to isolate improved biocatalysts.  
Chapter 1 
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1.2 OYE family overview 
The OYE family of flavoproteins are NAD(P)H (reduced Nicotinamide Adenine 
Dinucleotide (Phosphate)) - dependent enzymes [1], a range of which are detailed 
briefly in Table 1.1. OYEs have been shown to reduce a variety of oxidative 
substrates including: α/β unsaturated carbonyls, e.g. 2-cyclohexen-1-one (CH) [2]; 
nitrate esters, e.g. pentaerythritol tetranitrate (PETN) [3]; nitro compounds, e.g. 
2,4,6-trinitrotoluene (TNT) [4]; aromatic rings, e.g. also in TNT [5] and alkynes e.g. 
4-phenyl-3-butyne-2-one [6] (Scheme 1.1). In terms of size, OYEs are capable of 
accommodating a wide range of substrates from acrolein at the bottom end of the 
spectrum to multi ring steroid systems at the other extreme [2]. 
 
Scheme 1.1. Schematic representation of the generalised reactions of OYE homologues. Compounds 
represent generalised substrates. 
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1.2.1 Historical perspective 
The first OYE (OYE1) to be described was purified from Saccharomyces 
carlsbergensis (S. carlsbergensis) in 1932 by Warburg and Christian and initially 
described as ‘gelbe ferment’ [7]. The name derives from the yellow colouration 
present in the enzyme due to the non-covalently bound flavin mononucleotide 
(FMN) group [8]. The ‘Old’ in OYE was added to differentiate it from another yellow 
enzyme purified later [9].  
OYE has played a significant role in the development of enzymology, providing the 
first example of a cofactor dependent enzyme directly involved in the catalysis of a 
redox reaction [1], work for which Hugo Theorell was awarded the 1955 Nobel prize 
for outstanding contribution in Physiology or Medicine [10]. 
1.2.2 Family members 
While OYE1 is the best studied member of this family, a large number of 
homologous enzymes have been discovered and studied. The original old yellow 
enzyme (OYE1) from Saccharomyces carlsbergensis, was isolated from the native 
organism [11], which was found to consist of a mixture of 5 isozymes (termed OYE I-
V). These enzymes all have a similar molecular mass (~50 kDa), indistinguishable by 
Sodium Dodecyl Sulfate Polyacrylamide Gel Electrophoresis (SDS PAGE), and 
identical spectral properties, however differ in their oligomeric state and contain 
subtle variations in the shape of the active site as demonstrated by 13C NMR [12]. 
This OYE preparation was shown to be reduced by NAD(P)H [13]. The structure of 
recombinant OYE1 [14] was determined to 2 Å in oxidised and reduced forms, and 
with p-hydroxybenzaldehyde (HBA), β-estradiol and α-O2'-6B-cyclo-1,4,5,6-
tetrahydro-nicotinamide adenine dinucleotide phosphate (an NADPH analogue) as 
bound ligands [15]. Following the availability of a homogenous enzyme preparation 
the catalytic mechanism has been studied in great detail, particularly the oxidative 
half reaction, and will be discussed further in Section 1.4.  
Two OYE enzymes from Saccharomyces cerevisiae, OYE2 – 3 respectively, were 
characterised demonstrating 92% and 80% identity to OYE1 [16, 17]. One focus of 
Chapter 1 
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research into these enzymes has concentrated on the identification of the 
physiological function of OYE homologues. Despite years of research a definitive 
answer to the conundrum of the natural function(s) and physiological substrate(s) 
of this class of enzyme remains elusive (Section 1.2.6). 
Morphinone reductase (MR) is an NADH-dependent OYE homologue that catalyses 
the reduction of bulky α/β unsaturated carbonyl compounds, such as morphinone 
[18]. MR was initially isolated from a Pseudomonas putida strain due to its ability to 
utilise morphinone and codeinone as a sole carbon source [19]. The structure of MR 
has been solved [20], and this enzyme has become the focus of intense study to 
determine the mechanism for the OYE reductive half reaction. 
Due to the rapid increase in available sequence data, attributable to the advent of 
rapid genome sequencing, a wealth of OYE like proteins have now been discovered. 
The majority are categorised as putative OYE based purely on sequence homology, 
but a significant number have been studied in rather more detail. These are listed 
and referenced in table 1.1. 
Introduction 
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Strain Enzyme Ref 
S. carlsbergensis Old yellow enzyme 1 (OYE 1) [11] 
S. cerevisiae 
Old yellow enzyme 2 (OYE 2) 
Old yellow enzyme 3 (OYE 3) 
[16] 
[17] 
P. putida M10 Morphinone reductase (MR) [18] 
Enterobacter cloacae PB2 
Pentaerythritol tetranitrate reductase 
(PETNR) 
[21] 
P. putida KT2440 Xenobiotic reductase (XR A – F) [22] 
Agrobacterium radiobacter Glycerol trinitrate reductase (GTNR) [23] 
Arabidopsis thaliana 12-Oxophytodienoate reductase (OPR 1 – 2) [24] 
Lycopersicon esculentum Oxophytodienoate reductase 1-3 [25] 
P. putida II-B Xenobiotic Reductase A (XR A) [26] 
Pseudomonas fluorescens I-C Xenobiotic Reductase B (XR B) [26] 
Bacillus subtillis YqjM [27] 
Thermoanaerobacter 
pseudethanolicus E39 
Thermophillic OYE (TOYE) [28] 
Thermus scotoductus SA-01 Chromate reductase (CrS) [29] 
Escherichia coli N-Ethylmaleimide reductase (NEMR) [30] 
Aspergillus fumigatus OYE (AFOYE) [31] 
Candida macedoniensis  OYE (CMOYE) [32] 
Gluconobacter suboxydans OYE (GSOYE) [33] 
Hansenula polymorpha OYE (HPOYE) [34] 
Kluyveromyces lactis OYE (KLOYE) [35] 
Trypanosoma cruzi OYE (TCOYE) [36] 
Shewanella oneidensis OYE (SOOYE) [37] 
P. putida OYE (PPOYE) [22] 
Table 1.1 Summary of well characterised OYE homologues. A large number of additional putative 
OYEs have been identified from genome sequencing experiments, these are not included for reasons 
of clarity. 
Chapter 1 
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1.2.3 PETNR historical overview 
PETNR is a NAD(P)H dependent OYE that catalyses the reduction of α/β unsaturated 
activated alkenes e.g. 2-cyclohexen-1-one (CH) [38], aromatic and aliphatic nitro-
containing compounds e.g. PETN [3], and aromatic ring systems e.g. TNT [5].  
PETNR was derived from a strain of Enterobacter cloacae strain PB2, originally 
isolated from explosives-contaminated soil, selected for its ability to utilize PETN as 
a sole nitrogen source [3]. The gene was originally named organic nitrate reductase 
(onr), though the enzyme is commonly known as PETNR [39]. Following initial 
identification and characterisation, structural and sequence homology between 
PETNR and the OYE (Old Yellow Enzyme) family of flavoenzymes enabled the 
assignment of PETNR enzyme to this family [7]. 
1.2.4 Generalised familial structure 
Although there are structural differences between members of the OYE family of 
proteins, most markedly their variable oligomeric states, there are also common 
structural elements which appear in OYE homologues.  
The overall monomeric structure of the OYE family is based on an 8 stranded α/β 
barrel fold [15, 40-43]. The substrate-binding channel is relatively large and can 
accommodate the binding of both small and bulky substrates such as acrolein and 
multi-ring steroid structures [2]. Substrate specificity is governed by the residues 
lining the active site channel, leading from the FMN to the surface of the protein. 
These residues are largely hydrophobic, with loop β3, loop β5 and loop β6 being 
highly variable [15]. An overview of the structure of OYE is shown in Figure 1.1. 
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Figure 1.1. Overall structure of OYE; Panel A, the overall 8 stranded α/β barrel fold of OYE1 in 
cartoon format approximately along the axis of the barrel; Panel B, the same structure viewed from 
perpendicular to the barrel axis; Panel C, space fill model showing the substrate binding channel of 
OYE1 from 1OYA [15]. 
A number of OYEs exist and function as monomers such as PETNR [3] and glycerol 
trinitrate reductase (GTNR) [23]. There is, however, great variety throughout the 
family, for example OYE1 exists as a dimer [15] with a highly conserved dimer 
interface. This interface is highly conserved throughout the OYE family (even 
amongst non-dimeric proteins). In the case of MR which also exists as a dimer the 
dimer interface differs. In the case of 12-oxophytodienoate reductase 1 (OPDR) 
dimerisation has been shown to be of functional significance in self inhibition [42]. 
A more recent isolate YqjM from B. subtilis has been shown to exist as a tetramer 
with oligomer formation being important for function due to shared active site 
residues. In this unusual structure, R336 on a C terminal loop from one YqjM 
monomer contributes to the active site formation of the second monomer and is 
described as an ‘arginine finger’ [43]. This interaction along with the dimerisation 
interface can be seen in Figure 1.2.  
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Figure 1.2. Dimerisation interface of YqjM. Inset shows the interaction of R336 with the active site of 
the opposite monomer. Green, monomer 1; blue, monomer 2; yellow, FMN. From 1Z41 [43]. 
Importantly, a distinction can be drawn here between two structurally variable 
subclasses. One subclass contains traditional OYE like proteins including various 
OYE’s, PETNR, MR, etc. The other subclass is composed of largely thermophillic OYE 
homologues including YqjM, Thermophillic OYE (TOYE), Chromate Reductase (CrS), 
etc... This thermophile-like subclass is characterised by a highly conserved C 
terminal region incorporating an arginine finger motif which binds in the active site 
of the partner protein of the dimeric unit and is essential for function [28]. An 
alignment of both enzyme classes can be seen in Figure 1.3 highlighting key 
residues. 
Introduction 
22 | P a g e  
 
 
Figure 1.3 Alignment of a representative sample of OYE homologues highlighting key residues as 
discussed in the text below (PETNR numbering unless stated otherwise). Classical OYEs are above 
the dividing line thermophile like OYE are below. Yellow, residue 26; orange, residue 68; red, residue 
102; light green, residue 181; dark green, residue 184; cyan, residue 186; dark blue, residue 241; 
purple, residue 333 (TOYE numbering); brown, residue 351. 
1.2.5 General substrate profile 
The OYE family of enzymes have a number of conserved activities throughout the 
family, including the reduction of unsaturated carbonyl compounds (enones) [2]. 
This reaction proceeds by the selective reduction of the unsaturated carbon double 
bond without alteration of the carbonyl group. A simple member of this substrate 
class, CH, has been recognised as a good general oxidative substrate for many 
members of this family [2]. 
Several of the OYE’s, including PETNR, have been demonstrated to be able to  
perform the reductive denitration of nitrate esters and nitramines, particularly with 
Chapter 1 
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respect to the nitrate ester explosives, such as the reaction of PETNR with PETN and 
Glycerol Trinitrate (GTN), resulting in the respective alcohol product [44]. The direct 
reduction of nitro groups to give the respective amines proceeding through a 
hydroxyl amino intermediate has been observed in the reaction of PETNR with TNT 
[4]. OYE’s have been demonstrated to also be capable of the reduction of 
aromaticised unsaturated bonds, even in the presence of nitro groups exemplified 
again by the reaction of PETNR with TNT [5]. An outline of all these reactions has 
been shown in Scheme 1.1. 
1.2.6 Physiological role 
Despite study of the old yellow enzyme family beginning almost 80 years ago the 
physiological role of the enzyme family is still a matter of contention. A number of 
theories as to what role the OYE homologues play in different organisms have been 
put forward including the recycling of cellular cofactors [33, 35], the biosynthesis of 
a range of compounds [16, 31, 45], the detoxification of toxic compounds [34, 36, 
46], and the reaction to oxidative stress [27, 47, 48]. 
There is a high level of conservation throughout the OYE family, with OYE 
homologues being present in all kingdoms of life except higher eukaryotes, such as 
animals, and the presence of multiple homologues in a number of cases [12, 16, 22, 
34, 37]. This indicates to the possibility of important natural function(s).  
Early reports suggest that the ability to transfer electrons to molecular oxygen may 
be a facet of the natural role of OYE in NADPH recycling. It is suggested that in G. 
suboxydans NAD(P)+ is recycled by OYE at the expense of oxygen allowing turnover 
of the pentose phosphate pathway to provide glycolytic metabolites (Scheme 1.2) 
[33]. A similar effect has also been observed in K. lactis deficient OYE where a 
decreased rate of NADPH oxidation was reported to be responsible for a substantial 
increase in division time of the organism [35]. Such a role in S. carlsbergensis is 
thought unlikely due to slow turnover of OYE1 with molecular oxygen [11]. 
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Scheme 1.2. NADP+ recycling Scheme showing the turnover of NAD(P)H by OYE using molecular 
oxygen as the oxidative substrate. 
One well studied physiological role is in the biosynthesis of jasmonic acid, which is 
involved in plant signalling in the oxidative stress response [45]. The OYE 
homologue 12-oxophytodienoate reductase (OPR) has been demonstrated to 
reduce 9S,13S-12-oxophytodienoate to 1S,2S-3-oxo-2(29[Z]-pentenyl)-cyclo-
pentane-1-octanoate (Scheme 1.3, panel 1) [45]. The most recent studies on A. 
fumigatus OYE suggest a role in the synthesis of ergot alkaloids in fungi [31]. The 
gene for the OYE homologue is located within the ergot alkaloid biosynthesis gene 
cluster and the purified protein has been demonstrated to catalyse the reaction of 
chanoclavine-1-aldehyde to dihydrochanoclavinealdehyde allowing free rotation 
prompting a ring closure reaction (Scheme 1.3, panel 2) [31]. Another biosynthetic 
pathway potentially relying on OYE 2 is the synthesis of the fungal membrane sterol 
ergosterol [16]. 
 
Scheme 1.3. Biosynthesis reactions of various OYE homologues. Panel 1, the reaction of OPR1; panel 
2, reaction of AFOYE.  
In H. polymorpha, an OYE has been demonstrated to have a role in detoxification of 
acrolein to propionaldehyde generated by alcohol oxidase metabolism of allyl 
alcohol. This observation lead to the proposal that OYE could be involved in the 
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detoxification of a range of toxic α/β unsaturated carbonyl species [34]. In T. cruzi, 
the causative agent of Chagas’ disease, an OYE homologue has been demonstrated 
to metabolize a whole range of compounds used as drugs to treat the disease. In 
the case of naphthoquinone drugs, such as menadione, one electron reduction by 
TCOYE forms the naphthoquinone radical [36] which reacts with molecular oxygen 
to give the superoxide anion leading to cell death, which is thought to be the mode 
of action for this drug [49]. In the case of nitroheterocyclic drugs, such as 
nifurtimox, these have been demonstrated to undergo 2 electron reduction leading 
to detoxification [36]. A number of over-expressed proteins were identified from A. 
thaliana growing in TNT contaminated media. These proteins were classified as 
oxophytodienoate reductases (OPRs), a subclass of OYE’s. A number of these 
proteins were observed to be over expressed in the cytosol and peroxisome of root 
cells in response to TNT exposure providing a detoxification function allowing the 
plant to grow [46]. 
OYE’s have been shown to have a role on the progression of BAX-induced reactive 
oxygen species-mediated programmed cell death (PCD) in an artificial yeast system. 
OYE2 has been shown to have a protective effect against PCD. Conversely where 
OYE2 : OYE3 heterodimers are formed these serve to further sensitise the cell to 
the PCD mechanism [47]. Furthermore it is suggested that OYE3 is involved in the 
mechanism by which BAX induces reactive oxygen species (ROS) mediated PCD 
including the metabolism of lipid peroxidation products [48]. A more generalized 
role in the reaction to externally induced oxidative stress has been demonstrated 
for the OYE homologue YqjM [27]. 
It is unknown whether the repeatedly observed reactivity with α/β unsaturated 
activated alkenes is representative of the natural function or distinct from it, some 
of the reactions catalysed could represent opportunistic functions of the enzyme. 
This suggests that whilst maintaining a role in the organism’s response to oxidative 
stress, many OYEs have been opportunistically utilised for a wide range of functions 
[37], e.g. the degradation of nitrate ester explosives by PETNR [3] and morphinone 
derivatives by MR [18] could represent recent examples of this phenomenon.  
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1.2.7 Biocatalytic functions and other potential uses 
With the multitude of reaction mechanisms available from OYE homologues, it is 
not surprising that this family of enzymes have already attracted the attention of 
chemists seeking stereo and enantio selective biocatalysts.  
OYE homologues could potentially be used for the enantiospecific reduction of 
alkenes to give industrially useful products [50]. Reactions with alkenes conjugated 
to other electron withdrawing groups (EWG; required to induce δ+ charge on the β 
carbon, thus encouraging hydride attack) have also been studied including aldehyde 
[51], carboxylic acid, ester, nitro [52, 53], di-acids, di-esters [54].  
An excellent example of an OYE being used in synthesis is the use of S. cerevisiae or 
C. macedonis OYE in the chiral synthesis of (6R)-levodione. E. coli cells expressing a 
cloned OYE construct were used to catalyse the whole cell stereoselective reduction 
of 2,6,6-trimethyl-2-cyclohexen-1,4-dione (ketoisophorone) to (6R)-2,2,6-
trimethylcyclohexane-1,4-dione ((6R)-levodione). The reaction yielded 96.4 % 
product with a 95.5 % enantiomeric excess (e.e.) using OYE2 [55] while the C. 
macedonis enzyme yielded 98.7 % [32] (Scheme 1.4, panel 1). 
A further reaction of OYE of particular interest to synthetic chemists is the recently 
identified regioselective conversion of alkyneones (ynones) to the corresponding 
enone, which could provide a new route for the synthesis of trans-enones e.g. the 
reaction of 4-phenyl-3-butyne-2-one (Scheme 1.4, panel 2). As is to be expected 
however the enone can also be further reduced to the corresponding saturated 
carbonyl, and synthetic utility will depend on the ability to prevent this further 
reduction [6]. 
The use of MR has been demonstrated for the synthesis of synthetic opiate 
compounds, including the reaction of morphinone for therapeutic use (Scheme 1.4, 
panel 3) [56]. Similar alkaloid compounds, including the reaction of chanoclavine - I 
aldehyde, have been derived from reactions with  A. fumigatus OYE (Scheme 1.3, 
panel 2) [31].  
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The reaction of TNT with a small subset of OYE homologues, including PETNR, has 
been demonstrated to give diarylamine products, including secondary diarylamines 
(Scheme 1.4, panel 4) [57]. 
 
Scheme 1.4. Biocatalytic uses of OYE homologues 
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Other exploitations of OYE properties include the study of oxidative stress 
responses. Green fluorescent protein (GFP) fusions of OYE2-3 from S. cerevisiae 
were used to report the level of activity of the oxidative response in studies 
intended to demonstrate the degree of protection afforded by small molecule 
antioxidants [58]. The therapeutic activity of komaroviquinone against T. cruzi is 
reported to be attributable to the generation of ROS by OYE. It is also hypothesized 
that komaroviquinone can be used as a starting point for the discovery of novel 
therapeutics with a similar mode of action [49]. The use of PETNR for the 
bioremediation of explosive contaminated land was suggested early on in the study 
of this enzyme [5]. The over expression and bioremediation of solid media by 
oxophytodienoate reductase in A. thaliana has also been demonstrated [46]. 
1.2.8 Interim summary 
This section has described a number of important features of the OYE family of 
flavoproteins. Discussion of a number of OYE homologues and a brief historical 
account of the most prominent members helps provide context to the following 
more detailed chapters. Described above are the overall structural similarities with 
all OYEs being based an 8 stranded α/β barrel fold. However distinctions are drawn 
between classical OYEs and thermostable-like OYEs by the observation of an 
arginine finger motif.  
A range of activities are common within the OYE family including the reduction of 
activated alkenes and alkynes, the reductive denitration of a range of compounds, 
the reduction of nitro groups and the reduction of aromatic rings. A number of 
OYEs have been demonstrated as useful for biocatalytic synthesis reactions and a 
wealth of other such reactions are potentially plausible. Despite decades of study, 
consensus regarding the physiological function of these enzymes remains elusive. 
However, a range of substrates with physiological relevance has been identified and 
studied. 
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1.3 Reactions and substrates of  OYE homologues (specifically PETNR) 
The catalytic cycles of oxidoreductase enzymes are generally divided up into two 
half-reactions. First, the reductive half-reaction is where oxidized enzyme reacts 
with an electron donor to generate the reduced, catalytically active form of 
enzyme. Second, in the oxidative half-reaction a second substrate is reduced and 
the enzyme is reoxidised. For convenience in describing the mechanistic aspects of 
the OYE homologues, each half-reaction will be discussed separately (Scheme 1.5).  
 
Scheme 1.5. Generalised catalytic cycle of OYE homologues. Left half of the Figure the reduction of 
enzyme with NAD(P)H (reductive half reaction), Right half of the Scheme, regeneration of oxidised 
enzyme (oxidative half reaction). 
1.3.1 Reductive half-reaction 
In the reductive half-reaction, the reductant (NAD(P)H) donates two electrons and 
an associated proton (hydride; H-) to the enzyme-bound FMN cofactor (Scheme 
1.6). The reductive half-reactions of OYEs with nicotinamide cofactors have been 
shown to proceed via an enzyme-substrate charge transfer complex, which is 
characterised by an absorbance maxima at 560 nm [38]. Due to the fast reaction 
rates and complex nature of the transients, it is possible that there are additional 
unidentified intermediates in the reaction [38]. 
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Scheme 1.6. Schematic representation of OYE reduction 
1.3.2 Oxidative half-reaction 
1.3.2.1 Reduction of α/β activated alkenes 
The reaction is proposed to proceed via hydride attack at the β carbon, followed by 
protonation at the α carbon (Scheme 1.7) [6]. The main determinant of reactivity in 
this form of reaction is the activating group present, which is largely responsible for 
ligand/enzyme interaction [40].  
 
Scheme 1.7. Schematic representation of the oxidative half reaction; X, activating group; H+, derived 
from tyrosine residue or solvent, see Section 1.4.3. 
OYE family activity has been detected with a wide variety of activating groups 
including aldehydes (enal), ketones (enone), carboxylic acids, esters, nitroalkenes as 
shown in Scheme 1.8 
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Scheme 1.8. Generalised substrate profile of activated alkene substrates with OYEs. 
The most commonly described ene reduction of OYE’s is the reduction of ‘enone’ 
compounds where the activating groups is a ketone. This reaction has been 
observed with a wide variety of substrates including cyclic and acyclic enones. An 
example of this type of reaction is the reduction of CH which has been recognized 
as a good general substrate for OYE homologues [1]. This activity has been 
demonstrated to extend to related compounds including maleimides, which contain 
two carbonyl groups [59].  
One of the best characterised enone reductions is of the C1 to C2 double bond of 
the A ring of steroids such as prednisone. Steroids which lack this allelic bond, but 
like progesterone contain a C4 to C5 double bond, are effective inhibitors of PETNR 
[40]. Studies have also been performed using C2 and C3 substituted variants of cyclo 
pent/hex-enones, which have been shown to have a critical but differential effect 
on the substrate acceptance of OYEs [60]. Recent studies have widened the 
substrate acceptance of these substrates in YqjM by saturation mutagenesis studies 
[61]. 
A wide range of ‘enal’ compounds have been shown to be active with OYE 
homologues [2]. One example which has been observed in a wide range of OYE 
homologues is the reduction of cinnamaldehyde [21]. This class of substrates also 
includes a number of cyclic and acyclic terpenoids [59]. The substrate range for 
OYE1 has been demonstrated to include a range of short chain aliphatic, long chain 
aliphatic and branched aldehydes [2], with a similar profile for PETNR [59].  
Additional to the reactions with enones and enals a range of other carbonyls have 
also been demonstrated to be substrates including; carboxylic acids and esters, 
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however, a strong preference for the di-acid species and the di methyl esters is 
observed [54, 62].  
In addition to carbonyls nitro groups have also been shown capable of acting as 
activating groups for the reduction of unsaturated alkenes in OYEs, the simplest 
being nitrocyclohexene [63]. A range of α and β substituted nitro compounds have 
been studied with PETNR [63]. 
1.3.2.2 Reductive denitration of nitrate esters 
Several OYE homologues have been isolated with the ability to remove the nitrate 
groups from nitrate esters, including PETNR, GTNR and XR. The ability of PETNR-
containing bacteria to utilise nitrate explosives as a source of nitrogen stems from 
the ability of PETNR to reductively liberate nitrite from these compounds [3]. GTNR 
is capable of very similar oxidative chemistry to that of PETNR though with 
differences in the reductive chemistry [23]. Much of the mechanistic work 
performed on this pathway has been done on PETNR. 
Identification of the metabolites of PETN reduction by PETNR were investigated by 
high performance liquid chromatography (HPLC) and electrospray ionisation mass 
spectroscopy (EIMS) [3]. NO2
- groups were found to be sequentially removed, using 
one molecule of NADPH per NO2
-, to give the trinitrate and dinitrate derivatives of 
PETN (Scheme 1.9). However, as mononitrate was not detected, the dinitrate is 
probably not a good substrate for the enzyme [3]. When similar experiments were 
performed with a whole cell system, the degradation products were more complex 
as enzymes other than PETNR can act on the di- and trinitrate metabolites to give 
the aldehyde derivatives (rather than the alcohol derivatives from the initial 
liberation of the nitrate group) of the intermediate metabolites [3]. 
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Scheme 1.9. Reductive denitration of PETN by PETNR. Panels A and B show sequential reductive 
denitration of PETN as catalysed by PETNR, panel C shows the expected reaction of the dinitrate 
substrate which is not observed experimentally. 
PETNR has a similar activity toward other nitrate ester explosives such as GTN and 
ethylene glycol dinitrate (EDGN). Since the dinitrate is not a good substrate it can 
be inferred that other than the nitrate involved in the reaction a further two nitrate 
ester groups are required for good enzyme/substrate binding [3]. Since these initial 
experiments a whole range of nitrate esters were demonstrated to undergo the 
same reaction along with a number of nitramine species including erythritol 
tetranitrate, mannitol hexanitrate, xylitol pentanitrate, inositol hexanitrate, 
diglycerol tetranitrate, 1,2-propylene glycol dinitrate, 1,2-hexanediol dinitrate, 1,2-
pentanediol dinitrate, ethylene glycol dinitrate, 1,2-butanediol dinitrate, N-nitro-
diethanolamine dinitrate, butyleneglycol dinitrate, diethyleneglycol dinitrate, 1,3,5-
Trinitroperhydro-1,3,5-triazine (RDX), nitroguanidine, ethylene-1,2-dinitramine, 
1,3,5,7-tetranitro-1,3,5,7-tetrazocane (HMX) [44]. 
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1.3.2.3 Reduction of the aromatic ring 
At present the mechanism of dearomatisation has only been found in a few OYEs 
exhibiting high levels of homology with PETNR including PETNR, NEMR [4] and XRs 
[64]. Reduction of the aromatic ring was initially shown to proceed via the 
formation of a hydride Meisenheimer intermediate (H-TNT; Scheme 1.10). This 
intermediate is generated by a hydride attack on the C4 of the aromatic ring [5]. 
When following the reaction spectroscopically, orange/yellow products were 
detected from the reaction with TNT. These same orange/yellow products were 
also detected when PETNR was added to a chemically synthesised solution of 
hydride Meisenheimer complex, which has a purple/brown colouration. When 
chemically synthesised hydride Meisenheimer intermediate is left in an excess of 
borohydride, the orange colouration develops over an extended period of time 
indicating the orange/yellow products are a further reduction product of TNT [5]. 
The appearance of only the orange product in enzyme catalysed reactions indicates 
the hydride Meisenheimer complex exists only transiently and does not accumulate 
suggesting the overall rate limiting step is its formation [5]. The reaction in XR also 
proceeds via the addition of hydride to give di/hydride Meisenheimer 
intermediates and suggests a non-enzymatic mechanism for dimerisation and 
liberation of nitrite, which also involves hydroxylamino intermediates from the 
nitro reduction pathway indicating a balance between pathways rather than 
exclusion of one over another [57, 64]. 
 
Scheme 1.10. The ring reduction pathway including TNT substrate; Panel A, the hydride 
Meisenheimer intermediate; panel B, and the di-hydride Meisenheimer; panel C, generated during 
the reaction.  
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It has been suggested, by analysis of x-ray diffraction models of PETNR soaked with 
various substrates and inhibitors, that in order to facilitate hydride transfer the C5 
atom of the substrate needs to be localised above the N5 of the flavin [38]. In 
substrates such as TNT and picric acid (PA), the C3 and C5 atoms are resonance-
activated. In the case of the inhibitor 2,4-dinitrophenol (DNP), only C3 has 
resonance activation due to the absence of a nitro-group on C6 (Scheme 1.11). This 
is thought to be the mechanism of discrimination between substrate and 
competitive inhibitors as resonance activation at C5 is a requirement for catalysis 
[38]. 
 
Scheme 1.11. Resonance activation of the substrate picric acid and inhibitor 2,4-Dinitrophenol  
(DNP) demonstrating possible mechanism for the delineation of substrate and inhibitor. 
1.3.2.4 Nitro group reduction 
The mechanism by which OYEs reduce nitro groups to amines proceeds via the 
formation of an initial hydroxylaminodinitrotoluene (HADNT) product. This is 
followed by either reduction of a second nitro-group of HADNT to dihydroxylamino-
nitrotoluene, or reduction of the hydroxylamine group to form aminodinitrotoluene 
(ADNT; Scheme 1.12). While there seems to be potential for the dihydroxylamino-
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nitrotoluene species to be further reduced to give a diaminonitrotoluene species, 
none was detected in the above study [4]. The nitro reductive pathway has also 
been shown to provide potential substrates for the non enzymatic condensation 
with intermediates of the ring reduction pathway [57, 64]. 
 
Scheme 1.12. Proposed reaction Scheme for the reduction of nitro groups in TNT. The undetected 
diaminotoluene species is shown in brackets. 
As opposed to the ring reduction pathway, the nitro reduction pathway is 
consistently present in the OYEs tested [4]. In homologues where both pathways 
are present there is a delicate balance struck between the nitroreductive pathway 
and the direct reduction of the aromatic ring. The flux through these two pathways 
can be manipulated in PETNR by the substitution of a single amino acid [4]. 
1.3.2.5 Alkyne reduction 
In a more recent development the reduction of the alkyne 4-phenyl-3-butyne-2-one 
(Scheme 1.13) has been observed using a range of OYEs, suggesting a previously 
unknown activity of OYEs which may prove to have potential as a biocatalyst [6]. 
 
Scheme 1.13. Alkyne reduction observed in OYEs, Initial reduction to the alkene followed by second 
undesirable reduction to the alkane product.  
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1.4 Structure-function relationships in OYE family  
A number of structure-function relationships have been elucidated for the OYE 
family of enzymes. These are critical to understanding the enzymes function at a 
molecular level and as such will be critical in our attempt to manipulate the 
function of the enzyme. In the following section, the numbering of residues refers 
to PETNR residue identity throughout unless otherwise stated. 
1.4.1 FMN binding 
Each OYE monomer non-covalently binds a single FMN group, however, the nature 
of the interactions responsible for coordinating and modulating the function of the 
prosthetic group have only begun to become clear in the last 20 years. From the 
crystal structure of OYE1, the flavin prosthetic group was shown to be buried 
centrally within the 8 stranded barrel fold with access to the si face of the FMN 
from the solvent filled access channel (Figure 1.4) [15].  
 
Figure 1.4. Binding of FMN to OYE1; panel A, localisation of FMN in the active site of OYE1; panel B, 
binding of FMN in the OYE1 active site.   
The flavin is held in place by interactions from a wide number of protein 
interactions including side-chain hydrogen bonds, main-chain hydrogen bonds and 
water mediated hydrogen bonding (Table 1.2) [15, 65]; interactions similar in 
number and nature have been observed from structures of PETNR [40], MR [41] 
and OPR [45]. 
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Interaction Residue atoms FMN atoms 
Side Chain 
T37 O4 
Q114 N3, O2 
R243 O2’, O3’, O2 
R348 PO 
Main Chain 
P35 O2’ 
T37 N5 
G72 O4 
N325 PO 
G347 PO 
Water Mediated 
G324 PO 
F326 PO 
G345 PO 
Table 1.2. Interactions responsible for the coordination and mediation of FMN in OYE 
1.4.1.1 Role of residue 26 (OYE 37)  
This residue sits adjacent to the isoalloxazine ring of the FMN and forms hydrogen 
bonds between the backbone N of T37, the N5 of FMN and the side chain OH to the 
O4 group of the FMN (Figure 1.5; [66]). 
 
Figure 1.5 Hydrogen bonding between the Thr37 residue in OYE1 and its flavin group. From the PDB 
file 1OYA [15]. 
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Mutagenesis of this residue to alanine in OYE1 caused the rate of the reductive half 
reaction to be significantly reduced, though the rate of the oxidative half-reaction 
with several substrates increased [66]. This suggests the mutation has destabilised 
the reduced form of the flavin leading to a faster transfer of electrons to the 
substrate [66].  Similar results were observed with the T32A mutant of MR [67]. In 
YqjM, this residue is not conserved and its role is thought to be partially fulfilled by 
Y375 [43]. 
1.4.1.2 Role of residue 100 (OYE 114) 
Q114 from OYE1 is another highly conserved residue in the active site of the OYE 
family of enzymes. Its side chain atom O1 often hydrogen bonds to the N3 of the 
flavin isoalloxazine ring and the N1 interacts similarly with the O2 of the FMN.  The 
crystal structure of the Q114N mutant of OYE1 showed the isoalloxazine ring of the 
flavin was shifted 12° away from its position in the wild type enzyme, causing the 
ring to form hydrogen bonds with the His/Asn pair. This could explain the lowered 
affinity of this mutant for the oxidative substrate [68] as this would require the 
breaking of hydrogen bonding of the FMN to enzyme [68].  
1.4.1.3 Role of residue 181/184 
These residues have been demonstrated to have a significant effect on the binding 
of FMN [69]. The OYE1 N194H mutant incorporating histidine at both positions 
bound FMN poorly, which may be due to steric hindrance in a smaller OYE active 
site [69]. Similar results have also been obtained by mutating the critical His 
residues in GTNR [70]. 
1.4.2 Nicotinamide coenzyme binding  
The consensus sequence for binding nicotinamide coenzyme is well conserved 
among NADH-binding proteins and is represented by the sequence GXGXXG [71]. 
This sequence is usually well conserved in NADH binding proteins, but less so in 
proteins which bind NADPH. These residues form of a tight helix and provide space 
for the cofactor to bind [71]. There are often additional residues which stabilise 
parts of the bound cofactor. For example two arginine residues are usually found in 
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many NADPH-binding proteins downstream of the GXGXXG sequence responsible 
for coordinating the 2’ phosphate group present in NADPH but not in NADH, 
suggesting a possible mechanism for distinction between cofactors [71]. Further 
arginine residues in loop 3 (R142/R130) are thought to play a role in binding the 2’ 
phosphate group of NADPH [40]. 
Trends have been observed between the consensus sequence conservation of OYE 
homologues and the coenzyme preference, for example PETNR (GXGXXG – not 
conserved, Arg pair – well conserved) prefers NADPH while GTNR (GXGXXG – well 
conserved, Arg pair – not conserved) prefers NADH.  However this relationship is 
not absolute as MR contains a slightly modified consensus sequence and has a 
conserved Arg pair, yet it prefers NADH. Overall OYEs exhibit a requirement for 
NADH but a preference for NADPH, so the method of binding the cofactor is likely 
to exclude NADPH rather than actively select for either [72].  
Residues 181 and 184 have also been demonstrated in PETNR and MR to have a 
role in NADPH binding of the respective enzymes, which provide contrast between 
His/His and His/Asn pairs, and enzymes with different reductive cofactor 
preference. In the case of MR, the reductive half reaction is affected by altering the 
enzymes affinity for the cofactor enzyme charge transfer complex [73] with a 
similar role implied in PETNR [69]. In MR further research has shown that in the 
N189A mutant multiple conformations of NADH, all catalytically viable, were 
predicted and demonstrated to be kinetically distinguishable further supporting a 
role for this residue in binding of substrates [74]. 
1.4.3 Oxidative half reaction 
1.4.3.1 Role of residue 26 
T26 is conserved throughout all classical OYEs, in thermostable like OYE’s it is 
conserved as Cys. In PETNR and OYE it is positioned above the isoalloxazine ring of 
the FMN cofactor. Studies have shown that T26 in PETNR prevents the reduction of 
the C4 to C5 bond in steroid inhibitors, such as progesterone, by restricting access 
to a catalytically active conformation [73]. In order for hydride transfer to occur 
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with oxidative substrates, the angle between the N10 and N5 atoms of the flavin 
and the substrate Cβ atom must be in the region of 125-170°. However, crystal 
structures have shown that the N10 - N5 - C4 bond angle between PETNR FMN and 
progesterone is much too small [73]. The structure showed that progesterone is not 
bound in a catalytically optimal orientation (Figure 1.6) [73]. 
  
Figure 1.6. Structure of PETNR-bound progesterone showing the steric clash between progesterone 
and T26 side chain in the active site of PETNR.  Progesterone and FMN, atom coloured sticks with 
green carbons; T26, shown as a surface; C4, shown as sphere. Taken from the PDB file 2ABA [73]. 
Site-directed mutagenesis of T26 to smaller residues may remove the steric 
hindrance with steroid substrates. This could open up the possibility of engineering 
mutants able to catalyse the addition to the C4 to C5 bond of these inhibitors.  An 
analysis of the chemical environment of the double bonds suggests that both bonds 
may become partially activated by resonance forms, although the C5 is more 
sterically hindered (Scheme 1.14). 
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Scheme 1.14. Resonance forms of the A and B rings of generalised steroid backbone showing the 
partial charge activation on the C1 (top) and C5 (bottom). 
1.4.3.2 Role of residue 68 
The crystal structure of PETNR has shown that Y68 is one of a pair of spatially 
related tyrosines (along with Y351) which are positioned in the active site channel 
[40]. A role in oxidative binding is likely due to their positioning at the mouth of the 
active site channel (Figure 1.7). In MR a role as proton donor was suggested due to 
the absence of Y186, however such a function was disproved [67]. Interestingly 
mutants generated at this position proved to be catalytically competent, implying 
its identity is not strictly conserved [67] suggesting modification at this position 
could provide functionally improved mutants. 
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Figure 1.7 Location of the tyrosine residues 68 and 351, in PETNR, with relation to the active site 
tunnel; residues/substrate, atom coloured sticks; PETNR active site, surface. Taken from the PDB 
1GVO [38]. 
1.4.3.3 Role of residue 102 
W102 is highly conserved throughout the classical OYEs but not so in the 
thermostable-like OYEs. The crystal structure of picric acid bound PETNR showed an 
unusual electron density around W102 [38] which, following solution of a higher 
resolution data set, was interpreted as W102 occupying different conformations, in 
which the W102 residues overlapped, in the presence and absence of substrate 
[75]. This residue has little effect on either the reductive half reaction or on the 
binding of steroid substrates. However it has a profound effect on the flux between 
the ring reduction pathway and the nitroreductive pathway [75]. The crystal 
structures of W102Y and W102F mutants showed this residue adopted a single 
conformation, which removed the steric clash with the C6 nitro-group of TNT 
(Figure 1.8; [75]).  
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Figure 1.8. The role of Trp102 in substrate binding. Main panel, Unusual electron density 
surrounding Trp102 seen in the wild type PETNR structure shown as sticks with green carbons from 
PDB file 1VYR [75]: Panel A, alternate conformation of W102 shown as sticks with green carbons 
from 1VYR [75]; Panel B, W102F mutant shown as sticks with cyan carbons from PDB file 1VYP [75]; 
Panel C, W102Y mutant shown as sticks with magenta carbons from PDB 1VYS [75].  
In these mutants, the hydride Meisenheimer intermediate from the ring reduction 
pathway was formed at the same rate, but was broken down at a faster rate than in 
wild type enzyme. This suggests that the mutant enzymes favour the ring reduction 
pathway over the nitroreductive pathway (Scheme 1.15; [75]). Therefore, W102 is 
an attractive target for PETNR mutagenesis due to the possibility of generating 
mutants favouring the ring reduction pathway, as well as turning on this activity in 
OYE homologues which do not possess this activity. The role of the respective 
residue in the reduction of α/β unsaturated activated alkene compounds was 
investigated in MR and shown to be non-essential for catalysis but to have a 
substantial influence on specificity [67]. 
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Scheme 1.15 Flux down the two pathways available to some OYE family members. Bracketed arrows 
indicate the change in flux accompanying the mutations of W102Y and W102F (not to scale). 
1.4.3.4 Role of residue 181/184 
Residues 181/184 are highly conserved throughout the OYE family. These residues 
are located in the centre of the substrate binding pocket above the flavin (Figure 
1.9), and play a central role in substrate recognition in the oxidative half reaction. 
Throughout the OYE family, H181 is invariant whilst the amino acid equivalent to 
position 184 varies between histidine and asparagine (Table 1.3). The presence of a 
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H181/H184 pair (as in PETNR and NEMR; [4]) is rare, with residue 184 usually an 
asparagine (Figure 1.10). 
 
Figure 1.9 Overall structure of PETNR. His181 is shown as red sticks, 184 is shown as blue sticks, and 
FMN is shown as yellow sticks. Taken from the PDB file 1H50 [40].  
 
Figure 1.10 Interaction between the active site coordinating residues and enone substrate, 
comparison of the interaction of a His/His and His/Asn pair. Panel A, His/Asn, OYE1/HBA, green atom 
coloured sticks, 1OYB [15]; Panel B, His/His, PETNR/CH, cyan atom coloured sticks, 1GVQ [38]; Inset, 
Overlay of His 184 and the respective Asn showing colocalisation of coordinating nitrogen.  
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Protein Residue 181 Residue 184 
PETNR His His 
NEMR His His 
EBP His His 
OPDR His His 
XR His His 
YqjM His His 
TOYE His His 
MR His Asn 
GTNR His Asn 
OYE1 His Asn 
OYE2 His Asn 
OYE3 His Asn 
Table 1.3 Selected examples of OYE family members and their configuration around the 181/184 
positions. 
The binding of ligands to the PETNR active site has been extensively studied by 
crystallographic methods. The recognition of the substrate by the enzyme active 
site is achieved through interactions between the crucial 181 and 184 residues 
(Figure 1.11). Crystallographic studies of OYE1 identified residues equivalent to 181 
and 184 as potential hydrogen bond donors responsible for the coordination of the 
substrates p-hydroxybenzaldehyde and p-estradiol in a position where interaction 
between the substrate and prosthetic group can occur [15].  
Similar studies with PETNR have demonstrated that the residues form hydrogen 
bonds with the carbonyl group of the α/β unsaturated substrate and a range of 
other functionalities (Figure 1.11) leading to the localisation of the resonance 
activated double bond above the N5 atom of the flavin, in the correct orientation 
for hydride transfer [38, 40]. Other examples include OPR1 [45], GTNR [70], MR 
[67]. 
Introduction 
48 | P a g e  
 
 
Figure 1.11. Binding of a number of PETNR substrates into the active site through interaction with 
H181 and H184. Panel A, 2-cyclohexenone, 1GVQ [38]; Panel B, 1-nitrocyclohexene, 3F03 [63]; Panel 
C, 2,4,6 trinitrotoluene, 1GVR [38]; Panel D, picric acid, 1GVS [38]; Panel E, 2,4 dinitrophenol, 1GVO 
[38]; Panel F, prednisone, 1H61 [40]; Panel G, progesterone, 2ABA [73]; Panel H, 1,4-androstadien-
3,17-dione, 1H62 [40]. All residues and ligands are shown as atom coloured sticks. 
While the interactions between the 181/184 residues and substrates differ amongst 
OYEs, the nature of the interactions are similar. For example, the hydrogen bond 
between N1 of H184 and O1 of CH in PETNR [40] is replaced by a hydrogen bond 
between the N2 of A194 and O4 of a similar substrate hydroxybenzaldehyde in 
OYE1 (Figure 1.10; [15]). OYE1 mutants in which H191N and N194H mutants were 
isolated demonstrated severely compromised substrate binding attributed to sub 
optimal enzyme substrate interactions [15, 69]. Interestingly problems with 
expression [15] and flavination of these mutants [69] have also been observed. 
Chapter 1 
49 | P a g e  
H191 has also been shown to be critical for the effective reduction of nitrate esters 
by PETNR [76] and GTNR [70], possibly by binding the terminal nitro ester. The 
above studies however also provide contrasting data with respect to Kd values for 
substrate-enzyme complexes. In the case of the reaction with CH poorer substrate 
binding was taken to account for a reduction in overall reaction rate [69]. In the 
case of GTN, better substrate binding was observed, allied to an inferior catalytic 
rate, explained by the enzyme binding substrate in an sub-optimal conformation for 
catalysis [76]. The hypothesis that oxidative substrate binding is responsible for the 
inferior catalytic efficiency is supported by the observation that reduced H181A and 
H184A mutants are still capable of being reoxidised [73]. Similar roles have also 
been observed for the respective residues in MR [67].  
An interesting case study of the role of H181 and H184 in PETNR is the binding of 
steroid substrates and inhibitors. The crystal structure of PETNR is available with 
prednisone [40], progesterone [73] and 1,4-androstadien-3,17-dione [40], however 
despite this wealth of structural data the uncertainty surrounding the structural 
determinants of binding in catalytically active or inhibitory conformation remains 
[40]. 
There is also a correlation between the presence of a His at position 184 (or its 
equivalent) and the ability to catalyse the reduction of an aromatic ring [4]. When 
H184 in PETNR is mutated to Asn, the enzyme loses its ability to reduce the 
aromatic ring, as seen in naturally with OYE1. However, when provided with H- TNT 
as a substrate, all enzymes (including the mutants) were still able to further reduce 
this intermediate and complete the reduction of the aromatic ring of this partially 
reduced compound. This suggests that H184 is most likely involved in the first 
hydride attack generating H-TNT, and controls entry into the ring reduction 
pathway [4]. Mutation of this residue may allow us to deliberately affect the ability 
of the enzyme to enter the ring reduction pathway by the introduction of a single 
mutation. 
Residues 181/184 are attractive targets for mutagenesis due to the importance of 
these residues in substrate binding. This may enable the accommodation of a wide 
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variety of non-natural substrates, including ones containing novel activating groups, 
e.g. nitrile, in place of the carbonyl which binds to residues 181/184. However it is 
also important to note that studies thus far have indicated catastrophic loss in 
activity for α/β unsaturated carbonyls, for example PETNR H181A and H184A with 
cyclohexenone [73]. However, this is thought to be due to binding issues rather 
than an inability to perform the correct chemistry [69]. It is also notable that 
mutations at these positions have led to mutants which could not be isolated or 
were incapable of interaction with FMN, for example N191H  [69]. It has also been 
observed that generating mutants at these positions affects the reductive half 
reaction [69]. 
1.4.3.5 Role of residue 186 
In OYE1, an active site Tyr (Y196) is known to act as the proton donor [77]. 
Mutagenesis of Y196 to Phe had no effect on the reductive half reaction, but the 
oxidative half reaction with CH was severely compromised [77]. Crystal structures 
of wild type OYE1 showed that Y196 is correctly positioned to account for the 
stereochemistry of the reduction of the double bond (Figure 1.12; [77]).  
A similar role has also been hypothesised for Y186 in PETNR [38, 40] and OPR1 [45]. 
In GTNR the corresponding tyrosine is excluded from proton donation and thought 
to play a role in oxidative substrate binding [70]. However in the case of PETNR a 
role in proton donation was later ruled out in some substrates, by observation of 
the Y186F mutant, and solvent waters were implicated [73] 
The corresponding residue in MR is C191 which has been shown not to be the 
proton donor by mutagenesis studies, nor to have any role in the oxidative 
chemistry [40]. In this case the proton donor is thought to be solvent water 
molecules [67]. Mutagenesis of this residue, in some OYE homologues, may open 
up the possibility of changing the stereochemical properties of the enzyme by 
altering the nature of the proton donation. In other reaction mechanisms of OYE, 
for example the reductive denitration pathway, residue 186 was demonstrated to 
play a role in substrate binding rather than for proton donation [76]. 
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Figure 1.12. Tyr residues proposed as proton donors. Panel A, hydroxybenzaldehyde-bound OYE 
from 1OYB [15] showing the position of Y186 which has been demonstrated to act as the active site 
acid; Panel B, Overlay of residues posited to be active site acids in PETNR, Cyan, 1GVQ [38] and MR, 
Magenta, 1GWJ [41].  
1.4.3.6 Role of residue 351 
In classical OYE’s residue 351 represents the other half of the tyrosine pair 
occupying a position in the mouth of the active site channel (Figure 1.13) [40]. The 
equivalent residue in OYE1 was initially highlighted as functionally important in the 
hydrogen bonding of the carbonyl oxygen of HBA in OYE1 crystal structures [15]. 
This residue was also demonstrated to move slightly to accommodate steroid 
substrates [15, 40]. This residue was also implicated as a potential hydrogen donor 
in MR, but was later demonstrated to have no such function [78]. Interestingly this 
residue is absent in the thermophilic class of enzymes [28]. 
1.4.3.7 Role of other residues 
A wide range of other residues have been inferred from crystallographic studies 
[15, 40-42] to have mechanistic roles. Each of these residues is a potential site for 
library generation and hence influencing the substrate profile of PETNR. 
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Figure 1.13. Figure showing the active site of PETNR occupied by the substrate progesterone, 1H61 
[40]. Those residues identified in the text as being catalytically relevant have been highlighted, the 
inset gives a representation of the active site as a surface indicating where steric interactions may be 
present. 
1.4.4 Oligomerisation 
The oligomeric state of OYE homologues has been shown to vary greatly ranging 
from monomeric PETNR [3], through the dimeric OYE1 [15] and MR [41], up to the 
octomeric TOYE [28]. In the higher oligomeric states the enzymes are functional 
dimers due to the interactions of the arginine finger as discussed previously 
(Section 1.2.4).  
In some cases information regarding the nature of the dimeric interface has been 
determined from crystallographic data (Figure 1.14). For example the analysis of 
crystal contacts in the model of OYE1 suggests a dimer interface incorporating a 
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number of direct and water mediated hydrogen bonds involving helices 4, 5 and 6 
in both monomers [15], whilst the dimer interface in MR has been suggested to 
encompass helices 2 and 8 and β sheets A and B [41]. Whilst TOYE is considered as 
an octomer, the oligomeric organisation consists of 4 functionally active dimers 
rather than a traditional octomer, where dimerisation is achieved through yet 
another interface consisting of helices 1, E and F, oligomerisation of functional 
dimers occurs through the interaction of helices 6 and 7 [43]. 
 
Figure 1.14. Dimerisation interfaces of OYE’s. Panel A, dimerisation interface of OYE1 with 
interactions between helices 4, 5 and 6 from 1OYA [15]; panel B dimerisation interface of MR with 
interactions between helices 1, 2 and 8 from 1GWJ [41]. 
Interestingly a number of these dimeric interfaces have been demonstrated to be 
catalytically important. In the case of YqjM the formation of the dimer has been 
observed to result in the burying of R336 from one monomer into a second 
monomer to form a functional active site [43]. Interruption of this interaction, by 
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the addition of a poly histidine tag, lead to the loss of activity [79]. In the case of 
OPR dimerisation, the dimer formed by the binding of loop 6 in the active site was 
demonstrated to be functionally inhibited [42] highlighting another potential 
function of this phenomenon. 
1.4.5 Summary 
The information discussed in this Section is important in the consideration of two 
factors, first information regarding the structure-function relationships of the 
oxidative half reaction is used to inform the selection of residues at which to 
generate libraries. The review of the literature allied to analysis of the crystal 
structures of the OYE family has lead to the identification of T26, Y68, W102, H181, 
H184, Y186, Q241, and Y351 as a good initial selection of residues for library 
generation. 
Additionally information regarding the structure-function relationships of OYE’s 
with respect to a number of facets of enzyme activity, including oxidative half 
reaction, reductive half reaction, FMN binding and oligomerisation can be used to 
inform discussion of positive results and potential sources of error derived from the 
screening experiments.  
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1.5 Protein Engineering / Directed Evolution experiments  
1.5.1 Introduction 
There have been extensive studies of biotransformation reactions performed with 
OYE homologues both with isolated enzymes and whole cell preparations (Section 
1.2.7). Inevitably, however, natural biocatalysts tend not to provide complete 
idealised substrate profiles. Improvements can be made by experiments which 
mimic the natural process of evolution, generation of diversity followed by 
application of selective pressure, on a micro scale over accelerated timescales in an 
effort to improve biotransformation efficiency and stereospecificity.  
These experiments rely on the generation of genetic diversity followed by the 
application of selective/screening pressure to identify mutants with improved 
desired activity. Critical factors to the success of the experiment primarily involve 
the methods of library generation and screening [80].  
The aim of this project is to apply these experimental techniques to PETNR, as an 
example of an OYE homologue, in order to evolve properties of the enzyme, leading 
to the generation of improved biocatalysts.   
1.5.2 Library Generation 
Critical to the success of these experiments is the method of library generation. A 
wide range of techniques for generating diversity have been developed ranging 
from single site techniques through whole genome mutagenesis [81]. Inherent in 
the discussion of diversity generation is the discussion and solution of ‘the numbers 
problem’ for the individual experiment which relates the screening effort to the 
library coverage which are both key determinants in the success of the experiment.  
1.5.2.1 Gene Shuffling 
The strategy behind gene shuffling experiments relies on the diversity present in a 
series of structurally related enzymes, positing the hypothesis that homologous 
enzymes have evolved separately to accommodate various functions and that by 
combining fragments of related enzymes, a number of functions may be conserved 
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or generated in hybrid clones [80]. This approach consists of fragmenting the pool 
of homologous genes, then randomly reassembling to give a large number of 
individual clones providing a library of DNA clones (Figure 1.15). This approach is 
described and was verified using LacZ as a template [82]. The major limitation to 
this kind of approach is often a lack of homologous enzymes [80], however in the 
case of PETNR a vast number of structurally similar enzymes have been identified, 
suggesting this may be an attractive approach for PETNR. However due to the 
wealth of structural data available for OYE homologues more targeted approaches 
are also available. 
Methods have been developed for the generation of gene shuffled libraries to be 
completed by polymerase chain reaction (PCR), termed Staggered Extension 
Process (StEP), leading to the generation of gene shuffled libraries in a matter of 
hours. This procedure involves PCR with extremely short extension steps which 
allow only a short section of gene to be synthesised. The fragments are denatured 
and re-annealed, hopefully to a different parental gene [83]. 
 
Figure 1.15. Schematic outlining the generation of mutagenic libraries by gene shuffling. Genes are 
initially fragmented before being pooled and rejoined at random generating a library of novel 
mutants. 
1.5.2.2 Error Prone PCR (EPPCR) 
Error Prone PCR (Figure 1.16) was originally studied using polymerases naturally 
lacking the 3’  5’ exonuclease activity required for genomic ‘proofreading’ such as 
Thermus aquaticus (Taq) DNA polymerase [84]. This leads to error rates of 0.001-
0.02% errors per nucleotide per pass (resulting in 1 - 20 mutations per kb). The 
error rate achieved from Taq alone is rarely sufficient for the construction of highly 
randomised libraries and is often allied to the replacement of Mg2+ in the PCR 
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reaction with Mn2+ [85], the balance of Deoxyribonucleotide triphosphates (dNTPs) 
included in the PCR reaction for incorporation onto the growing chain [85], and 
additional nucleotide analogues which lead to various mis-incorporations [86]. This 
method requires very little prior knowledge of the structure-function relationship of 
the protein. 
In vivo methods for the rapid generation of large random libraries using engineered 
mutator strains of E. coli (which lack DNA repair mechanisms) have been 
demonstrated to accumulate mutations at an enhanced rate [87]. Whilst not using 
PCR methods or mutagenic polymerases this method is random and attributable to 
errors in fidelity of replication. 
  
Figure 1.16. Scheme showing the principles behind error prone PCR methods. PCR of the plasmid or 
gene of interest under mutagenic conditions introduces mutations in the resulting product DNA. 
Small vertical triangles indicate the position of mutations in the EPPCR product.  
The main disadvantage of these methods is that bias can be a significant problem. 
The fact that there are more residues distant from the active site dictates that a lot 
of mutants will have no effect on activity. Different polymerases vary in their 
tendency to mutate different nucleotides meaning some substitutions are 
represented more frequently than others. It is much more likely that some codons 
will be mutated to a selected subset of other codons, for example a single 
nucleotide change in a codon is more likely than all 3 changed therefore, AAA is 
more likely to be mutated to AAC than CCC. Mutations early in the PCR reaction are 
often present in a larger fraction of the products because they are templates for 
further cycles [81]. Despite the drawbacks and limitations of this approach even in 
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its simplest form EPPCR has led to improved biocatalysts, such as the improvement 
of subtilisin E in non-natural solvent [88].  
Since the initial trials with EPPCR a number of improvements in the technique have 
to some extent overcome some of the limitations, such as the utilisation of multiple 
polymerases, each with distinctive mutational spectrum, in each reaction to offset 
mutational bias [89]. In order to localise the region where error prone PCR is carried 
out, thus limiting mutations to the gene of interest negating potential problems 
associated with whole plasmid methods, megaprimer methods (Figure 1.17) were 
developed where the mutagenic PCR is used to generate a mutagenic megaprimer 
which replicates the rest of the plasmid in conjunction with a regular high fidelity 
polymerase [90]. Where random libraries are utilised a number of possible 
mutations are incredibly rare by change (such as the mutation of 2 nucleotides in 
one codon), even in the absence of this type of bias the number of possible 
permutations containing all 20 amino acids in each position quickly become 
experimentally inaccessible, this means that only low levels of coverage are 
possible experimentally.  
  
Figure 1.17. Generalised Scheme showing the principles behind megaprimer PCR library generation, 
The gene is amplified by PCR under mutagenic conditions, the resulting DNA sequence is used as a 
megaprimer for the high fidelity PCR of the rest of the plasmid. 
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An interesting extension of the idea of EPPCR is the idea of neutral drift, which 
while applicable to any form of mutagenesis seems most amenable to use with 
EPPCR methods. Neutral drift posits that by pre screening libraries and selecting 
clones that maintain wild type (WT) activity, you are selecting mutants which have 
demonstrated correct folding and catalytic competency. This leads to the 
generation of enhanced libraries which are more likely to yield functional mutants 
[91]. 
1.5.2.3 Site directed mutagenesis 
Site directed mutagenesis is a PCR based method where mutagenic primers are 
incorporated into the gene at specific locations. This method is often used for the 
generation of rationally designed mutants using oligonucleotides of known 
sequence, but the use of degenerate oligonucleotide primers at specific positions 
can be used for the generation of mutagenic libraries [81].  
In applying this range of techniques, a wide range of strategies have been employed 
to generate libraries both at single positions and multiple positions throughout the 
gene of interest (Figure 1.18). These approaches can require the screening of much 
smaller libraries and can approach complete coverage in certain cases. However the 
amount of sequence space sampled is extremely small compared to other 
approaches and to increase the likelihood of positive results, a substantial body of 
knowledge highlighting mechanistically or structurally important residues is needed 
to select appropriate residues to target. 
The simplest application of this phenomenon to mutagenesis is the generation of 
single site saturation libraries [92]. These involve the substitution of all (or a 
number of) amino acids at a single position, the selection of which is generally 
guided by knowledge of structure function relationships. These single site libraries 
require smaller screening efforts to ensure a large degree of coverage, however 
also access corresponding lower sequence space [92].  
An important consideration for making saturation type libraries is the nucleotide 
degeneracy used. By incorporation of a subset of different nucleotides at certain 
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positions one can limit the number of clones to be screened to give a high level of 
coverage. For example in NNN (where N represents any nucleotide) degeneracy, all 
64 possible combinations of nucleotides are represented including all 20 amino 
acids, additionally NNK degeneracy (where K represents only Keto nucleotides i.e. 
T/G) also represents all 20 amino acids however only represents half the number of 
codons [93]. Use of the NNM degeneracy (when M represents aMino nucleotides) 
also represents half the number of possible codons, however, only represents 18 
amino acids and includes 2 termination codons as opposed to 1 with NNK. This 
example represents the first level of minimisation with further reduced alphabets 
allowing higher degrees of coverage whilst simultaneously sacrificing sequence 
space sampled [94, 95].   
Following initial site specific libraries being screened, hits can be subjected to 
multiple rounds of mutagenesis and screening at other positions, known as Iterative 
Saturation Mutagenesis (ISM) [96]. The screening of libraries in a different order 
leads to the possibility of several different pathways to the same mutant e.g. 
XAX/XBX could be accessed by screening library B with XAX as a template or 
screening library A with XBX as a template. It has been demonstrated that the 
relationship between all pathways leading to the same mutant are complex and all 
pathways do not necessarily lead to the same mutant, leading to a whole new layer 
of complexity added to the experiment [97]. 
Combinatorial active site saturation testing (CASTing) is a technique developed to 
maintain reasonably small libraries whilst evolving the active site of the enzyme to 
accept non wild type substrates [98]. In this method, two residues known to be 
important in catalysis and/or substrate binding are randomised to saturation. As 
combinations of positive mutations in more than one position may be additive, 
results from Combinatorial Active Site Saturation Testing (CASTing) experiments on 
multiple pairs of randomised residues could hopefully generate improved 
biocatalysts at a faster rate than screening single site saturation libraries [98]. The 
advantage of CASTing is that active site residues can be systematically screened 
whilst maintaining a more manageable library of only about 3,000 mutants (when 
compared to 160,000 mutants for 4 residues) per mutational round [98]. Since the 
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pairs of residues are located near each other, there is also the potential to find 
some improvements for which some degree of synergy between residues is 
required. This is unlikely in random mutagenesis or single site saturation 
mutagenesis. The repetition of library generation at novel positions using the 
leading candidates as templates has also been demonstrated and described as 
iterative casting [99]. 
Extending the idea of screening multiple positions at the same time leads to the 
multiple mutation reaction (MMR) method of generating libraries which uses 
multiple primers to introduce up to 9 distinct mutations on separate 
oligonucleotides and theoretically more mutations in a single reaction [100]. A 
further extension uses long degenerate oligonucleotides to randomise large 
cassettes within the genome whose positions are selected according to structure 
function information, and which has been demonstrated to be superior in this case 
to EPPCR methods [101]. 
The limitations of EPPCR with respect to saturation mutagenesis are demonstrated 
dramatically in the study of subtilisin, where the saturation mutagenesis of amino 
acids lead to superior increases in thermal stability [92]. It is important to note 
however that these amino acids were identified from EPPCR libraries demonstrating 
that both types of library generation can be accommodated in a successful strategy. 
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Figure 1.18. Generalised Scheme showing a variety of site directed mutagenesis methods of library 
generation. PCR of the gene of interest is performed with degenerate oligonucleotides using high 
fidelity PCR (HFPCR). SSSM, single site saturation mutagenesis; ISM, iterative saturation 
mutagenesis; CASTing, combinatorial active site saturation testing; ICASTing, iterative combinatorial 
active site saturation testing; MMR, multiple mutagenesis reaction. 
1.5.2.4 Library generation statistics 
The most important factor to consider when calculating the statistics describing 
mutagenic library construction is the equation outlined below (Equation 1.1, 
derived from first principles in [102] and [95])  
 
Equation 1.1. Completeness of mutagenic libraries. Pc, the probability of a level of completeness; V, 
maximum degeneracy of the library. 
This equation is compiled in the programme CASTER (an excel worksheet produced 
by the Reetz group) [103]. It is important to note however that all these 
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mathematical treatments make the critical assumption that all possible 
transformations are likely, and that no biological factors are taken into account. 
This simplification is required for the applicability of the treatments, however is not 
always accurate or representative of the true situation [102].   
1.5.2.5 Summary 
Throughout the planning of a protein engineering experiment it is important always 
to consider that you are balancing the coverage/completeness of the library you 
will be screening against the sequence space you are exploring. The extreme 
examples are demonstrated by SSSM libraries where experimentalists can get close 
to complete coverage of a library which represents a tiny proportion of the 
available sequence space. At the opposite extreme full gene random mutagenesis 
approaches allow you to sample a massive amount of sequence space, however a 
vast screening effort is required and it is impossible to approach complete 
coverage. Several factors which influence the decision of which library generation 
approach to use are summarised in Table 1.4. A consideration of when certain 
methods might be appropriate is given in [104]. Recent trends in the field show an 
increase in experiments which merge the random approaches with the focussed 
approaches and lead to the generation of smart focussed libraries. 
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Library generation method 
Sequence 
Space Sampled 
Screening Effort 
Required 
Specificity 
EPPCR Very High Very High None 
Site Directed 
Single Site 
Saturation 
Mutagenesis 
(SSSM) 
Very Low Very Low Very High 
Iterative 
Saturation 
Mutagenesis 
(ISM) 
Low Very Low Very High 
CASTing Low Low High 
Multiple 
Mutagenesis 
Medium Medium/High Medium 
Cassette 
Mutagenesis 
Medium/High High Low 
Table 1.4. Summary of library generation methods including estimates of a number of factors to be 
considered when designing an experiment. 
1.5.3 Library screening  
Following library generation, it is necessary to identify those mutants which have 
acquired novel or improved functionalities. This step mimics the application of 
selective pressure present during natural macro-scale evolution, and can be 
achieved by selective or screening methods. Selective methods work on the 
principle that the desired property of the enzyme can provide an 
advantage/disadvantage to survival under certain conditions. This situation can 
occur naturally or under certain conditions be artificially engineered. Screening 
methods rely on monitoring a property which is proportional to the activity of the 
enzyme, due to the nature of the experiments a lot of experiments are performed 
with few improvements. 
1.5.3.1 Selection 
Selection has been demonstrated to be an excellent method for the isolation of 
clones grown under conditions lethal or growth inhibitory to WT constructs. Only 
clones which reduce the growth inhibitory phenotype are present. This enables 
very large libraries, with library sizes up to 1013 quoted [105], to be assessed easily 
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as only a small fraction of clones grow, growth being indicative of improved 
mutants. 
In vivo selection techniques usually consist of auxotrophic host strains transformed 
with library DNA, in the case of a functional mutant the deficiency in the strain is 
complemented enabling survival. This method is generally applicable to modulating 
the specificity of enzymes and without modification is restricted to situations where 
substrates/products are essential/toxic, for example the rescue of the pyruvate 
auxotrophic E. coli PB25 using 2-Keto-3-deoxy-6-phosphogluconate aldolase mutant 
libraries [106]. Following careful consideration these approaches can be used in 
some cases to engineer other properties such as improvements in 
enantioselectivity, for example the linkage of the desired enantiomer to a 
metabolic precursor (positive selection) and the alternate enantiomer to a toxin 
(negative selection) [107]. This approach has been extended further by the 
development of three hybrid systems where the substrate is responsible for holding 
together a protein complex responsible for activation of transcription. Activity is 
then monitored using the expression of a reporter gene, for example the linkage 
between cephalosporinase activity and the expression of a lacZ reporter gene, 
allowing blue white screening [108, 109]. Variations in the transcription factor and 
reporter gene can lead to tailored selective techniques. 
In vitro selection techniques have largely been exploited by the modification of 
enzyme substrate binding with the intention of changing the enzyme’s affinity 
towards substrate, transition state, inhibitors and product, thus modifying catalysis. 
A number of display technologies, whereby folded proteins are expressed on the 
external surface of the organism and as such are tethered to its genetic material, 
have been demonstrated using phage [110], bacteria [111] and ribosomes [112]. 
Examples include the expression and immobilisation of membrane anchored 
Endoxylanase I mutants [113]. With modification this type of protocol can also be 
used to directly assess catalysis, by displaying both the enzyme and substrate on 
the cellular surface, catalysis can be performed in situ and variants can be selected 
using an antibody with affinity for the product [114].  
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1.5.3.2 Screening 
Screening approaches are by far the most common method of applying selective 
pressure to mutant libraries in order to isolate improved variants [115]. They cover 
a multitude of approaches ranging from agar plate screening at the low end of the 
throughput spectrum, to approaches such as fluorescence activated cell sorting 
(FACS) which are at the limits of what can currently be achieved by screening 
approaches [115]. 
Agar plate screening involves the incubation of libraries on agar plates containing 
the substrate of choice. An important consideration is that the 
substrate/product/by-product/cofactor of the reaction is detectable. Common 
approaches include the use of colorimetric substrates, for example evolving β-
fucosidase activity towards nitrophenyl-β-D-fucopyranoside substrate [116]; 
coloured secondary substrates, for example monitoring the uptake of safranin O in 
response to substrate turnover [117]; pH indicators, for example detection of the 
release of hydrofluoric acid during glycosynthase reactions using methyl red [118] 
or by degrading insoluble components of the media leading to clear zones, for 
example the hydrolysis of agar by agarase [119]. Additional external selective 
conditions can also be applied to agar plates during growth allowing the assay or 
multiple conditions such as temperature and pH [120]. 
Microtitre based methods are widely used in a number of different types of 
experiments but also have implications for the screening of mutagenic libraries. 
Individual library clones are grown in microplates followed by optional purification 
steps, before either being monitored spectrophotometerically, or by alternate 
methods such as gas chromatography (GC). A vast number of possible detection 
methods have been demonstrated for estimating the conversion of substrate to 
product including colour/fluorometric reaction participants, for example the 
characteristic absorbance of NADPH and indigo [121]; colour/fluorometric 
secondary metabolites, for example by the liberation of fluorophores from the 
secondary enzymatic reaction with endocellulase [122]; pH change, for example the 
use of 4-nitrophenol to screen for hydrolase activity [123]; temperature, for 
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example the monitoring using thermistors of temperature change associated with 
β-lactamase activity [124]; metal ion concentration, for example monitoring the 
Cu2+ ion concentration using a metal chelating compound with an orange 
absorbance, when the metal is chelated by the reaction product an orange 
absorbance is detected [125] and HPLC methods, for example monitoring turnover 
of the carbon bond forming reactions of transketolases [126].  
A number of methods have also been described for the estimation of the 
enantiomeric excess of the product by including fluorometric methods, by 
calculating the rates of separate reactions both leading to the release of a 
fluorescent product [127] or mass spectrometry, for example using an isotopically 
labelled enantiomer [128]. Additionally, by relying on the principle of microscopic 
reversibility, often the reverse reaction can be screened with the chiral product 
used as substrate for the reverse reaction [129]. 
A vast quantity of assay methods have been published which are designed or 
adaptable for use in a microplate medium throughput format ranging in complexity 
and applicability (as discussed above). Microplate assays provide an almost 
ubiquitous option for the assay of mutagenic libraries. However, these provide far 
inferior throughput when compared to other techniques. 
Several technologies have been exploited to increase the throughput of microplate 
screening experiments including the use of progressively smaller wells including 384 
and 1,536 microplates and readers, all the way down to performing the reactions in 
1,000,000 well plates [130]. Other groups have demonstrated that mutants can be 
pooled and hits can be sequentially plated and identified, multiplying the screening 
effort several fold [131]. 
FACS is the only screening procedure which can compete with selective methods in 
the throughput stakes with library sizes > 108 often quoted [132]. This approach 
requires the generation and localisation of a fluorescent reporter, for example 
membrane immobilisation [132]. Cells are then sorted on an individual basis by the 
presence or absence of fluorescence by specialised equipment allowing the 
identification of positive hits.  
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1.5.3.3 Summary 
In general a selective approach is far superior to a screening approach as it allows 
the sorting of huge numbers of transformants to find the few positive mutants with 
minimal experimental effort. However at the higher throughput end of screening 
experiments, the number of transformants which can be screened is increasing 
dramatically. However the activity with many substrates does not lead to a 
selectable phenotype, meaning a selective approach is not possible. In some cases 
the selective phenotype can be engineered, however in a lot of cases a screening 
approach is the only one available. 
1.5.4 Example protein properties engineered 
A large number of protein properties have been shown to be evolvable, detailed in 
the following passage are a number of examples which have been reported 
previously. Whilst considering these examples an attempt has been made to 
provide examples of a variety of approaches with respect to library generation and 
assay method.   
1.5.4.1 Thermostability 
The generation of thermostable variants is a common theme for directed evolution. 
Enzymes evolved for an increase in the thermostability often demonstrate an 
increased stability in organic solvents [133] or extremes of pH [120], which is 
particularly of interest for biocatalytic purposes, allowing the utility of enzymes 
under a wider range of conditions.   
Experiments associated with increasing thermal stability tend to adopt a whole 
genome approach to randomisation [119, 120, 133] since there is no ‘active site’ 
associated with thermal stability and residues affecting this property are located 
throughout the enzyme structure. However, in cases where crystallography data is 
available, experimentally derived B factors, which represent the degree of motion 
in the crystallographic model, can be used to guide targeted mutagenesis 
experiments. The programme B-fitter has been developed to identify potential 
hotspots for thermal stability [134]. 
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Potential assay methods used include the application of heat to catalytic reactions, 
for example by application of heat to agar plates [120] and the direct monitoring of 
protein unfolding by a number of methods, for example circular dichroism [135].  
1.5.4.2 Thermolability 
Under certain circumstances, for example where the functional inactivation of an 
enzyme is required, it can be advantageous to engineer a decrease in protein 
stability into an enzyme. Whilst these examples are less frequent, previous 
experiments have included whole gene mutagenesis approaches, such as in the 
evolution of thermolabile transglutaminase [136], and more targeted approaches 
directed by structural knowledge, for example in the evolution of thermolabile 
lipases [137].    
1.5.4.3 Solvent Stability 
The engineering of increased stability of enzyme in a variety of solvents is intended 
to allow access to a greater range of conditions for biocatalysis with respect to 
solvent profile, since it is common for industrial reactions to use organic solvents 
[88]. Enzymes have largely evolved to function in an aqueous environment and a 
substantial subset of enzymes requires water for function. It is therefore not 
surprising that enzymes suffer from instability in the presence of organic solvents. 
As with thermal stability there is no ‘active site’ for solvent stability, hence a large 
number of the experiments take a random approach to library generation, for 
example in the evolution of subtilisin E  to function in dimethylformamide (DMF) 
[88, 133, 138, 139]. It has been noted that the majority of results from these 
experiments, predictably, provide results with mutants in solvent exposed areas. 
However, there is no immediately obvious mechanism for isolating these positions 
in library generation [139]. 
1.5.4.4 pH tolerance 
Another condition limiting the utility of enzymes for industrial biotransformation is 
the often restrictive pH profiles [120]. The evolution of catalysts to function under 
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novel conditions of pH has also been described [120, 140, 141]. These experiments 
were largely carried out using random mutagenesis methods, for example using 
DNA shuffling methods to evolve xylanase B to function under more alkaline 
conditions [120, 140], however structure guided approaches were also used where 
appropriate, such as the use of position scores in the evolution of Sphingomonas 
capsulata prolyl endopeptidases (SCPEP) to function under gastric conditions [140, 
141]. This property also provides an interesting aside giving an example of the 
evolution of a protein to increase its functionality as a therapeutic [141]. 
1.5.4.5 Increase native activity 
Protein engineering approaches have been used frequently for the improvement of 
native activity i.e. the improvement of binding properties or the improvement of 
catalytic rate. These experiments are frequently performed using structural data to 
guide the construction of far more focussed libraries with reduced screening effort. 
Examples are available of random mutagenesis, for example in the improvement of 
the horse heart myoglobin peroxidase activity [142], a combination of random and 
saturation mutagenesis, for example in the improvement of benzoylformate 
decarboxylase carboligase activity [143] and more rational approaches, for example 
the improvement of pyranose-2-oxidase against a range of substrates involved in 
biofuel production [144]. In some cases this involves modifying the balance 
between reaction mechanisms to favour what is normally a by-product, as in the 
case of benzoylformate decarboxylase  [143].  
1.5.4.6 Increase activity towards poor substrate 
One of the most common aims of protein engineering experiments is to widen the 
substrate acceptance of enzymes to accommodate novel substrates. A variety of 
methods have been used to generate libraries for changing substrate acceptance 
ranging from completely random approaches, for example in the evolution of 
adenosine diphosphate (ADP) glucose pyrophosphorylase to accommodate novel 
sugar substrates [145] to site directed approaches, for example in the evolution of 
transketolase to accommodate an aldehyde [146] with combinations of both 
methods also proving effective, for example in the evolution of P450 2A6 to 
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accommodate large indoles [147]. This represents by far the most popular use for 
enzyme evolution currently. 
1.5.4.7 Variation in Stereo/Enantioselectivity 
There have been many studies carried out on screening procedures monitoring the 
improvement of stereo and enantio selectivity of enzyme reactions. These methods 
require the detection of a chiral product or the monitoring of a chiral substrate. 
These experiments are often performed by generating diversity at specific positions 
identified as mechanistically important from structure/functional data, for example 
the modification of the enantiopreference of OYE1 [148]. Often less directed 
approaches are used to garner structural information which then targets positions 
to become the subject of further library generation, for example in the generation 
of stereocomplementary variants of N-acetylneuraminic acid lyase [149]. 
Sometimes more random approaches alone have been demonstrated to be 
efficient, for example in the reversal of enantiopreference in tagatose-1,6-
bisphosphate aldolase [150]. 
One of the major problems encountered with this type of experiment is the 
development of suitable high throughput screens to distinguish between both 
substrate, product(s) and to determine the enantiopurity of product. When 
investigating reactions with alternate chiral substrates, initial efforts require the 
separation of enantiomers or reactions with alternate enantiomers, for example the 
monitoring of rates with chiral compounds in the evolution of Pseudomonas 
aeruginosa lipase [151], the screening for chiral products is discussed previously in 
Section 1.5.3.2. 
A number of studies have suggested reasons for the enantio preference of enzyme 
systems both from experimental results in specific systems, for example the binding 
orientation of various enantiomers [152], and from more general principles, for 
example the principle of mirror image active site as derived from crystal structure 
analysis [153].   
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1.5.4.8 Variation in cofactor specificity 
Rational design approaches have also led to the reorientation of coenzyme 
specificity, for example the realignment of glutathione reductase cofactor 
specificity [71], such results could potentially lead to the ability to replace more 
expensive coenzymes such as NADPH with less expensive alternatives such as 
NADH. 
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2 Materials & methods 
2.1 Materials 
2.1.1 Chemicals & reagents 
Oxygen free nitrogen (OFN) was purchased from BOC. Deoxyribonucleotide 
triphosphates (dNTPs) were purchased from Fermentas. Bromophenol blue sodium 
salt, ethanol (ETOH), ethylenediaminetetraacetic acid (EDTA), glacial acetic acid, 
glycerol, glycine, isopropanol, D-lactose, magnesium sulfate (MgSO4), methanol, 
potassium chloride (KCl), potassium dihydrogen phosphate (KH2PO4), potassium 
hydroxide (KOH), potassium phosphate (K2HPO4), sodium chloride (NaCl), sodium 
dihydrogen phosphate (NaH2PO4), sodium hydroxide (NaOH), sodium phosphate 
(Na2HPO4) were all purchased from Fisher chemicals. Agar, ampicillin, carbenicillin, 
isopropyl β-D-1-thiogalactopyranoside (IPTG), tris base were purchased from 
Formedium. Quant-it dsDNA broad range (BR) reagent, quant-it dsDNA high 
sensitivity (HS) reagent, qubit BR/HS standard #1 (TE buffer, 0 ngµl-1 λ dsDNA), 
qubit BR standard #2 (TE buffer, 100 ngµl-1 λ dsDNA), qubit HS standard #2 (TE 
buffer, 10 ngµl-1 λ dsDNA) were purchased from Invitrogen. Dithiothreitol (DTT), 
magnesium chloride (MgCl2), NADPH, sodium dodecyl sulphate (SDS), D-sorbitol, 
were purchased from Melford. Oligonucleotide primers (as described in Appendix 
1) were purchased from MWG. Complete mini Ethylenediaminetetraacetic acid 
(EDTA) free protease inhibitor cocktail tablets were purchased from Roche. 
Ammonium sulphate ((NH4)2SO4), calcium chloride (CaCl), cinnamonitrile, 
coomassie brilliant blue R250, cyclohexanecarbonitrile, cyclohexanecarboxylic acid, 
CH, cyclohex-1-enecarbonitrile, cyclohex-1-enecarboxylic acid, cyclohex-2-enone, 
cyclopentanone, cyclopent-2-enone, dimethyl sulfoxide (DMSO), ethidium bromide 
(EtBr), hexamine cobalt chloride, hydrochloric acid (HCl), imidazole, manganese 
chloride (MnCl2), 2-mercaptoethanol, 3-methylcyclohexanone, 3-methylcyclohex-2-
enone, 2-methylcyclopentanone, 3-methylcyclopentanone, 2-methylcyclopent-2-
enone, 3-methylcyclopent-2-enone, 2-methyl-3-phenylpropanal, methyl 3-
phenylpropanoate, α-methyl-trans-cinnamaldehyde, methyl-trans-cinnamate, 
mineral oil, nickel sulphate (NiSO4), (n-morpholino) ethane sulfonic acid (MES), PCR 
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grade water, 3-phenylpropanal, 3-phenylpropanenitrile, 3-phenylpropanoic acid, 
potassium acetate, sodium acetate, sodium cacodylate, trans-cinnamaldehyde, 
trans-cinnamic acid, triton x-100 were purchased from Sigma Aldrich. All chemicals 
were of analytical grade or equivalent purity where available. 
2.1.2 Media 
For the production of selective media antibiotic was dissolved to the correct 
concentration, filter sterilised using a 0.2 µM syringe driven filter and added to 
media following autoclaving and cooling (in the case of agar media before 
hardening). For standard growth and purification of plasmid DNA during molecular 
biology protocols all strains were grown in Luria Broth (LB) consisting of 10 gl-1 
tryptone, 5 gl-1 yeast extract, 10 gl-1 NaCl (premixed solid components available 
from Formedium) dissolved in the required volume of ddH2O before autoclaving. In 
order to isolate individual bacterial colonies during molecular biology protocols 
plates of LB agar containing 10 gl-1 tryptone, 5 gl-1 yeast extract, 10 gl-1 NaCl, 15gl-1 
agar (premixed solid components available from Formedium) dissolved in the 
required volume of ddH2O before autoclaving, which following addition of antibiotic 
were poured into Petri dishes. Super optimal broth with catabolite repression (SOC) 
media used during transformation protocols was made by the addition of 20 gl-1 
glucose, 20 gl-1 tryptone, 5 gl-1 yeast extract, 0.5 gl-1 NaCl, 2.44 gl-1 MgSO4, 0.186 gl
-1 
KCl (premixed solid components available from Formedium) dissolved in the 
required volume of ddH2O before autoclaving. Initial purifications of PETNR were 
performed using double yeast tryptone (DYT) broth made by the addition of 16 gl-1 
tryptone, 10 gl-1 yeast extract, 5 gl-1 NaCl (premixed solid components available 
from Formedium) dissolved in the required volume of ddH2O before autoclaving. 
Auto induction library growths were performed using a range of auto induction 
media (AIM) including; DYT AIM containing 16 gl-1 tryptone, 10 gl-1 yeast extract, 3.3 
gl-1 (NH4)2SO4, 6.8 gl
-1 KH2PO4, 7.1 gl
-1 Na2HPO4, 0.5 gl
-1 glucose, 2 gl-1 Lactose, 0.15 
gl-1 MgSO4 (premixed solid components available from Formedium) dissolved in the 
required volume of ddH2O before autoclaving; LB AIM containing 10 gl
-1 tryptone, 5 
gl-1 yeast extract, 3.3 gl-1 (NH4)2SO4, 6.8 gl
-1 KH2PO4, 7.1 gl
-1 Na2HPO4, 0.5 gl
-1 
glucose, 2 gl-1 Lactose, 0.15 gl-1 MgSO4 (premixed solid components available from 
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Formedium) dissolved in the required volume of ddH2O before autoclaving. Super 
broth (SB) AIM containing 35 gl-1 tryptone, 20 gl-1 yeast extract, 3.3 gl-1 (NH4)2SO4, 
6.8 gl-1 KH2PO4, 7.1 gl
-1 Na2HPO4, 0.5 gl
-1 glucose, 2 gl-1 Lactose, 0.15 gl-1 MgSO4 
(premixed solid components available from Formedium) dissolved in the required 
volume of ddH2O before autoclaving; Terrific broth (TB) AIM containing 12 gl
-1 
tryptone, 24 gl-1 yeast extract, 3.3 gl-1 (NH4)2SO4, 6.8 gl
-1 KH2PO4, 7.1 gl
-1 Na2HPO4, 
0.5 gl-1 glucose, 2 gl-1 Lactose, 0.15 gl-1 MgSO4 (premixed solid components available 
from Formedium) dissolved in the required volume of ddH2O before autoclaving;  
2.1.3 Strains 
Escherichia coli strain AVB100 (Avidity) genotype - MC1061, araΔ139, Δ(ara-
leu)7696, Δ(lac)l74, galU, galK, hsdR2, (rΚ-, mΚ+), mcrB1, rpsL (Str
r), birA gene stably 
integrated into the chromosome - was used for the expression and in vivo 
biotinylation of biotin tagged proteins. Escherichia coli strain JM109 (Promega) 
genotype - recA1, endA1, gyrA96, thi-1, hsdR17, (rK–, mK+), supE44, relA1, Δ(lac-
proAB), [F´ traD36, proAB, lacIqZΔM15] - was used for growth/expression of 
recombinant PETNR and mutagenic libraries. Escherichia coli strain XL1 Blue 
(Stratagene) genotype - recA1, endA1, gyrA96, thi-1, hsdR17, supE44, relA1, lac [F´ 
proAB, lacIqZΔM15, Tn10 (Tetr)] - was trialed for the expression of mutant libraries. 
Escherichia coli strain XL10 Gold (Stratagene), genotype - Tetr, Δ(mcrA)183, 
Δ(mcrCB-hsdSMR-mrr)173, endA1, supE44, thi-1, recA1, gyrA96, relA1, lac, Hte [F´ 
proAB, lacIqZΔM15, Tn10 (Tetr) Amy (Camr)] - was used for the replication and 
purification of plasmid DNA during molecular biology protocols. 
2.1.4 Plasmids 
The PETNR was originally cloned into pBluescript SK+ (Stratagene) plasmid. All the 
studies described in this thesis are performed using this construct. 
2.1.5 Markers 
For analytical agarose gel electrophoresis of plasmid DNA the Generuler 1 kbp 
ladder from Fermentas was used. This ladder consisted of DNA fragments from 250 
bp to 1000 bp in 250 bp increments, 1000 bp to 4000 bp in 500 bp increments and 5 
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kbp, 6 kbp, 8 kbp, 10 kbp fragments. For analytical agarose gel electrophoresis of 
plasmid DNA the 1 kbp ladder from NEB was also used. This ladder consisted of 
DNA fragments from 0.5 kbp to 2 kbp in 0.5 kbp increments, from 2 kbp to 6 kbp in 
1 kbp and fragments at 8 kbp and 10 kbp. For analytical agarose gel electrophoresis 
of smaller DNA fragments the Generuler 100 bp Ladder from Fermentas was used. 
This ladder consisted of DNA fragments at from 100 bp to 1000 bp in 100 bp 
increments. For analytical agarose gel electrophoresis of smaller DNA fragments the 
100 bp Ladder from NEB was also used. This ladder consisted of DNA fragments at 
from 100 bp to 1000 bp in 100 bp increments and fragments at 1.2 kbp, 1.5 kbp, 2 
kbp and 3 kbp. For SDS-PAGE analysis of proteins Pageruler plus prestained protein 
ladder purchased from Fermentas was used. This ladder consists of proteins with 
molecular weights of 10 kDa, 17 kDa, 28 kDa, 36 kDa, 55 kDa, 72 kDa, 95 kDa, 130 
kDa, 250 kDa. For SDS-PAGE analysis of proteins low range prestained protein 
ladder purchased from bio-rad was used. This ladder consists of proteins with 
molecular weights of 21 kDa, 29 kDa, 34 kDa, 50 kDa, 77 kDa, 103 kDa. 
2.1.6 Enzymes 
Phusion DNA polymerase was purchased from Finnzymes. Antarctic phosphatase 
(AP), BsmI, T4 polynucleotide kinase (PNK), quick ligase and Taq DNA polymerase 
were purchased from NEB. Benzonase and rLysozyme were purchased from 
Novagen. DNAase and lysozyme were purchased from Sigma Aldrich.  
2.1.7 Consumables 
Biomek aluminium foil seals were purchased from Beckman Coulter. Econopac 10 
DG column and ready gel tris-HCl precast gels (0.375 M Tris-HCl pH 8.8, 2.6 % bis-
acrylimide, 4 % stacking gel, 12 % separating gel) were purchased from Bio-Rad. 
Parafilm and petri dishes were purchased from Fisher. Polypropylene 96 well 
microplates and UV star 96 well microplates were purchased from Greiner. High 
and medium volume robotic tips were purchased from Hamilton. Cloverleaf sitting 
drop crystallography trays and crystallography loops were purchased from 
Hampton. Qubit assay tubes were purchased from Invitrogen. D-Tube dialyser mega 
6-8 kDa MW cut off and HisMag magnetic beads were purchased from Novagen. 
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QIAprep spin column and QIAquick spin column were purchased from Qiagen. 
Tubes (1 ml, 15 ml, and 50 ml) were purchased from Sarstedt. Air permeable 96 
well format seal, thin walled PCR tubes, 96 well deep well blocks, 96 well PCR plate 
and 96 well silicone sealing mat were purchased from Starlabs. Vivaspin 20 spin 
concentrators 10, 30 kDa MW cut off were purchased from Vivascience.  
2.1.8 Equipment 
DB wax analytical GC column was purchased from Agilent. PCR workstation UV 
sterile hood was purchased from Alphalabs. SX18MV stopped flow was purchased 
from Applied Photophysics. Allegra X22R centrifuge, avanti J26-XP centrifuge and 
centrifuge tubes (1 L, 500 ml, 50 ml) were purchased from Beckman Coulter. 
Anaerobic glove boxes were purchased from Belle Technologies. Mini protean tetra 
cell electrophoresis apparatus and powerpac 300 power supply were purchased 
from Biorad. Gen 5 plate reader was purchased from Biotek. UV-50 bio UV–visible 
scanning spectrophotometer was purchased from Cary. JB1 water bath was 
purchased from Grant. Magnetic block and ML-STAR robotics platform were 
purchased from Hamilton. Titramax 1000 incubator was purchased from Heidolph. 
Quartz cuvettes (1 ml, 0.1 ml) were purchased from Hellma. HT incubator was 
purchased from Infors. Qubit fluorometer was purchased from Invitrogen. 
Accublock dry block heater was purchased from Labnet. StarPet E automatic multi-
channel pipette was purchased from Starlabs. UV trans-illuminator was purchased 
from Syngene. TC 512 thermal cycler was purchased from Techne. French press, 
micro CL17 bench top centrifuge and owl B1 electrophoresis apparatus were 
purchased from Thermo Scientific. CP-3800 gas chromatograph with a combiPAL 
auto sampler was purchased from Varian.  
2.1.9 Chromatography 
Q-Sepharose resin (25 ml) was purchased from GE Healthcare. Immobilised 
monomeric avidin (10ml) was purchased from Pierce. Mimetic orange resin (25 ml) 
was purchased from Prometic Biosciences. Nickel-nitrilotriacetic acid (Ni - NTA) 
resin (25 ml) was purchased from Qiagen. Liquid chromatography column (18 ml), 
luer locked, non jacketed was purchased from Sigma Aldrich.  
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2.1.10 Buffers 
2.1.10.1 Gel buffers 
For the analysis of proteins by SDS PAGE; SDS loading buffer (2 ×; 62.5 mM TRIS-
HCl, 2 % SDS, 25 % glycerol, 0.01 % bromophenol blue, 5 % 2-mercaptoethanol pH 
6.8), SDS running buffer (25 mM TRIS-HCl, 192 mM glycine, 0.1 % SDS, pH 8.3 
(unadjusted)), coomassie stain (0.25 % (w/v) Brilliant blue R250, 50 % methanol 
(v/v), 10 % glacial acetic acid and 40 % water), and destain (50 % methanol (v/v), 10 
% glacial acetic acid and 40 % water) were used.  
For the analysis of DNA by agarose gel electrophoresis DNA gel loading buffer (6 ×; 
6 × TAE, 30 % glycerol (v/v), 0.25 % bromophenol blue (w/v)), tris acetate EDTA 
(TAE) buffer (40 mM tris acetate, 1 mM EDTA, pH 8) and DNA gel running buffer (1 × 
TAE, 0.001 % EtBr) were used. 
2.1.10.2 DNA manipulation buffers 
For the preparation of plasmid DNA buffers P1, P2, N3, PB, PE, EB were used from 
the miniprep kit as prepared by Qiagen. For the purification of DNA from an 
agarose gel or a PCR reaction buffers QG, PE, PBI were used as prepared by Qiagen. 
For PCR reactions 5 × Phusion GC buffer as prepared by Finnzymes or 10 × Standard 
Taq Buffer as prepared by NEB were used. For plasmid annealing STE buffer (10 mM 
TRIS-HCl, 50 mM NaCl, 1 mM EDTA, pH 8) was used. For the ligation of DNA 1 × DNA 
Ligase buffer (66 mM TRIS-HCl, 10 mM MgCl2, 1 mM DTT, 1 mM ATP, 7.5 % 
polyethylene glycol 6000, pH 7.6) was used. For restriction digestion reactions NEB 
2 buffer (10 mM TRIS-HCl, 50 mM NaCl, 10 mM MgCl2, 1 mM DTT, pH 7.9) and NEB 
3 buffer (50 mM TRIS-HCl, 100 mM NaCl, 10 mM MgCl2, 1 mM DTT, pH 7) were 
used. For transformation protocols standard transformation buffer (10 mM MES pH 
6.3 with KOH), 100 mM KCl, 45 mM MnCl2, 10 mM CaCl2, 3 mM HACoCl3) and 
Dimethyl sulfoxide (DMSO) and Dithiothreitol (DTT) (DND) (0.9 ml DMSO, 0.153 g 
DTT, 100 µl 1 M Potassium Acetate, pH 7.5 were used. 
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2.1.10.3 Mimetic orange purification buffers 
For the purification of PETNR using mimetic orange mimetic orange loading buffer/ 
equilibration buffer (10 mM potassium phosphate pH 7), and mimetic orange 
elution buffer (50 mM potassium phosphate, 250 mM NaCl, pH 7) were used.  
2.1.10.4 Q-Sepharose purification buffers 
For the purification of PETNR using Q-Sepharose, Q-Sepharose loading buffer (20 
mM TRIS-HCl pH 8), Q-Sepharose low salt elution buffer (20 mM TRIS-HCl, 50 mM 
NaCl, pH 8), Q-Sepharose high salt elution buffer (20 mM TRIS-HCl, 500 mM NaCl, 
pH 8) were used. 
2.1.10.5 Ni - NTA purification buffers 
For the purification of PETNRHis using Ni - NTA agarose, Ni - NTA loading buffer (50 
mM potassium phosphate, 300 mM NaCl, 10 mM imidazole pH 8), Ni - NTA Wash 
buffer 1 (50 mM potassium phosphate, 40 mM imidazole, pH 8), Ni - NTA wash 
buffer 2 (50 mM potassium phosphate, 40 mM imidazole, 0.5 M NaCl pH 8), Ni - 
NTA wash buffer (50 mM potassium phosphate, 300 mM NaCl, 20 mM imidazole, 
pH 8), Ni - NTA elution buffer 1 (50 mM potassium phosphate, 300 mM NaCl, 250 
mM imidazole, pH 8), Ni - NTA elution buffer 2 (50 mM potassium phosphate, 300 
mM NaCl, 500 mM imidazole pH 8) were used. 
2.1.10.6 Monomeric avidin purification buffers 
Phosphate Buffered Saline (PBS; 0.1 M sodium phosphate, 0.15 M sodium chloride 
pH 7), Biotin Elution buffer (2 mM D-biotin in PBS). 
2.1.10.7 Crystallography buffers 
PETNR mother liquor (100 mM sodium cacodylate pH 6.2, 100 mM sodium acetate, 
19 – 24 % PEG 3000, 12 – 18 % isopropanol). 
2.1.10.8 Robotics buffers 
For the robotics protocols a number of buffers were used including PBS, 2 × glycerol 
stock buffer (20 % glycerol in PBS), magnetic bead storage buffer (20 mM  
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potassium phosphate, 150 mM NaCl, 0.1 % triton X-100, pH 7.0), magnetic bead 
charge buffer (50 mM NiSO4), magnetic bead binding buffer (50 mM potassium 
phosphate, 0.3 M NaCl, 5 mM imidazole, 40 % (w/v) sorbitol, pH 7.9), magnetic 
bead strip buffer (20 mM potassium phosphate, 0.5 M NaCl, 100 mM EDTA, pH 7.9), 
magnetic bead lysis buffer (1 × bugbuster, 50 mM potassium phosphate, 100 µg ml-
1 lysozyme, 5 U ml-1 Benzonase, EDTA free protease inhibitor tablets, 100 mM FMN, 
pH 7), magnetic bead equilibration buffer (5 ×) (1.5 M NaCl, 0.2 M imidazole, pH 
7.9), magnetic bead wash buffer (50 mM potassium phosphate, 0.3 M NaCl, 40 mM 
imidazole, pH 7.9), magnetic bead elution buffer (50 mM potassium phosphate, 0.3 
M NaCl, 250 mM imidazole, pH 7) and enzyme dilution/assay/kinetic buffer (50 mM  
potassium phosphate, pH 7). 
  
Materials & Methods 
81 | P a g e  
2.2 Methods 
2.2.1 General DNA methods 
2.2.1.1 DNA agarose gel electrophoresis 
Agarose gel electrophoresis for the separation of DNA fragments was performed 
using an Owl B1 DNA Gel apparatus. Gels were made by boiling 0.6 - 1.5 % (w/v) 
agarose in 1 × TAE buffer followed by the addition of 0.001 % Ethidium Bromide 
(EtBr) (v/v). The gel was poured into the casting apparatus and a comb was added 
to generate sample loading wells. Samples were prepared by DNA gel loading buffer 
to 1 ×, and were loaded into the wells. The gel was covered with 1 × TAE buffer and 
run at 100 v (constant voltage) for 45 - 60 min, dependent on the concentration of 
agarose and size of the gel. 
2.2.1.2 Plasmid DNA purification (miniprep) 
For the miniprep of plasmid DNA buffers P1, P2, N3, PB, PE, EB were used from the 
miniprep kit as prepared by Qiagen. E. coli containing the desired plasmid was 
grown in LB medium (5 ml) containing 100 µg ml-1 ampicillin at 37 ˚C with 200 rpm 
shaking using a glycerol stock as the inoculum. Cultures were harvested by 
centrifugation at 13,300 g and the pellet was resuspended in 250 µl of Buffer P1. 
Buffer P2 (250 µl), containing LyseBlue (1 µl ml-1), was added and gently mixed to 
lyse the cells. Lysate was neutralised and protein precipitated by the addition of 
350 µl of Buffer N3. The lysate was centrifuged at 13300 g for 10 min to pellet the 
precipitated cell debris and precipitated protein/SDS. The clarified supernatant was 
applied to the QIAprep spin column and centrifuged at 13300 g for 1 min to allow 
the DNA to bind and the supernatant was discarded. The column was washed with 
0.5 ml PB buffer followed by 0.75 ml PE buffer with intermediate centrifugation 
steps at 13300 g for 1 min. An additional centrifugation step was included after 
supernatant removal to ensure complete removal of residual ethanol. Plasmid DNA 
was eluted into a sterile 1 ml tube with 50 µl EB buffer, allowed to stand for 1 m 
before being centrifuged  at 13300 g for 1 min. Plasmid DNA was stored at -80 ˚c 
until required.  
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2.2.1.3 Gel purification 
For the gel purification of plasmid DNA buffers QG, PE, EB were used from the gel 
purification kit as prepared by Qiagen.DNA bands of interest in agarose gels were 
excised using a scalpel whilst the gel was visualised using a UV trans-illuminator. 
The excised fragment was weighed and solubilised in 3 volumes (w/v) of buffer QG 
and incubated at 50 ˚C for 10 min until completely soluble. Isopropanol was added 
until equivalent in volume to the mass of the excised fragment and the solution was 
applied to a QIAquick column and centrifuged at 13300 g for 1 min. The column was 
washed with 500 µl QG buffer then 750 µl PE buffer with centrifugation at 13300 g 
for 1 min and supernatant removal after each step. An additional centrifugation 
step was included after supernatant removal to ensure complete removal of 
residual ethanol. The DNA was eluted into a sterile 1 ml tube with 50 µl EB buffer, 
allowed to stand for 1 min before being centrifuged at 13300 g for 1 min.  
2.2.1.4 DNA quantitation (Qubit) 
Plasmid DNA was quantified using a Qubit fluorometer in conjunction with the 
Qubit dsDNA BR or HS assay kit. The following method describes the procedure for 
the BR kit. The method for the more sensitive HS kit was identical except for the 
substitution of the appropriate reagents/buffers/standards. All reagents and 
buffers were equilibrated at room temperature before use. The 200 × fluorescent 
dye was diluted to 1 × in the dilution reagent and aliquoted into clear 500 µl 
reaction tubes to a volume of 200 µl minus DNA volume (1 – 20 µl). Standards (10 µl 
aliquots of 0 ng µl-1 and 100 ng µl-1) were added to the calibration tubes and 1-20 µl 
of sample DNA was added to the remaining sample tubes. All tubes were mixed by 
vortexing before incubation at room temperature for 5 min. The Qubit Fluorometer 
was calibrated using the standard reactions, before reading the sample DNA Q 
values. Final dsDNA concentration was calculated using the equation below 
(Equation 2.1). 
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Equation 2.1. Calculation to derive the concentration of dsDNA using the Qubit quantitation method. 
Q is the experimentally derived parameter. Final concentration is in the same units as Q, which is 
included in the output from the fluorometer.    
2.2.1.5 Sequencing reactions 
Sequencing of experimentally derived DNA was performed by Eurofins MWG 
operon. Samples were processed using the value read tube service grade. Samples 
were prepared to a concentration of 75 ng µl-1 to a minimum volume of 15 µl with 
sterile water. Sequencing could be performed from standard or from custom 
synthesised oligonucleotides, details of which are included in Appendix 1. Results 
were aligned using the Clustal online tool (European Bioinformatics Institute, EBI). 
2.2.1.6 Phusion PCR 
PCR reactions were carried out in thin walled PCR tubes according to the standard 
reaction with Phusion DNA polymerase configuration detailed below (Table 2.1). 
Reactions were performed in a total volume of 50 µl using sterile PCR grade water. 
PCR reactions were performed using standard cycling parameters detailed below 
(Table 2.2) unless otherwise stated. Oligonucleotide primers were designed to have 
a Tm ~5 - 10 ˚C above the annealing temperature and were analysed for the 
presence of undesirable secondary structure using mfold (Integrated DNA 
technologies, IDT). Primers were synthesised by Eurofins MWG operon. 
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Component Final concentration 
5× Phusion GC buffer 1 × 
dNTP (dATP, dTTP, dGTP, 
dCTP) 
200 µM (Each) 
Primers 0.5 µM (Each) 
PETNRHis template DNA 1 ng µl-1 
Phusion DNA Polymerase 0.02 U µl-1 
Water Up to 50 µl 
Fig 2.1. Composition of reaction mixture of standard Phusion PCR reactions.  
Temperature (˚C) Time (s) Cycles (×) 
98 120 1 
98 10 
20 
72 90 
72 300 1 
Table 2.2. Reaction cycles of standard Phusion PCR reactions.  
2.2.1.7 Taq PCR 
PCR reactions were carried out in thin walled PCR tubes according to the standard 
reaction with Taq DNA polymerase configuration detailed below (Table 2.3). 
Reactions were performed in a total volume of 50 µl using sterile PCR grade water. 
PCR reactions were performed using standard cycling parameters detailed below 
(Table 2.4) unless otherwise stated. Oligonucleotide primers were designed as 
discussed in section 2.2.1.6. 
Component Final concentration 
10× standard Taq buffer 1 × 
dNTP (dATP, dTTP, dGTP, 
dCTP) 
0.2 mM (Each dNTP) 
Primers 0.2 µM (Each primer) 
PETNR template DNA 1 µl lysate 
Taq DNA Polymerase 0.025 U µl-1 
Table 2.3. Composition of reaction mixture of standard Taq PCR reactions.   
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Temperature (˚C) Time (s) Cycles (×) 
94 120 1 
94 15 
35 54 30 
68 30 
68 120 1 
Table 2.4. Reaction cycles of standard Taq PCR reactions.  
2.2.1.8 Kod PCR 
PCR reactions were carried out in thin walled PCR tubes according to the standard 
reaction with Kod DNA polymerase configuration detailed below (Table 2.5). 
Reactions were performed in a total volume of 50 µl using sterile PCR grade water. 
PCR reactions were performed using standard cycling parameters detailed below 
(Table 2.6) unless otherwise stated. Oligonucleotide primers were designed as 
discussed in section 2.2.1.6. 
Component Final concentration 
10× Kod buffer 1 × 
MgCl2 1.5 mM 
dNTP (dATP, dTTP, dGTP, 
dCTP) 
0.2 mM (Each dNTP) 
Primers 0.4 µM (Each primer) 
Template DNA 0.2 ng µl-1 
Kod DNA Polymerase 0.02 U µl-1 
Fig 2.5. Composition of reaction mixture of standard Kod PCR reactions.  
Temperature (˚C) Time (s) Cycles (×) 
95 120 1 
95 20 
20 65 10 
70 100 
Fig 2.6. Reaction cycles of standard Kod PCR reactions.  
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2.2.1.9 DpnI digestion 
To increase the fraction of PCR products before transformation into E. Coli, 
template (miniprep) DNA was digested with DpnI at 0.4 U µl-1 for 1 h at 37 ˚C. The 
restriction enzyme DpnI is specific for methylated DNA and so is only able to cut 
paternal DNA not PCR product. 
2.2.1.10 PCR purification 
To facilitate the clean-up of PCR reactions not analysed by electrophoresis, the 
Qiagen PCR purification kit was used according to the manufacturer’s protocol. The 
PCR product was added to 5 equivalent volumes of PBI buffer, and centrifuged in a 
QIAquick spin column at 13300 g for 1 min. The column was washed with 750 µl PE 
buffer, and the centrifugation step was repeated to remove residual ethanol. The 
DNA was then eluted into a sterile 1 ml tube with 50 µl EB, allowed to stand for 1 
min before being centrifuged at 13300 g for 1 min. 
2.2.1.11 Oligonucleotide annealing  
Complementary pairs of oligonucleotides (400 nM each) were mixed in STE buffer 
and overlaid with sterile mineral oil to prevent evaporation. The pairs of 
oligonucleotides were re-annealed by heating to 94 °C in a dry block heater 
followed by slow cooling to room temperature over a 90 min period with the dry 
block removed from the heat.  
2.2.1.12 Oligonucleotide phosphorylation 
The pairs of primers to be annealed were phosphorylated separately using T4 
Polynucleotide Kinase (PNK) at 37 ˚C for 30 min.  The reaction mixture was 
composed of 1 × DNA Ligase buffer 120 nM of each of the annealed primers and 10 
U PNK.  
2.2.1.13 Plasmid digestion using BsmI  
Plasmid was digested in a 50 µl reaction with the restriction enzyme BsmI. The 
reaction mixture was composed of 1 × NEB 2 buffer, ~180 µg ml-1 plasmid DNA and 
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10 U of BsmI. The mixture was covered with a layer of sterile mineral oil, to prevent 
evaporation, and incubated at 65 °C for 12 h. 
2.2.1.14 Dephosphorylation of digested plasmid 
The dephosphorylation reaction was catalysed by the enzyme Antarctic 
phosphatase (AP). The 50 µl reaction mixture was composed of 1 × NEB 3 buffer, ~ 
100 µg ml-1 digested plasmid DNA and 10 U of AP. The reaction was incubated at 37 
˚C for 15 min. 
2.2.1.15 DNA ligation 
The ligation reaction was carried out according to the standard protocol for quick 
ligase.  The 10 µl reaction mixture was composed of 1 × DNA Ligase buffer, ~50 ng 
digested plasmid DNA, and ~ 150-300 ng phosphorylated DNA insert and 1 µl of 
Quick Ligation enzyme. The reaction was incubated at room temperature for 5 min 
before placing on ice. 
2.2.1.16 Generation of competent E. coli 
An overnight starter culture growth (10 ml) in LB medium of the E. coli strain 
AVB100 was grown at 37 ˚C with shaking at 200 rpm. These were used as an 
inoculum for 100 ml LB growth, to OD550 = 0.5, under the same conditions. Cells 
were incubated on ice for 15 min before being centrifuged at 3900 g at 4 ˚c for 15 
min and the supernatant discarded. The cell pellet was resuspended in 25 ml 
standard transformation buffer (TFB). Cells were centrifuged at 3900 g at 4 ˚C for 15 
min and resuspended in 25 ml TFB 3 times, before finally being resuspended in 4 ml 
TFB and frozen at -80 ˚C.  
2.2.1.17 Pre-treatment of competent cells 
The protocol for the pre-treatment of competent cells varies according to cell type. 
For AVB 100 7 µl of DMSO and DTT (DND) was added to 200 µl of the pre-treated 
cells and incubated on ice for 10 min, a second addition of DND gives a final 
concentration of 7 % (v/v). Following this addition the cells were incubated for 20 
min. In the case of XL10 Gold 4 µl of the included 2-mercaptoethanol mix was 
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added to 100 µl of cells, the mixture was then incubated on ice for 10 min with 
mixing every 2 min.  
2.2.1.18 Transformation of competent cells 
In the case of JM109 no pre-treatment was required. Following appropriate pre-
treatment 50 ng of plasmid DNA was added to the aliquots of cells, the 
transformation reaction was mixed by flicking the tube gently. Reactions were 
incubated on ice for 10 min before a heat shock of 50 s at 42 ˚C, following heat 
shock transformations were incubated on ice for 2 min. 900 µl SOC was then added 
and the reactions were incubated at 37 ˚C, 225 rpm. Transformants were then 
plated at a range of concentrations on selective plates. 
2.2.1.19 Small scale lysis method for Colony Pick PCR (CPPCR) 
Individual colonies of clones of interest grown in selective LB agar were picked and 
inoculated into 5 ml of LB media containing 100 µg ml-1 ampicillin. These colonies 
were grown at 37 ˚C, 180 rpm for 12 h. Glycerol stocks were produced by 
combining 0.5 ml of the culture with an equal volume of glycerol stock buffer. 
Stocks were frozen on dry ice, and stored at -80 ˚C. The remaining cells were 
harvested by centrifugation at 1000 g for 1 min and the supernatant was discarded.  
The pellet was resuspended in 50 μl of sterile water and boiled for 5 min at 100 ˚C 
to lyse the cells. The extracts were centrifuged at 1000 g for 1 min and the 
supernatant was transferred to clean sterile reaction tubes for use in PCR reactions.   
2.2.2 General protein methods 
2.2.2.1 SDS PAGE 
SDS PAGE analysis was performed using Bio-Rad ready gel Tris-HCl precast gels with 
standard SDS running buffer. Samples were prepared by addition of equal volumes 
of sample and 2 × SDS buffer and boiled at 95 ˚C for 5 min. The gel was run for 45 
min at 180 V (constant voltage). Once running was complete the gel was removed 
from the tank and extracted from the casing. This was incubated with shaking in 
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coomassie stain for 3-4 h followed by incubation with destain until bands are 
visible. 
2.2.3 General analytical methods 
2.2.3.1 Anaerobic methods 
2.2.3.1.1 Preparation of anaerobic buffers/reaction components 
Anaerobic buffers were prepared by bubbling solutions with oxygen free nitrogen 
(OFN) at 2 bar for ~30 - 60 min. Buffers were placed inside the glove box and left 
exposed to the OFN (at < 5 ppm O2) for at least 12 hours prior to use. 
Substrates were dissolved in anaerobic solvents and/or buffer solutions within an 
anaerobic glove box. 
2.2.3.1.2 Preparation of anaerobic enzyme solutions 
Traces of oxygen in the enzyme solution were removed by passing oxidised enzyme 
solution through a Bio-Rad Econopac 10 DG column pre-equilibrated with anaerobic 
buffer. Yellow fractions were collected and the concentration of enzyme was 
determined using the extinction co-efficient of ε464 = 11,300 M
-1 cm-1.  
2.2.3.1.3 Preparation of chemically reduced enzyme 
In order to study the oxidative half reaction of PETNR in single turnover 
experiments pre-reduced enzyme is required. Reduced enzyme was generated from 
the reductive titration of PETNR in an anaerobic cuvette sealed with a size 13 
Subaseal, sodium dithionite was added using a 25 µl Hamilton syringe, with the 
flavin absorbance monitored spectrophotometrically. 
2.2.3.1.4 Anaerobic steady state/single turnover assays 
Anaerobic assays were performed within an anaerobic glove box (Belle technology) 
to prevent the re-oxidation of the reduced enzyme by molecular oxygen. The 
anaerobic atmosphere (< 5 ppm oxygen) was maintained using an atmosphere of 
OFN combined with external gas cycling and oxygen removing catalysts.  
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2.2.3.2 Spectrophotometric steady state assays 
Steady state analyses of enzyme variants were performed on a Cary UV-50 Bio UV–
visible scanning spectrophotometer using a 1 ml quartz cuvette (Hellma) housed in 
a Belle technology anaerobic glove box. Reactions (1 ml) were composed of kinetic 
buffer pH 7 containing 0 - 1 mM NADPH, 0 - 5 µM PETNR and 0 - 50 mM oxidative 
substrate. The reaction was usually initiated by addition of the oxidative substrate 
and A340/365 (characteristic absorbance of NADPH) was monitored continuously. 
Initial rates were determined using Cary WinUV software and fitted to the Michaelis 
Menten steady state kinetic equations (Equations 2.2 and 2.3) using Origin 7 
software. 
 
Equation 2.2. Michaelis Menten equation describing the relating of the initial rate of reaction with 
the concentration of substrate under standard conditions. v0 represents the initial rate, [S] is the 
substrate concentration, vmax represents the maximal rate under a set of conditions and KM is the 
Michaelis constant.  
 
Equation 2.3. Michaelis Menten equation describing the relating of the initial rate of reaction with 
the concentration of substrate under conditions of substrate inhibition. v0 represents the initial rate, 
[S] is the substrate concentration, vmax represents the maximal rate under a set of conditions, KM is 
the Michaelis constant and Ki is the inhibition constant. 
2.2.3.3 Stopped flow pre steady state assays 
Data were recorded on an Applied Photophysics SX18MV stopped flow housed in a 
Belle technology anaerobic glove box. Concentrated (2 x) solutions of enzyme and 
substrate were added to the syringes of the stopped flow apparatus. Solutions were 
injected into the measurement cell by firing the pressurised drive syringe. Data 
were recorded using the single wavelength detection module set to 464 nm to 
monitor FMN reduction/oxidation. Exponential curves were fitted to a single 
exponential expression (Equation 2.4) using spectra kinetics software from Applied 
Materials & Methods 
91 | P a g e  
Photophysics. These data were then plotted in Origin 7 and fitted to the Strickland 
equation (Equation 2.5, [154]).  
 
Equation 2.4. Single exponential equation for determining kobs experimentally derived absorbance 
changes. is the observed absorbance change,  is the amplitude, is the observed rate 
and t is the time. 
 
Equation 2.5. Strickland equation for the analysis of single turnover kinetic results.  is the 
observed rate from equation 2.4,  is the limiting rate constant for reduction and  is the 
dissociation constant. 
2.2.3.4 Plate reader kinetics 
Plate reader steady-state analysis was performed in a Biotek Gen 5 plate reader, 96 
well microtitre plates were used in the place of individual cuvettes.  Reactions were 
monitored in the UV region of the spectrum (340 nm) therefore, UV transparent 96 
well microplates were used (Greiner, UV-star). Wavelength was determined using 
the plate reader monochromator. For reactions monitored in the visible wavelength 
spectrum, standard polypropylene 96 well microplates were used (Greiner).  
Reactions (300 μl volume) were composed of anaerobic kinetic buffer containing 0 - 
1 mM NADPH, 0 - 5 µM PETNR and 0 - 50 mM substrate. The reaction was initiated 
by the addition of the oxidative substrate followed by a 10 cycles of mixing with the 
pipette at maximum available speed. After allowing 10 s for the surface of the well 
to settle following mixing, the kinetic transient in 1 s intervals was monitored at 340 
nm to follow the oxidation of the cofactor. Initial rates were derived from numbers 
exported by Biotek Gen 5 software using excels ‘SLOPE’ function and fitted to the 
appropriate Michalis Menten steady state kinetic equations using Origin 7 
(Equation 2.2 and 2.3). 
2.2.3.5 GC reactions 
2.2.3.5.1 Reaction conditions 
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Reactions (1 ml) were composed of assay buffer containing 5 % ethanol, 5 mM 
oxidative substrate, 6 mM NADPH and 2 µM enzyme. Reactions were prepared in 2 
ml vials under anaerobic conditions and sealed with parafilm before being 
incubated at 37 ˚C for 4 - 24 h with shaking at 200 rpm.    
2.2.3.5.2 Solvent extraction 
Products were extracted in ethyl acetate (900 µl) containing 0.5 % (v/v) limonene, 
the latter acting as an internal standard for GC. The phases were mixed vigorously 
by inversion and vortexing repeatedly, followed by centrifugation at 13300 g for 5 
min. This enabled the phases to separate and 700 µl of the solvent phase was 
removed and transferred to glass vials.  
Substrates containing carboxylic acid functionalities required further treatment 
entailing acidification prior to extraction by the addition of 50 µl of 1 M HCl. Once 
extraction was completed methylation reaction was performed by the addition of 
200 µl methanol and 10 µl 2 M trimethylsllyldiazomethane in hexane, followed by 
incubation in a fume hood at room temperature for 10 min. Excess catalyst was 
inactivated by addition of 5 µl glacial acetic acid. 
2.2.3.5.3 Quantitative GC 
Quantitative detection of products was performed on a Varian CP-3800 gas 
chromatograph with a CombiPAL auto sampler using a DB-Wax column (30 m, 0.25 
mm). Samples were vaporized using a split injector in a ratio and loaded onto the 
capillary column using a stream of helium (BOC) carrier gas. Samples were analyzed 
using temperature methods as detailed in table 2.7 consisting of a pause at a lower 
start temperature, before a temperature ramping segment, followed by a pause at 
a higher finishing temperature. Eluted compounds were detected using the Flame 
Ionization Detector (FID). 
Substrate and product peaks were processed using star chromatography 
workstation software (Varian) and identified by comparison with verified authentic 
standards. Conversion and yield values were calculated from integration of the 
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peaks according to equation 2.6, 2.7 and 2.8, which takes into account calibration 
curves of each substrate product mixture. 
 
 
Equation 2.6. Calculations used to derive concentrations of substrate and product used for 
quantitative GC. Concentrations derived from these calculations were used to determine conversion 
(%) of substrate and yield (%) of product.  
 
Equation 2.7. Calculation used to derive a value for conversion of substrate in biotransformation 
assays. 
 
Equation 2.8. Calculation used to derive a value for yield of product in biotransformation assays. 
2.2.3.5.4 Chiral GC 
Quantification of the enantiomeric excess (e.e.) from biotransformation reactions 
was performed on a Varian CP-3800 gas chromatograph with a CombiPAL auto 
sampler using a CP Chirasil DEX CB column (25 m, 0.32 mm, 0.25 µm film). Samples 
were vaporized, run and analysed as described previously (Section 2.2.3.5.3). Peaks 
were integrated and identified by comparison with authentic chiral standards e.e. 
was calculated from equation 2.9. 
 
Equation 2.9. Calculation used to determine enantiomeric excess of biotransformation assays.   
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Analyate 
Split injector 
ratio (1:x) 
Flow rate 
(ml min-1) 
Injector 
temp (˚C) 
Start Temp 
(˚C) 
Start Temp 
Hold (min) 
End Temp 
(˚C) 
End Temp 
Hold (min) 
Temp 
ramping 
(˚C/min) 
Detector 
temp (˚C) 
2-Cyclohexenone 20 1 220 40 10 200 1 20 250 
Trans-cinnamic acid 20 1.7 250 100 2 230 3 20 250 
Cinnamonitrile 20 1 250 100 2 240 3 20 250 
1-Cyclohexene-1-
carboxylic acid 
20 1 220 60 5 200 1 20 250 
Cyclohexene-1-
carbonitrile 
20 1 220 60 5 200 1 20 250 
Trans-
cinnamaldehyde 
20 1 250 100 2 200 2 20 250 
α-Methyl-trans-
cinnamaldehyde 
20 2 250 100 2 220 2 20 250 
α-Methyl-trans-
cinnamaldehyde (Chiral) 
100 3 250 90 30 180 1 20 250 
methyl trans-
cinnamate 
20 1.7 250 100 2 200 2 20 250 
3-Methyl-2-
cyclohexenone 
20 1 220 40 10 200 1 20 250 
2-Methyl-2-
cyclopentenone 
20 1 220 70 10 200 2 20 250 
2-Methyl-2-
cyclopentenone (Chiral) 
100 2.5 250 50 25 180 1 20 250 
3-Methyl-2-
cyclopentenone 
20 1 220 40 10 200 3 15 250 
Table 2.7. Temperature methods used to analyze conversion and yield of biotransformation reactions with mutant PETNR. Chiral methods are highlighted in grey. 
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2.2.3.6 Protein crystallography 
2.2.3.6.1 Crystal growth 
PETNR crystals were grown using the sitting drop method in crystallography trays. 
The enzyme crystallised in drops composed of 2 µl enzyme solution (7 mg ml-1) and 
2 µl mother liquor with 1 ml of the latter reagents located in the central wells of the 
tray. Drops were covered with crystallography tape and incubated at 20 ˚C for 2 - 5 
days. Crystals were mounted in standard crystallography loops in the absence of 
additional cryoprotectant and frozen in liquid nitrogen 
2.2.3.6.2 Collection of diffraction data 
A full PETNRHis (1.4 Å) x-ray diffraction dataset was collected from a single crystal at 
the European Synchrotron Radiation Facility (ESRF; Grenoble, France) on station ID 
14.4 (wavelength 1.07 Å; 100K) using an ADSC CCD detector. 
2.2.3.6.3 Model generation 
Crystallographic data sets were processed and scaled using the programmes 
MOSFLM [155] and Scala [156]. The structures were solved via molecular 
replacement using the coordinates for the acetate bound PETNR reductase (PDB 
1H50 [40]). Model rebuilding and water addition was performed automatically 
using REFMAC5 [156] combined with ARP/warp [157]. Positional and anisotropic B-
factor refinement was performed using REFMAC5 [156], (hydrogens included in the 
refinement) with alternate rounds of manual rebuilding of the model in coot [158]. 
2.2.4 Thesis specific methods 
2.2.4.1 Wild type PETNR (PETNRWT) purification 
PETNR was purified from the E. coli strain JM109 expressing the PETNR gene from a 
pBluescriptII SK+ plasmid under the control of an IPTG inducible promoter. Starter 
cultures (5 ml then 100 ml LB) containing 100 µg ml-1 ampicillin were grown from a 
glycerol stock at 37 ˚C mixing at 180 rpm for 12 h. Larger scale cultures (1 – 12 L) of 
Double yeast tryptone (DYT) medium containing 100 µg ml-1 ampicillin were 
inoculated from the starters and grown at 37 °C mixing at 180 rpm until they 
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reached an OD600 of 0.7. Protein expression was induced by IPTG addition to a final 
concentration of 0.4 mM followed by growth at 37 ˚C mixing at 180 rpm for 12 h. 
Alternatively cells were grown at 37 ˚C mixing at 180 rpm for 18 h in TBAIM 
containing 100 µg ml-1 ampicillin.  
Cells were harvested by centrifugation at 7,000 g at 4 ˚C for 20 min.  The pellet was 
re-suspended in Mimetic Orange loading buffer (50 mM potassium phosphate pH 7) 
to a concentration of 1 g ml-1. A small amount of lysozyme and DNAase were added 
to the cell slurry to initiate cell lysis and DNA degradation, the latter of which was 
essential for decreasing the viscosity of the slurry. An EDTA free protease inhibitor 
tablet (Roche) containing a cocktail of protease inhibitors was added to prevent 
degradation of the expressed protein by cellular proteases. Further cell lysis was 
achieved by passing the enzyme repeatedly through a french press at 4 ˚C. The cell 
lysate was spun at 20,000 g at 4 ˚C for 20 min, and the supernatant was retained. 
The extract was dialysed into 12 L Mimetic Orange loading buffer using 10 kDa MW 
cut off dialysis tubing at 4 ˚C. 
The dialysed extract was applied to a 25 ml mimetic orange column, pre-
equilibrated with 500 ml Mimetic Orange loading buffer. The column was washed 
with 500 ml equilibration buffer followed by enzyme elution in Mimetic Orange 
elution buffer (50 mM potassium phosphate, 250 mM NaCl, pH 7). PETNR 
containing fractions were pooled and dialysed using 12 L Q-Sepharose loading 
buffer (20 mM TRIS-HCl buffer pH 8) using 10 kDa MW cut off dialysis tubing at 4˚C. 
Dialysed eluates were concentrated on a Vivaspin 20 (Vivascience) spin filter with a 
30 kDa MW cut off at 3000 g at 4 ˚C. 
PETNR was further purified by application to a 25 ml Q-Sepharose column pre-
equilibrated with 500 ml Q-Sepharose loading buffer. The column was washed with 
500 ml loading buffer followed by enzyme elution using a gradient of 50 to 500 mM 
NaCl in 20 mM TRIS-HCl buffer pH 8.  
Purified PETNR was defined as having an A280:A464 ≤ 10 as well as a single band on 
SDS PAGE. Active fractions were pooled and dialysed into kinetic buffer and 
concentrated using 10 kDa MW cut off vivaspin concentrator at 3000 g at 4 ˚C. 
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Protein (~14 mg ml-1) was frozen in small aliquots in liquid nitrogen and stored at -
80 ˚C. 
2.2.4.2 His tagged PETNR (PETNRHis) generation 
Due to the nature of the PETNR construct, enzyme was expressed at very high levels 
(~50 mg L-1). In order to maintain the high levels of expression the His tag was 
added in the same vector to the 3’ end of the gene. Addition of a His tag required 
the insertion of 15 bp, CATCATCACCATCACCAT, to the gene in a multi-step PCR 
method. The mutation was located at the 5’ or the 3’ end of the two non-
complementary primers which anneal flanking the insertion site, just before the 
PETNRWT STOP codon. The sequence to be included was included as a tail at 
opposite ends of each primer. This resulted in the generation of the tagged enzyme 
construct with staggered nicks. A graphical summary of the first PCR reaction is 
shown in Fig 2.1. 
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Fig 2.1. Summary of His tag addition to PETNR, top image shows the binding of the oligonucleotide 
primers to either side of the insertion site (selected nucleotides are labelled), arrows indicate the 
direction of DNA synthesis from the primer. The Hisx tag sequence is derived from the 3’ and 5’ 
overhangs, and the resulting nicked plasmid is shown in the lower part of the figure. The first PCR 
reaction is represented in the figure, the second reaction is performed along similar principles, 
however the existing part of the tag from the first reaction is included in the primers. 
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Incorporation of the His tag to PETNR was performed in 2 reactions. The primers, 
named His3T and His6T, for these PCR reactions are detailed in Appendix 1. 
Concentrations for the PCR reaction and cycling parameters are detailed in Section 
2.2.1.6.  
The final PCR product was gel purified according to Section 2.2.1.3 and transformed 
into XL10 Gold E. coli according to the protocol in Section 2.2.1.17 and 2.2.1.18. 
Resulting colonies were screened for the presence of the His tag by colony pick PCR, 
according to the method in Section 2.2.1.7 and 2.2.1.19, and sequenced, Section 
2.2.1.5, to confirm the identity. 
2.2.4.3 Biotin Tagged PETNR (PETNRBio) generation 
Immobilisation using the biotin method required the addition of a 45 bp insert 
(GGCCTGAACGATATTTTTGAAGCGCAGAAAATTGAATGGCATGAA) corresponding to a 
15 amino acid recognition sequence (GLNDIFEAQKIEWHE). This is the recognition 
sequence for the enzyme Biotin Ligase to covalently attach a biotin molecule on the 
highlighted K residue of the sequence. 
In order to incorporate the biotin tag, 2 pairs of oligonucleotides Bio3 and 5, 
sequences of which are detailed in Appendix 1, were annealed separately according 
to the protocol discussed in Section 2.2.1.11. These oligos, when assembled, 
encode the biotin ligase recognition sequence including complementary ends. 
Annealed oligonucleotide pairs were then phosphorylated to enable joining of the 
sequences according to the protocol in Section 2.2.1.12. Also prepared was a gel 
purified BsmI digested PETNR construct, according to the protocols in Section 
2.2.1.3 and 2.2.1.13, which was subsequently dephosphorylated to prevent 
religation without the insert, Section 2.2.1.14. The half inserts and the digested 
PETNR were ligated together, according to the method in Section 2.2.1.15, to give 
the final PETNRBio construct. A simplified graphical representation is given below in 
Figure 2.2. 
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Fig 2.2. Summary of biotin tag (biotin ligase recognition sequence) addition to PETNR, The top image 
illustrates the mixing of complementary pairs of primers, these were then heated and cooled slowly 
to anneal correctly as shown in the second image, the final image shows the incorporation of 
annealed oligonucleotide cassette into the BsmI digested vector ready for ligation.  
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Following the ligation into the vector, clones which have potentially taken up the 
tag were detected by colony pick PCR, according to the methods discussed in 
Section 2.2.1.8 and 2.2.1.19, and sequenced, Section 2.2.1.5, to confirm the 
identity. 
2.2.4.4 Ni - NTA batch purification 
PETNRHis was purified from the E. coli strain JM109 expressing the PETNRHis gene 
construct from the same plasmid as the wild type. Cultures, 5 ml then 100 ml, were 
inoculated from a glycerol stock into TBAIM containing 100 µg ml-1 ampicillin and 
grown at 37 ˚C mixing at 180 rpm for 18 h. Cells were then harvested by 
centrifugation at 7,000 g for 20 min. Cell lysis was performed in Ni - NTA loading 
buffer as for the wild type enzyme (Section 2.2.4.1). The lysate was clarified at 
20,000 g at 4 ˚C for 20 min. Clarified lysate (1 ml) was added to a 1.5 ml tube 
containing the 250 µl of 50 % Ni - NTA agarose beads. The beads were agitated for 1 
min then centrifuged at 13,300 g at 4 ˚C for 1 min. The supernatant was discarded 
and the loading steps were repeated until the desired quantity of PETNR was bound 
to the resin. Beads were split into equal aliquots and washed with either 3 × 1.5 ml 
Wash buffer 1 or wash buffer 2. Elution was performed sequentially with 300 µl 50 
mM potassium phosphate pH 7, ± 0.5 M NaCl, with a range of imidazole 
concentrations from 100 mM to 500 mM. Following addition of each wash/elution 
step, beads were agitated and incubated for 1 min before centrifugation at 13,300 
g at 4 ˚C for 1 min and buffer removal.  
2.2.4.5 Large scale purification of PETNRHis 
Cultures, 5 ml then 100 ml, were inoculated from a glycerol stock into TBAIM 
containing 100 µg ml-1 ampicillin and grown at 37 ˚C mixing at 180 rpm for 18 h, 
cells were then harvested by centrifugation at 7,000 g for 20 min. Cell lysis was 
performed in Ni - NTA loading buffer as for the wild type enzyme (Section 2.2.4.1). 
The lysate was clarified at 20,000 g at 4 ˚C for 20 min. The extract was loaded 
directly onto Ni - NTA agarose column, pre-equilibrated with 500 ml Ni - NTA 
loading buffer. The column was washed with 100 ml Ni - NTA loading buffer 
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followed by 500 ml Ni - NTA Wash Buffer. Enzyme elution was performed using 
Elution Buffer 1, with a final elution step with Elution Buffer 2.  
PETNR-containing fractions, as described previously (Section 2.2.4.1), were then 
pooled and dialysed overnight into Kinetic Assay buffer, using 10 kDa MW cut off 
dialysis tubing. Pooled eluates were concentrated on a Vivaspin 20 spin filter with a 
30 kDa MW cut off at 3000 g at 4 ˚C. Protein (~14 mg ml-1) was frozen in small 
aliquots in liquid nitrogen and stored at -80 ˚C. 
2.2.4.6 PETNRBio induction trials 
PETNRBio was purified from the E. coli strain AVB100 expressing the PETNR gene 
from our pBluescriptII KS+ plasmid, containing the PETNRBio construct under the 
control of an IPTG inducible promoter and the biotin ligase gene encoded 
chromosomally under the control of an arabinose inducible promoter. Starter 
cultures (5 ml then 100 ml) LB containing 100 µg ml-1 ampicillin were grown from a 
glycerol stock at 37 ˚C at 180 rpm for 12 h, were used to inoculate larger cultures of 
Terrific Broth (TB) medium 100 µg ml-1 ampicillin. Cultures were grown at 37 °C at 
180 rpm until they reached an OD600 of 0.7. The culture was divided into equal 
aliquots to test a variety of induction conditions. Biotin was added to all cultures to 
a final concentration of 50 µM. Induction was performed by the addition of 0 – 0.5 
% (w/v) arabinose and 0 – 0.4 mM IPTG, Followed by growth at 37 ˚C at 180 rpm for 
18 h, cells were harvested by centrifugation at 7,000 g at 4 ˚C for 20 min.  Cells 
were lysed in 1 × bugbuster, 7.5 kU ml-1 rLysozyme, 50 U ml-1 Benzonase and 
protease inhibitors for 1 h at 37 ˚C. The lysate was clarified at 20,000 g at 4 ˚C for 20 
min. Clarified lysate (1 ml) was added to a 1.5 ml tube containing the 200 µl of 50 % 
monomeric avidin beads pre-equilibrated with PBS. Immobilisation was incubated 
at 25 ˚C at 180 rpm for 1 h. Following this, incubation resin was centrifuged at 
13,300 g at 4 ˚C for 1 min, before the supernatant was discarded. Resin was washed 
twice with 1 ml Phosphate Buffered Saline (PBS), before being eluted with 200 µl 
monomeric avidin elution buffer, all fractions were stored for analysis by SDS PAGE. 
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2.2.4.7 High throughput lysis trials 
Lysis trials were performed on 1 ml cultures of PETNRHis purified in 96 well format 
with Ni - NTA agarose beads. Columns of PETNRHis from the same culture were 
aliquoted into 4 columns of a DWB, centrifuged at 1107 g at 4 ˚C for 20 min. Pellets 
from each row were resuspended in 250 µl of a different lysis buffer from; Cell lytic 
B, Bugbuster or 50 mM potassium phosphate, 300 mM NaCl, 10 mM Imidazole pH 8 
containing either 0.05 % Tween or 0.1 % Triton-X 100. Resuspended pellets were 
shaken at 180 rpm for 1 h. Following centrifugation at 1107 g at 4 ˚C for 20 min, the 
supernatant was transferred to a new DWB, before the addition of 50 µl 5 × 
equilibration buffer (1.5 M NaCl, 0.2 M Imidazole, 1 mM FMN pH 7.9). Ni - NTA 
agarose beads (200 µl, 50 %) were added to the cell lysate and shaken at 180 rpm 
for 30 min. Supernatant was removed following separated of the Ni - NTA beads by 
centrifugation at 1107 g at 4 ˚C for 1 min. The same procedure was repeated to 
perform 3 × 500 µl washes with Ni - NTA wash buffer followed by a 100 µl elution 
with Ni - NTA elution buffer. The resulting eluates were analysed by SDS PAGE and 
spectrophotometric activity assays. 
2.2.4.8 Purification trials 96 well format 
2.2.4.8.1 His-Mag/Talon 
Both His-Mag and Talon Magnetic beads (1 ml, 50 %) were resuspended in 7 ml 
binding buffer, and 50 µl was aliquoted per well. PETNRHis (250 µl of 5 µM) was 
added to each well and the slurries were shaken for 1 min to allow enzyme binding. 
The supernatant was removed by magnetic bead pull down using the magnetic 
block. The beads were washed with 3 × 500 µl magnetic bead wash buffer using the 
procedure of addition, agitation, incubation and supernatant removal as previously. 
Enzyme was eluted by the addition of 50 µl elution buffer. To assess the amount of 
enzyme purified, 50 µl of eluate was assayed with 6.5 mM 2CH, 0.1 mM NADPH in a 
96 well format as described in Section 2.2.4.9.5. 
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2.2.4.8.2 His-Grab HBC plates 
For each plate 250 µl of 5 µM purified PETNRHis in pH 7 potassium phosphate buffer 
was added to each well. The plates were shaken for 1 h at 25 ˚C allowing maximal 
binding of enzyme to the plate. The plate was washed 3 times with Phosphate 
Buffered Saline (PBS), and a further 2 times with 50 mM potassium phosphate 
buffer pH 7 to avoid nonspecific binding observed in early trials. Assays were 
performed as in Section 2.2.4.9.5. without the enzyme addition steps. 
2.2.4.9 Library generation PCR 
Mutagenic libraries were generated by the binding of degenerate oligonucleotide 
primers to the WT template during a PCR reaction and the reaction proceeds to 
generate the remainder of the plasmid as described in figure 2.3. 
 
Fig 2.3 Method of generating mutagenic libraries using degenerate oligonucleotides. Degenerate 
oligonucleotides bind template DNA and are extended, replicating the remainder of the plasmid and 
incorporating the mutation specified by the degenerate oligonucleotide. Following PCR, nicked 
plasmids are transformed into E. coli and ligated. 
Single site saturated libraries were generated at a number of positions around the 
active site of PETNR by PCR mutagenesis with KOD DNA polymerase (Section 
2.2.1.8), using NNK degenerate oligonucleotides (Appendix 1). All products were 
DpnI digested (Section 2.2.1.9) and analysed by DNA gel electrophoresis (Section 
2.2.1.1). The correct sized band was gel purified using a Qiagen gel purification kit 
(Section 2.2.1.3) and quantified using Qubit fluorometer (Section 2.2.1.4). Library 
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DNA was transformed into the E. coli strain JM109 (Section 2.2.1.18) and grown on 
LB agar containing 100 µg ml-1 ampicillin at 37 ˚C for 12 h. 
2.2.4.10 Robotics methods 
2.2.4.10.1 Colony pick method 
Deep well blocks (96 wells, 2.2 ml each) containing 1 ml per well TB with 100 μg ml-1 
ampicillin were manually prepared in a PCR workstation UV sterile hood and 
introduced to the robotics glove box along with LB agar plates containing the 
correct density of E. coli colonies (~150 per plate) for colony picking. The robotics 
platform picked 96 using an 8 channel pipetting system with disposable tips which 
were transferred into the wells of the media containing DWB. The block was 
removed from the anaerobic environment and covered with a sterile, air 
permeable, self adhesive film. Cultures were incubated at 37 °C at 1050 rpm for 18 
h in a Titramax 1000 incubator.  
Following the growth period 50 µl of overnight growth were added to 50 µl of 
glycerol stock buffer (80 % v/v PBS, 20 % v/v Glycerol) in a 96 well PCR plate 
(Starlabs) and covered with a 96 well silicone sealing mat (Starlabs). Glycerol stocks 
were then frozen on dry ice for 30 minutes before being transferred to a -80 °C 
freezer for medium-long term storage.  
2.2.4.10.2 96 well growth method – AIM  
Glycerol stocks of clones in 96 well format were used to inoculate 1 ml cultures in 
DWB of TB AIM containing 100 μg ml-1 ampicillin. Cultures were grown at 37 °C at 
1050 rpm for 24 h, which allows additional time for auto induction of protein 
production. 
2.2.4.10.3 Harvesting of 96 well growth 
Following growth, the breathable seal was replaced with a Biomek aluminium foil 
seal and cultures were centrifuged at 1109 g at 4 °C for 20 min. The supernatant 
was discarded and pellets were frozen at -20 °C for short term storage. 
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2.2.4.10.4 96 well purification 
Cell pellets were lysed by the addition of 200 µl of lysis buffer, followed by 10 × 150 
µl mixing cycles. The DWB was moved to the shaker and agitated for 5 min. 
Following lysis, 50 µl of equilibration buffer was added to the lysate to ensure 
maximal flavination of mutant enzymes and to idealise conditions for immobilising 
enzyme to the magnetic beads. The magnetic bead slurry (50 µl of a 7 % stock in 
binding buffer) was added to the cell lysate by the robot. The bead slurry was 
shaken on a shaker for 3 min to allow binding of the tagged enzymes to the beads. 
The DWB was removed from the shaker and placed on the magnet plate to 
immobilise the beads and enable supernatant removal. Three wash steps were then 
performed consisting of resuspention of magnetic beads in 700 µl (or 200 µl for 
subsequent washes) wash buffer, immobilisation of the magnetic beads on the 
magnet (30 sec) and removal of the wash buffer to waste. The enzyme was eluted 
in 120 µl of elution buffer and the DWB was shaken for 3 min to maximise protein 
elution. The eluate was removed further 180 µl of dilution buffer in a 96 well 
microplate in order to reduce the final imidazole concentration.  
2.2.4.10.5 Bead cleaning and regeneration 
Following each use magnetic beads were stripped and regenerated using 3 aliquots 
of strip buffer followed by 3 aliquots of charge buffer, each followed by rinsing with 
3 aliquots of water. This procedure was usually performed on the large magnet with 
pooled magnetic bead solutions and aliquots of 15 ml. 
2.2.4.10.6 Robotic assay 
Library assays were performed in 96 well UV transparent - UV Star - microplates. 
Each library extraction provided enough purified enzyme for up to 3 assays. Assay 
buffer (150 µl) was added to all wells of the reaction plate followed by the reductive 
substrate NADPH (50 µl of 600 µM in buffer) and the enzyme eluant to a final 
volume of 250 µl. To start the assay, 50 µl of a 6 × stock, in 30 % EtOH, of the 
oxidative substrate was added to the reaction. The robotics platform transferred 
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the assay plate to an anaerobic plate reader, followed by shaking for ~ 10 s, before 
NADPH consumption was monitored at 340 nm for 10 min. 
2.2.4.10.7 Calculation of Z factor 
Data derived from screening experiments were analysed using a method of non 
controls based normalisation, called Z factor scoring [159].This method involves the 
calculation of z scores from experimental parameters according to Equation 2.10.  
 
Equation 2.10. Calculation of z factor for screening data according to the method of [159].  is the z 
value for a given well,  is the experimental data for a given well,  is the mean for the entire 
sample and  is the standard deviation for the sample. 
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3 Generation, purification and characterisation of novel tagged PETNR 
variants and robotic growth, lysis, purification and assay trials.  
3.1 Introduction 
The overall focus of the work described in this chapter was the generation and 
robotic screening of libraries of PETNR mutants to generate novel biocatalysts with 
improved activity towards a range of industrially relevant substrates (Figure 3.1). To 
achieve this, the PETNR construct was altered to incorporate C-terminal tags, to 
facilitate rapid and efficient protein purification in a 96 well format on a robotics 
platform. A number of immobilisation technologies have been demonstrated 
including the immobilisation of a poly-histidine tag using metal affinity 
chromatography [160] and the immobilisation of biotin tagged protein to resins 
related to the bacterial protein streptavidin [161]. Options for the robotic high 
throughput purification include the use of coated microplates or the use of 
magnetic beads. 
 
Figure 3.1. Experimental outline of protein engineering experiments to change the properties of 
PETNR for more adventitious use as a biocatalyst. 
In order to accurately assess the potential usefulness of each tagged enzyme 
construct, none tagged enzyme (PETNRWT; [21]) was  prepared and kinetically 
characterised [162]. The activity and structure of the tagged enzymes was 
determined and compared to PETNRWT  to ensure the tags had no major effects on 
biocatalytic potential, as has been observed previously in the case of other OYE 
homologues [79]. Successful tagged constructs were then used for optimising 
robotic screening and validation procedures such as protein expression and 
purification. 
A number of components for robotic screening of enzyme variants were trialled and 
optimised, including the development of a colony picking methodology, cell growth 
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and PETNR expression in a 96 well format, culture lysis, protein purification and 
activity detection. 
After optimisation of the robotics protocols, trial studies were performed with all 
PETNRWT cultures to determine the range of errors inherent in the new protocols, 
such as variation in protein expression, levels of protein purified and enzyme 
activity assays. 
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3.2 PETNR Wild Type (PETNRWT) 
Initially, PETNRWT was expressed, purified and characterised kinetically by 
determining the reductive half-reaction using transient (single turnover) kinetic 
methods and steady-state reaction rates. These data were generated to provide a 
basis for comparison with the tagged enzymes to investigate if the presence of the 
tags compromised activity.  
3.2.1 PETNRWT purification 
PETNRWT (encoded by gene pONR-1 [3]) was expressed in large quantities (~50 mgL
-
1) from the Lac promoter of pBluescript SK+ [21]. PETNRWT was purified according to 
the previously published protocol incorporating affinity separation using mimetic 
orange resin followed by ion exchange  chromatography using Q-Sepharose resin 
[40], as described in Section 2.2.4.1. Purification was followed by monitoring the 
relationship between the total protein aromatic residue content (estimated from 
absorbance measurements at 280 nm) and the oxidised FMN content (measured at 
the flavin peak absorbance at 464 nm). The extent of purification was monitored 
visually by SDS-PAGE, an example of which is presented in Figure 3.2. 
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Figure 3.2. SDS-PAGE analysis of PETNRWT purification protocol. Lane M, Pageruler plus marker 
(Fermentas; 10, 17, 28, 36, 55, 72, 95, 130 and 250 kDa); Lane A, cell extract; Lane B, unbound 
fractions from the mimetic orange column; Lane C, mimetic orange column high salt eluates; Lane D, 
unbound fractions from the Q-Sepharose column; Lane E, Q-Sepharose column high salt eluates; 
Analysis was performed on a 12 % SDS PAGE gel electrophoresed at 180 V for 45 min. The gel was 
stained with Coomassie Brilliant Blue R250. 
3.2.2 Kinetic behaviour of PETNRWT 
Steady-state and single turnover kinetic data were determined for PETNRWT with 
the model substrates NADPH and cyclohex-2-enone (CH). Data for the steady-state 
reactions are shown in Figures 3.3 and 3.4 and data for the pre steady-state 
reactions are shown in Figure 3.5. 
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Figure 3.3. The steady-state rate as a function of NADPH concentration of PETNRWT. Data were 
recorded by monitoring the rate of NADPH oxidation at 340 nm over a maximum period of 120 s. 
Data were recorded at 0.1 μM PETNR, 6.5 mM CH, 25 °C in 50 mM KH2PO4/K2HPO4 pH 7. Panel A, 
non-linear least squares fit to the Michalis-Menten equation (Section 2.2.3.2, Equation 2.2) and 
kinetic parameters were estimated; Panel B, example trace obtained for an assay performed with 
100 µM NADPH. 
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Figure 3.4. The steady-state rate as a function of CH concentration of PETNRWT. Data were recorded 
by monitoring the rate of NADPH oxidation at 340 nm over a maximum period of 120 s. Data were 
recorded at 0.1 μM PETNR, 150 µM NADPH, 25 °C in 50 mM KH2PO4/K2HPO4 pH 7. Panel A, non-
linear least squares fit to the Michalis-Menten equation incorporating substrate inhibition (Section 
2.2.3.2, Equation 2.3) and kinetic parameters were estimated; Panel B, example trace obtained for 
an assay performed with 6 mM CH. 
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Figure 3.5. The pre steady-state reductive half-reaction of PETNRWT. Data were recorded by 
monitoring the rate of FMN reduction at 464 nm over a period of 1 s following rapid mixing of 
oxidised enzyme with NADPH. Data were recorded for reactions containing 10 μM PETNR, in 50 mM 
pH 7 KH2PO4/K2HPO4 buffer at 25 °C. Panel A shows a non-linear least squares fit to the Strickland 
equation (Section 2.2.3.3, Equation 2.5) and kinetic parameters were estimated. Panel B, data 
obtained for a reaction with 800 µM NADPH, red line shows the fit to a single exponential equation 
(Section 2.2.3.3, Equation 2.4); Panel B, residuals plot of the of the fit shown in panel A.  
From the above data, the apparent kinetic parameters associated with the reaction 
of PETNR with NADPH and CH were estimated as kcat = 8.5 ± 0.8 s
-1, KM
NADPH = 128.1 
± 24.5 μM for the steady-state turnover at fixed CH concentration (6.5 mM). For 
steady-state reactions at fixed NADPH concentrations (150 µM) kcat = 7.5 ± 0.3 s
-1, 
KM
CH = 1.8 ± 0.2 mM. Substrate inhibition was observed and the value of Ki
CH = 20.4 
Chapter 3 
115 | P a g e  
± 1.9 mM. From the single turnover stopped-flow studies of the reductive half-
reaction (i.e. reduction of enzyme by NADPH) the flavin reduction rate, kred was 
calculated as kred = 34.9 ± 0.4 s
-1 and the apparent dissociation constant, KD, for the 
E-NADPH complex was calculated as KD = 70.9 ± 4.6 μM. The results above are 
consistent with published data where they are available (Table 3.1). Other 
parameters have not been determined previously and provide additional data for 
comparison with tagged enzymes. 
Experiment Parameter This study 
Published 
value 
Ref 
Steady-
state 
Fixed CH 
kcat (s
-1) 8.5 ± 0.8 
nd n/a 
KM
NADPH (μM) 128.1 ± 24.5 
Fixed 
NADPH 
kcat (s
-1) 7.5 ± 0.3 
nd n/a KM
CH (mM) 1.8 ± 0.2 
Ki
CH (mM) 20.4 ± 1.9 
Single 
turnover 
Reductive 
half-
reaction 
kred (s
-1) 34.9 ± 0.5 34 ± 0.4 
[162] 
KD (μM) 70.9 ± 4.6 73 ± 4 
Table 3.1. Summary table of PETNRWT kinetic data. Comparison between the experimentally derived 
data for PETNRWT and published values where appropriate. 
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3.3 His Tagged PETNR (PETNRHis) 
A crucial factor in the robotic protocol is the requirement for small-scale enzyme 
purification in a 96 well format. The only feasible approach is the use of affinity 
purification via the incorporation of an affinity tag to the enzyme.  
The poly histidine tag is a commonly used N- and C- terminal protein tag [160]. The 
number of residues in the tag can vary, but is most commonly between 6 and 12 
residues long [160]. Proteins with this amino acid sequence can coordinate to 
divalent metal ions such as Ni and Co as demonstrated in Figure 3.6.  
 
Figure 3.6. Histidine side chain interacting with a divalent metal ion in immobilised metal affinity 
chromatography. High concentrations of imidazole are required to compete with His residues in the 
target protein for the metal ion, leading to elution of the His-tagged protein.  
Once immobilised, the protein of interest can be eluted using a high concentration 
of imidazole, which then competes with the His residues in the protein in binding 
the metal ion. One notable problem of this technique is the potential for other E. 
coli proteins to co-purify with the protein of interest, such as FK506 - binding 
proteins [160], including SlyD [163]. 
It has been observed that addition of a His-tag to the C terminal region of YqjM 
impairs protein function dramatically [79]. However, this loss of function is probably 
due to the impairment of oligomerisation [43] and is not expected to be a problem 
for PETNR as it is thought to function as a monomer [3].  The tag was localised on 
the C-terminal end as it was thought that an N-terminal tag might disrupt or block 
access to the active site channel.  
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3.3.1 PETNRHis construction 
The poly-His tag was added in two sequential PCR reactions, each incorporating 
either 3 or 6 histidine residues by incorporating an overhanging tail (as discussed in 
Section 2.2.4.2). Following each PCR, the product was analysed by agarose gel 
electrophoresis, and the amplified product was purified from the gel to yield the 
template for the next reaction (first round) or the final product (second round). 
Agarose gel electrophoretic analysis of the ‘tagged’ PCR product is shown in Figure 
3.7. The template (first round product) encoding PETNR3T was purified from the 
agarose gel and used as a template for the second PCR reaction using the ‘6T 
primers’ to incorporate additional bases that encode the final 3 residues of the His-
tag. In addition, a second PCR reaction was carried out with the ‘His6 primers’ using 
the gene encoding wild-type PETNR as the template. Surprisingly, the expected 4.5 
kb PCR product, encoding the PETNRHis protein, was obtained from both templates 
negating the need to perform the initial His3 incorporation step. It is likely that the 
Tm of the complementary part of the ‘His6 primers’ was sufficiently high to allow 
annealing of the larger primer to the wild-type template at 72°C, most likely due to 
its high GC content.  
 
Figure 3.7. Agarose gel showing the construction of PETNRHis. Lanes M, 1 kbp ladder (NEB; 0.5, 1, 1.5, 
2, 3, 4, 5, 6, 8, 10 kbp); Lane A, reaction with PETNRWT template and 3T primers; Lane B, reaction 
with PETNR3T template and 6T primers; Lane C, reaction with PETNRWT template and 6T primers. The 
major band at 4.5 kb corresponds to the expected size of the PETNR construct. Analysis was 
performed on a 0.6 % agarose gel electrophoresed at 100 V for 45 min.  
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Agarose gels of PCR products amplified from individual colonies (Colony pick PCR, 
CPPCR) containing the PETNRHis encoding plasmid were electrophoresed for 1 - 1.5 
h. This enabled separation of DNA fragments with small differences in base pair 
content (18 bp). To overcome problems of uneven lane running due, attributed to 
heat generation during the long electrophoresis running time, control (PETNRWT) 
DNA samples were electrophoresed at regular intervals throughout the gel. An 
example is given in Figure 3.8. Positive results from the CPPCR were further 
characterised by DNA sequencing to confirm the presence of nucleotides encoding 
the poly-histidine tag. 
 
Figure 3.8. Agarose gel showing the PCR products from ‘colony pick PCR’ of PETNRHis clones. Lane M, 
100 bp Ladder (NEB; 100, 200, 300, 400, 500, 600, 700, 800, 900, 1000 bp, 1.2, 1.5, 2, 3 kbp); Lane C, 
control reaction with wild-type template; Numbered lanes, sample PCR products Arrows indicate 
lanes sequenced. Analysis was performed on a 1.3 % agarose gel electrophoresed at 100 V for 1 – 
1.5 h.  
Clones shown in lanes 7 and 8 (hereafter termed His7 and His8) of Figure 3.8 show 
the greatest difference in migration in the agarose gel compared to the control 
product. Sequencing of these clones showed that both contained DNA encoding an 
in-frame poly-histidine tail immediately before the stop codon.  However, it was 
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found that both clones encoded eight instead of the expected six histidines. Figure 
3.9 shows an alignment of the sequence of the 3’ terminus of clone His8 compared 
to the wild-type sequence. It is likely that the two additional codons were 
incorporated as a result of primer mis-annealing.  However, as tags in the range of 6 
- 12 histidine residues are frequently used to bind to Nickel affinity resins, the His8 
clone was used for further studies. 
Clone His8 was further sequenced and was found to contain an additional mutation 
A921G compared to the PETNR deposited sequence [21]. This corresponds to a 
silent mutation at residue 307 changing GAA to GAG.  However, sequencing of wild-
type PETNR template revealed the presence of this mutation. This silent mutation 
could be a natural isoform of the gene, or more likely is a mistake in the initial 
sequencing of the gene. In any circumstance there are no anticipated consequences 
for the proposed scheme of research. 
 
Predicted     TGATTATCGGGGCGGGTGCGTATACGGCAGAAAAAGCCGAGGATTTGATCGGTAAAGGCC 
PETNR His 8   TGATTATCGGGGCGGGTGCGTATACGGCAGAGAAAGCCGAGGATTTGATCGGTAAAGGCC 
              ******************************* **************************** 
 
Predicted     TGATCGACGCCGTGGCCTTTGGCCGTGACTACATTGCTAACCCGGATCTGGTTGCCCGTT 
PETNR His 8   TGATCGACGCCGTGGCCTTTGGCCGTGACTACATTGCTAACCCGGATCTGGTTGCCCGTT 
              ************************************************************ 
 
Predicted     TGCAGAAAAAAGCCGAACTGAACCCGCAGCGTCCTGAAAGCTTCTATGGCGGCGGCGCGG 
PETNR His 8   TGCAGAAAAAAGCCGAACTGAACCCGCAGCGTCCTGAAAGCTTCTATGGCGGCGGCGCGG 
              ************************************************************ 
 
Predicted     AAGGTTATACCGACTACCCTTCACTGCATCATCACCATCACCAT------TAATCCCGCT 
PETNR His 8   AAGGTTATACCGACTACCCTTCACTGCATCATCACCATCACCATCACCATTAATCCCGCT 
              ********************************************      ********** 
 
 
Figure 3.9. Clustal alignment of the 3’ sequence of the deposited PETNRWT encoding DNA sequence 
with the resultant His8 sequence [164]. Green, DNA encoding the expected His6 tag; cyan, additional 
bases in the experimentally derived His8 tag encoding region; yellow, triplet affected by the silent 
mutation; red text, the silent mutation in PETNR; underline, stop codon. 
3.3.2 Trial batch purification of PETNRHis with Ni - NTA agarose 
Before any further studies with PETNRHis variant could be conducted, optimisation 
of the purification was required. Standard protocols for the purification of poly 
histidine-tagged enzymes include varying concentrations of imidazole (100 - 500 
mM) and NaCl concentration (0 – 0.5 M; Figures 3.10 and 3.11) during elution [165]. 
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Figure 3.10. Purification of PETNRHis in the absence of NaCl. Lane A, ‘low range’ prestained protein 
ladder (bio-rad; 21, 29, 34, 50, 77, 103 kDa); Lane B, PETNRWT authentic standard; Lane C, flow 
through; Lanes D-H, washes 1-5; Lane I, 100 mM imidazole eluate; Lane J, 150 mM imidazole eluate; 
Lane K, 200 mM imidazole eluate; Lane L, 250 mM eluate; Lane M, 300 mM imidazole eluate; Lane 
N, 400 mM imidazole eluate; Lane O, 500 mM imidazole eluate. Analysis was performed on a 12 % 
SDS PAGE gel electrophoresed at 180 V for 45 min. The gel was stained with Coomassie Brilliant Blue 
R250.   
 
Figure 3.11. Purification of PETNRHis in the presence of 0.5 M NaCl. Lane A, ‘low range’ prestained 
protein ladder (bio-rad; 21, 29, 34, 50, 77, 103 kDa); Lane B, PETNRWT authentic standard; Lane C, 
flow through; Lanes D-H, washes 1-5; Lane I, 100 mM imidazole eluate; Lane J, 150 mM imidazole 
eluate; Lane K, 200 mM imidazole eluate; Lane L, 250 mM eluate; Lane M, 300 mM imidazole eluate; 
Lane N, 400 mM imidazole eluate; Lane O, 500 mM imidazole eluate. Analysis was performed on a 
12 % SDS PAGE gel electrophoresed at 180 V for 45 min. The gel was stained with Coomassie Brilliant 
Blue R250. 
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SDS PAGE analysis of the batch purification of PETNRHis using Ni - NTA agarose in the 
presence or absence of salt indicated identical purification results, this observation 
suggests salt can be included in the purification to interrupt potential non specific 
binding of redox active proteins interfering with the assay. Results indicated that 
the minimal amount of imidazole required for significant elution of PETNRHis was 
around 200 mM. This is similar to the standard six His tagged protein purification 
protocols [165]. Therefore 0.5 M NaCl and 200 mM imidazole were used 
throughout the purification of PETNRHis in all subsequent studies [165]. 
Compared to the standard PETNRWT protocol, PETNRHis purification can be 
accomplished in a single preparative step, consistent with the requirement for 
incorporation into a robotic screening process.  
3.3.3 Preparative scale purification of PETNRHis 
A larger scale purification of PETNRHis was performed from a 1L culture of 
recombinant E. coli cells using the optimised protocol and a 25 ml Ni - NTA agarose 
column. At various stages of the purification samples were taken for analysis by 
SDS-PAGE (Figure 3.12) and UV/visible spectrophotometry. The ratio of absorbance 
at 280 nm and 464 nm (A280:A464) was determined at different stages of the 
purification to assess purity. 
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Figure 3.12. Ni - NTA purification of PETNRHis. Lane A, low range prestained protein ladder (bio-rad; 
21, 29, 34, 50, 77, 103 kDa); Lane B, cell lysate (10%); Lane C, flow through (10%); Lane D – G, wash 
fraction 1 – 4; Lane H, eluate (10%). Analysis was performed on a 12 % SDS PAGE gel 
electrophoresed at 180 V for 45 min. The gel was stained with Coomassie Brilliant Blue R250. 
A small amount of PETNRHis is leached from the resin with every wash step, but 
when compared to the intensity of the eluted bands the amount of protein lost is 
minor. The final lane (lane H, Figure 3.12) indicates that PETNRHis can be isolated in 
pure form using this purification method. 
3.3.4 Analysis of kinetic behaviour of PETNRHis 
The addition of a poly-histidine tag to the OYE YqjM has previously been 
demonstrated to be problematic [79]. To investigate the kinetic effects of 
incorporating a poly histidine tag to the C-terminus of PETNR, a kinetic profile for 
the tagged enzyme was determined under steady-state and pre steady-state 
conditions. Such an analysis also provides baseline data for comparison with variant 
forms of PETNRHis. Data for the steady-state reactions are shown in Figures 3.13 and 
3.14 and data for the pre steady-state reactions are shown in Figure 3.15.   
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Figure 3.13. The steady-state rate as a function of NADPH concentration of PETNRWT. Data were 
recorded by monitoring the rate of NADPH oxidation at 340 nm over a maximum period of 120 s. 
Data were recorded at 0.1 μM PETNR, 6.5 mM CH, 25 °C in 50 mM KH2PO4/K2HPO4 pH 7. Panel A, 
non-linear least squares fit to the Michalis-Menten equation (Section 2.2.3.2, Equation 2.2) and 
kinetic parameters were estimated; Panel B, example trace obtained for an assay performed with 
150 µM NADPH. 
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Figure 3.14. The steady-state rate as a function of CH concentration of PETNRWT. Data were recorded 
by monitoring the rate of NADPH oxidation at 340 nm over a maximum period of 120 s. Data were 
recorded at 0.1 μM PETNR, 150 µM NADPH, 25 °C in 50 mM KH2PO4/K2HPO4 pH 7. Panel A, non-
linear least squares fit to the Michalis-Menten equation incorporating substrate inhibition (Section 
2.2.3.2, Equation 2.3) and kinetic parameters were estimated; Panel B, example trace obtained for 
an assay performed with 6 mM CH. 
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Figure 3.15. The pre steady-state reductive half-reaction of PETNRWT. Data were recorded by 
monitoring the rate of FMN reduction at 464 nm over a period of 1 s following rapid mixing of 
oxidised enzyme with NADPH. Data were recorded for reactions containing 10 μM PETNR, in 50 mM 
pH 7 KH2PO4/K2HPO4 buffer at 25 °C. Panel A shows a non-linear least squares fit to the Strickland 
equation (Section 2.2.3.3, Equation 2.5) and kinetic parameters were estimated. Panel B, data 
obtained for a reaction with 800 µM NADPH, red line shows the fit to a single exponential equation 
(Section 2.2.3.3, Equation 2.4); Panel B, residuals plot of the of the fit shown in panel A. 
From the above data, the apparent kinetic parameters associated with the reaction 
of PETNRHis with NADPH and CH were estimated as kcat = 8.7 ± 0.4 s
-1, KM
NADPH = 
115.2 ± 11.3 μM for the steady-state turnover at fixed CH concentration (6.5 mM). 
For steady-state reactions at fixed NADPH concentrations (150 µM) kcat = 5.9 ± 0.4 s
-
1, KM
CH = 1.2 ± 0.2 mM. Substrate inhibition was observed and the value of Ki
CH = 
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21.0 ± 3.5 mM. From the single turnover stopped-flow studies of the reductive half-
reaction the flavin reduction rate was calculated as kred = 33.1 ± 0.4 s
-1 and the 
apparent dissociation constant was calculated as KD = 81.8 ± 4.7 μM. The results 
above are consistent with the data derived previously for PETNRWT (Table 3.2) 
suggesting the enzyme variants are largely catalytically indistinguishable 
Experiment Parameter PETNRWT PETNRHis 
Steady-
state 
Fixed CH 
kcat (s
-1) 8.5 ± 0.8 8.7 ± 0.4 
KM
NADPH (μM) 128.1 ± 24.5 115.2 ± 11.3 
Fixed 
NADPH 
kcat (s
-1) 7.5 ± 0.3 5.9 ± 0.4 
KM
CH (mM) 1.8 ± 0.2 1.2 ± 0.2 
Ki
CH (mM) 20.4 ± 1.9 21.0 ± 3.5 
Single 
turnover 
Reductive 
half-
reaction 
kred (s
-1) 34.9 ± 0.4 33.1 ± 0.4 
KD (μM) 70.9 ± 4.6 81.8 ± 4.7 
Table 3.2. Summary table comparing kinetic parameters for PETNRWT and PETNRHis 
 
3.3.5 PETNRHis crystal structure 
In order to observe any changes in the structure of PETNRHis, which could lead to 
subtle changes in catalytic profile, the structure of the PETNRHis variant was 
determined to 1.4 Å resolution (statistics described in Table 3.3). This work was 
performed in collaboration with Dr Helen S. Toogood (University of Manchester). 
Apart from the obvious exception of the C-terminal residues the structure of 
PETNRHis is almost identical to the previously solved structure of PETNRWT [40] 
(Figure 3.18). From the omit map |F0|-|Fc| (Figure 3.16), it is clear that on removing  
the His tag residues from the model aberrant density is present which corresponds 
to one full and one partial histidine residue. Hence, the first two residues of the 
tags were included in the structure. A number of interactions are observed 
incorporating tag residues, solvent water molecules, other PETNR residues and 
residues from symmetry related molecules in the crystal. An overview of the PETNR 
active site (Figure 3.18) shows very little change in any of the active site residues, 
which would potentially lead to large changes in the catalytic profile. 
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Parameters PETNRHis 
Space group P212121 
Cell dimensions 
a, b, c (Å) 58.96, 68.95,88.48 
, ,  (o) 90.0, 90.0, 90.0 
Resolution (Å) 37.2-1.4 (1.48-1.40) 
Rmerge (%) 6.7 (29.0) 
I/ I 12.7 (3.8) 
Completeness (%) 99.5 (99.9) 
Redundancy 3.4 (3.4) 
Unique reflections 71252 
Rwork/Rfree 12.6/15.6 (16.2/20.2) 
RMS deviations 
Bond angles (o) 1.436 
Bond lengths (Å) 0.012 
Ramachandran 
plot 
Allowed region 
(%) 
95.7 
Additionally 
allowed region (%) 
4.0 
Rmerge = hkl i |Ii(hkl)-[I(hkl)]|/ hkl i Ii(hkl), where Ii(hkl) is the intensity of the ith 
observation of unique reflection hkl. 
Redundancy = total number of reflections / total unique reflections. 
Rwork = ||Fobs|-|Fcalc||/ |Fobs|, where Fobs and Fcalc are observed and model 
structure factors, respectively.  Rfree was calculated by using a randomly selected set 
(5%) of reflections. 
Table 3.3. X-ray crystallographic data collection and refinement statistics for PETNRHis. 
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Figure 3.16. His tag model including electron density and its interactions with PETNR monomer and 
its symmetry related molecule in the crystal. Magenta, PETNR monomer; blue, symmetry related 
PETNR monomer; green, |F0| - |Fσ| map showing aberrant electron density associated with the 
histidine tag. 
 
Figure 3.17. Alignments of PETNRHis (blue, as derived in this study) and PETNRWT (green, 1GVQ [38]). 
Panel A, alignment of cartoon representations of the structure; Panel B, alignment presented as Cα 
backbone ribbon showing tiny variations in the backbone; Panel C, active site residues and FMN 
revealing virtually no change in residues implicated in catalysis and mechanism.  
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3.4 Biotin Tagged PETNR (PETNRBio) 
A PETNR construct with the biotin ligase recognition sequence was constructed to 
provide an alternative to PETNRHis for the robotic purification of library clones. 
Additional advantages include purification in a plate format potentially allowing the 
immobilisation and assay of library clones in a single microplate.  
The biotin tag is a specific sequence of amino acids which undergoes a post-
translational biotinylation reaction catalysed by the enzyme biotin ligase [166].  
Biotin is added to the terminal amino group of a specific lysine residue surrounded 
by the consensus sequence GLNDIFEAQKIEWHE [166]. Bacterial strains are available 
that contain the biotin ligase gene stably inserted into the hosts genomic DNA 
under the control of an arabinose-inducible vector.  Transformation of the gene of 
interest into these strains, in an IPTG-inducible vector, enables independent control 
of expression of both the biotin ligase and the target protein (as described at 
http://www.avidity.com/). Supplementing the growth media with biotin enables 
the post-translational biotinylation reaction to proceed in vivo.  
Biotin-tagged proteins can be affinity purified using streptavidin-agarose beads on 
the basis of the strong interaction between biotin and the egg white protein avidin 
(or its bacterial counterpart streptavidin) [161]. The association constant for this 
interaction is in the region of 1015 M-1. Following immobilisation, the protein of 
interest can be eluted using competing concentrations of soluble biotin. 
3.4.1 PETNRBio construction 
Due to the length of the biotin tag, cassette-based incorporation (as described in 
Section 2.2.4.3), was chosen to avoid extensive PCR reactions, screening of colonies 
and sequencing. Following annealing and ligation steps, only one clone from a total 
of 41 colonies produced a significantly larger CPPCR product (Figure 3.18). This PCR 
product is approximately 350 bp, corresponding to the larger expected size of a full-
length biotin tag incorporated PETNR construct.   
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Figure 3.18. Agarose gel showing the PCR products from CPPCR of one biotin tag clone. Lane A, 100 
bp Ladder (NEB; 100, 200, 300, 400, 500, 600, 700, 800, 900, 1000 bp, 1.2, 1.5, 2, 3 kbp); Lane B, 
control reaction with wild-type template (pONR1, pBluescript SK+); Lane C, Biotin7 clone PCR 
product. Analysis was performed on a 1.3 % agarose gel electrophoresed at 100 V for 1 - 1.5 hr. 
As the biotin tag cassette contains complementary sticky ends to the same 
restriction enzyme, there is a 50 % chance the insert could be incorporated the 
wrong way around. Sequencing reactions of the Biotin 7 clone at the 3’ end of the 
gene showed the presence of an 18 amino acid tag, incorporated in the correct 
orientation (Figure 3.20).  However, it was found that this clone also contained a 
mutation, G1138A, which corresponded to an amino acid change of E380K.  This 
mutation is located within the incorporated biotin tag, suggesting the mutation may 
be the result of a mistake in the sequence of the incorporated primers. As this tag 
sequence has been optimised for biotin incorporation [166], and post-translational 
biotin incorporation occurs at the lysine residue only two amino acids away from 
this mutation, the addition of a second lysine residue close to the key lysine may 
affect biotin incorporation. Therefore this clone was used as a template for site-
directed mutagenesis to correct the mutation. Biotin7 was further sequenced and 
was found to contain the additional silent mutation/isoform A921G, as discussed in 
Section 3.3.1. 
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Nucleotide sequence 
 
Predicted     GACTACCCTTCACTGGAATGCCAGGGCCTGAACGATATTTTTGAAGCGCAGAAAATTGAA  
PETNR Biotin7 GACTACCCTTCACTGGAATGCCAGGGCCTGAACGATATTTTTGAAGCGCAGAAAATTAAA  
              ********************************************************* ** 
                                                                         
Predicted     TGGCATGAATAATCCCGCTTTGTACATTGATAGCGGCGACCTTTCGCCGCTATACTAAAA  
PETNR Biotin7 TGGCATGAATAATCCCGCTTTGTACATTGATAGCGGCGACCTTTCGCCGCTATACTAAAA  
              ************************************************************ 
 
Amino acid sequence 
 
Predicted     D Y P S L E C Q G L N D I F E A Q K I E W H E Stop  
PETNR Biotin7 D Y P S L E C Q G L N D I F E A Q K I K W H E Stop  
 
Figure 3.19. Clustal alignment of the 3’ sequence of the deposited PETNRWT encoding DNA sequence  
with the resultant Biotin7 sequence [164]. Cyan, tag nucleotide sequence; red, error in the tag 
sequence; underline, stop codon. 
Following mutagenesis to repair of the unexpected mutation, the product was 
isolated from the agarose gel (Figure 3.20), and sequencing was repeated to 
confirm the correct incorporation of the full recognition sequence (Figure 3.21).  
 
Figure 3.20. Agarose gel showing the PCR product from the PCR designed to correct the sequence of 
the biotin tag. Lane A, 1 kbp ladder (NEB; 0.5, 1, 1.5, 2, 3, 4, 5, 6, 8, 10 kbp); Lane B, PETNRWT plasmid 
control; Lane C, Biotin repair PCR product. Analysis was performed on a 0.6 % agarose gel at 100 V 
for 45 min. 
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Nucleotide sequence 
 
Predicted      CCAGGGCCTGAACGATATTTTTGAAGCGCAGAAAATTGAATGGCATGAATAATCCCGCTT 
Biotin repair  CCAGGGCCTGAACGATATTTTTGAAGCGCAGAAAATTGAATGGCATGAATAATCCCGCTT 
               ************************************************************ 
 
Amino acid sequence 
 
Predicted     Q G L N D I F E A Q K I E W H E Stop   
PETNR Biotin7 Q G L N D I F E A Q K I E W H E Stop  
 
 
Figure 3.21. Clustal alignment of the 3’ sequence of the deposited PETNRWT encoding DNA sequence 
with the Biotin repair PCR product [164]. Cyan, tag nucleotide sequence; red, the position of the 
error in the tag sequence; underline, stop codon. 
3.4.2 PETNRBio double induction trials 
Expression trials of PETNRBio in E. coli strain AVB100 were carried out by varying 
both the concentration of IPTG and arabinose in search of conditions optimal for 
protein expression and in vivo biotinylation, respectively (Figure 3.22). Samples 
were grown with induction ranging from 0 – 0.4 mM IPTG and from 0 – 0.5 % 
arabinose followed by the immobilisation of tagged protein using avidin beads 
using a batch purification protocol (Section 2.2.4.6). 
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Figure 3.23. Expression and purification trials of PETNRBio at variable IPTG (induction of PETNRBio) and 
arabinose (induction of Biotin Ligase) concentrations. Lane M, low range prestained protein ladder 
(bio-rad; 21, 29, 34, 50, 77, 103 kDa); Lane A, 0.05 mM IPTG, 0.1 % Arabinose; Lane B, 0.05 mM IPTG, 
0.5 % Arabinose; Lane C, 0.4 mM IPTG, 0.1 % Arabinose; Lane D, 0.4 mM IPTG, 0.5 % Arabinose; Un, 
Un-induced; I, IPTG only 0.4 mM; Ar, Arabinose only 0.5 %. SDS PAGE was performed on a 12 % SDS 
PAGE gel electrophoresed at 180 V for 45 min. The gel was stained. The gel was stained with 
Coomassie Brilliant Blue R250. 
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In spite of the range of conditions trialled, PETNRBio was poorly expressed in all 
cases compared to both PETNRWT and PETNRHis. The levels of PETNRBio in the 
monomeric avidin eluate were used to estimate the levels of biotinylation across 
different induction condition. The biotinylation levels were found to be 
approximately invariant for different growth conditions as demonstrated by the 
presence of similar amounts of PETNRBio in the eluate and the pellet of all 
experiments. Thus, fine control as discussed in the literature [167] does not appear 
to have much influence on the biotinylation levels achieved. Biotin ligase (~30 kDa), 
the enzyme responsible for the in vitro biotinylation, is not visible in any fractions 
derived from the purification protocol suggesting it is expressed at low levels. 
Due to the lack of success in expressing PETNRBio at high levels and given the 
apparent success of the initial PETNRHis purification trials, the His-tagged variant 
was carried forward for further study. 
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3.5 Robotic methods optimisation 
3.5.1 Robotic colony picking 
Colony picking on the robotics platform was fully automated using the 8 channel 
pipettor to transfer colonies from agar plates to 96 well deep well blocks pre-
prepared with media. Efficient robotic colony picking was achieved when the agar 
plates contained well separated colonies (~150 – 200 per plate) of uniform size and 
shape. This enabled the software to pick the ‘best’ 96 colonies as defined by the 
colony selection criteria (min/max colony size and closeness to an ‘ideal’ circular 
colony). Due to variation in the transformation reactions, consistent numbers of 
colonies were difficult to obtain, so library transformation slurries were plated by 
serial dilution, and the plate with the appropriate colony density was selected. 
Libraries were grown and archived as glycerol stocks as described in Section 
2.2.4.10.1. 
3.5.2 Optimisation of E. coli growth in 96 well format 
Critical to the success of the screening strategy is the growth and expression of 
protein libraries. To ensure experimental conditions are optimal for expression, a 
range of growth media and E. coli strains were trialled. Initially, 96 well cultures 
were grown for 12 h at 37 ˚C followed by a 4 hour induction with IPTG at a final 
concentration of 0.4 mM. This approach was considered sub-optimal due to a 
number of factors. First, inducing cells after a fixed time period does not take into 
account the variation of cell densities of individual variants at the time of induction 
which is often critical in determining the level of over expression. Second, short 
induction times often produce large amounts of non-flavinated protein as in vivo 
flavin production is slower than protein production. Third, mutations are often toxic 
and strong induction protocols often retard cell growth and lead to cell lysis. 
To potentially counteract these problems, auto induction media was trialled. Auto 
induction media provides a blend of glucose and lactose to the growing cells. During 
initial periods of growth glucose is used preferentially until its supply is exhausted 
as glucose is a known Lac operon repressor. This prevents protein expression at low 
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cell density. Once sufficient cell density is obtained, indicated by the utilisation of 
all glucose, the cells then switch metabolism over to utilise lactose thus activating 
the Lac operon and inducing the protein of interest [168]. This type of medium 
provides a slow, steady means of protein expression tailored to each individual 
culture, increasing the likelihood of producing flavin-containing enzymes and 
minimising the occurrence of inclusion bodies.  
In addition, a variety of E. coli strains, including some designed specifically for 
protein expression, were trialled to determine the strain providing the highest and 
most consistent levels of expression of PETNRHis.   
3.5.2.1 Library expression with auto induction media 
Following initial un-induced growth and glycerol stock storage as detailed in Section 
2.2.4.10.1, libraries were re-grown, by inoculation from glycerol stock, using auto 
induction media. Trials of different auto induction media (Section 2.1.2) were 
conducted to determine the best media required to generate consistent protein 
expression levels. Protein expression levels were characterised by SDS PAGE 
analysis (Figure 3.24). 
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Figure 3.24. Expression trial testing a variety of auto-induction media for use in growing mutant 
libraries. Lane M, Pageruler plus prestained protein ladder (Fermentas, 10, 17, 28, 36, 55, 72, 95, 
130, 250 kDa); LB, Luria Broth AIM growths; DYT, Double Yeast Tryptone AIM growths; SB, Super 
Broth AIM growths; TB, Terrific Broth AIM growths. All cultures were PETNRHis in JM109 cells grown 
for 24 h. SDS PAGE was performed on a 12 % SDS PAGE gel electrophoresed at 180 V for 45 min. The 
gel was stained. The gel was stained with Coomassie Brilliant Blue R250. 
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The results indicate that all media tested yield expression of PETNRHis. LB AIM being 
the least rich of the media showed significantly weaker expression levels than the 
other media. Growth in DYT AIM and SB AIM media show vastly enhanced 
expression levels compared to LB AIM. However DYT AIM showed a large degree of 
variation in expression. TB AIM appears to show a further enhanced degree of 
expression. Due to the far greater expression levels, TB was selected for further 
investigation in the optimisation of the cell growth and protein expression trials.  
3.5.2.2 Library expression from different E. coli strains 
Library DNA (Section 2.2.4.9) was transformed into a range of E. coli strains before 
colonies were picked individually and grown in a 96 well format. Individual colonies 
were picked from transformation plates of the T26X library and grown in 1 ml LB 
AIM for 24 h at 37˚C. A random selection of colonies from each plate were analysed 
by SDS PAGE (Figure 3.25). It is important to note that this experiment was 
performed with library DNA to assess the consistency of transformation and 
expression with a range of mutants. 
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Figure 3.25. Expression trial of a variety of E. coli expression strains transformed with T26X library 
with TB AIM. Lane M, Pageruler plus prestained protein ladder (Fermentas, 10 (not visible), 17 (not 
visible), 28, 36, 55, 72, 95, 130, 250 kDa); lanes A, XL10 Gold; lanes B, XL1 Blue; lanes C, JM109. SDS 
PAGE was performed on a 12 % SDS PAGE gel electrophoresed at 180 V for 45 min. The gel was 
stained. The gel was stained with Coomassie Brilliant Blue R250. 
All three cell strains demonstrated substantial over-expression in the majority of 
cases, with XL1 Blue showing the best levels of expression. In the case of XL1 Blue, 
protein expression was variable with some clones not producing an observable 
protein band for PETNR. Strain JM109 shows a strong over-expressed band for 
PETNRHis and expression at these levels is consistent across the sampled colonies, 
Results 1 
140 | P a g e  
consequently this strain was taken forward to further studies. It is important to 
note that all three strains are individual transformations of the same library DNA 
and as such individual lanes do not correspond to the same variant, hence 
individual lanes are not necessarily comparable between gels. In this case, it is 
assumed that the colonies picked at random represent an average of the entire 
library.  
3.5.3 Robotic cell lysis and clarification optimisation 
An appropriate cell lysis method needed to be developed for the robotic protocols. 
Conventional techniques such as sonication or French press with accompanying 
centrifugation steps are not amenable to an anaerobic 96 well protocol. Therefore 
the use of chemical lysis approaches resulting in the production of lysates not 
requiring clarification by centrifugation was trialled to optimise protein recovery. 
A variety of commercial and tailored lysis buffers were trialled and assessed for 
their ability to completely lyse cells to yield the active protein. All buffers contained 
additionally lysozyme, benzonase and protease inhibitor tablets. Lysates were 
purified using a standard Ni - NTA batch purification protocol (Section 2.2.4.4), 
analysed by SDS PAGE to assess the available protein content of the eluate (Figure 
3.26), and assayed for activity with the PETNR model substrates NADPH and 
cyclohexenone. 
The presence of PETNRHis was detected in all the pellets and all the cell lysates 
indicating that the same level of PETNR was present in all induced cells. No visible 
pellet was present after lysis with commercial lysis buffers (bugbuster, Cell Lytic B). 
However, with both of the tailored solutions (Tween 20 and Triton X-100) small, but 
significant, orange pellets were observed following lysis, indicating the need for a 
centrifugation step. SDS PAGE analysis of all lysates showed that large quantities of 
protein were liberated from cells and were available for binding to the resin.  
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Figure 3.26. The effectiveness of different lysis buffers to produce clarified lysates. Lane M, low 
range prestained protein ladder (bio-rad; 21, 29, 34, 50, 77, 103 kDa); Lanes A, bugbuster; Lanes B, 
cell lytic B; Lanes C, Tween 20 buffer; Lanes D, Triton X-100 buffer. SDS PAGE was performed on a 12 
% SDS PAGE gel electrophoresed at 180 V for 45 min. The gel was stained. The gel was stained with 
Coomassie Brilliant Blue R250. 
Kinetic assays of the eluates from the purification experiment indicated that there 
was only a partial correlation between visual protein levels and activity detection. 
Bugbuster was found to produce the highest level of active protein, so was selected 
as the lysis buffer for the robotic protocols. 
Lysis buffer Initial rate (µM s-1) 
Water 0.019 
Tween – 20 0.009 
Triton X – 100 0.085 
Cell lytic A 0.173 
Bugbuster (50 %) 0.231 
Table 3.4. Anaerobic turnover assays with 6 mM CH and 150 µM NADPH. Data were recorded for the 
reaction catalysed by 20 μl of cell lysate, except for bugbuster since the reaction with this volume 
was too fast to be recorded (10 μl was used in this case). 
3.5.4 Robotic 96 well purification trial 
Following optimal lysis it was next necessary to develop a micro-scale purification 
method which yielded the substantial amounts of purified protein to ensure the 
maximal amount of assays per purification. Importantly consistency in purification 
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is also needed to ensure results are comparable across the 96 well plate. Potential 
types of purification assessed included purification with magnetic beads (Section 
2.2.8.1) and immobilisation onto a coated microplate surface (Section 2.2.8.2).  
In the case of plate purifications, assays were added directly into the wells of the 
microplate and performed according to the method discussed previously with 
buffer added instead of enzyme (Section 2.2.4.10.6).  
 
Average rate 
(nM s-1) 
Standard 
Deviation 
(nM s-1) 
Error (%) 
His Mag magnetic beads (Novagen) 206.8 55.4 27 
Talon Magnetic beads (Clonetech) 92.0 44.9 49 
His grab HBC plates (Pierce) 13.9 3.5 25 
Figure 3.5. Anaerobic turnover assays with 6 mM CH and 150 µM NADPH with 50 µl eluate (from 
beads) and assays were performed in the purification plate (for plate purification). Values represent 
average and standard deviation of 96 wells. 
A further consideration is that plate purification methods are not reusable and only 
provide enough protein for a single assay. However beads provide a volume of 
eluate which can potentially be used for multiple reactions and the beads can be 
regenerated and reused for multiple experiments. 
The results indicated that the plate purification method resulted in lower activity 
detection compared with the bead methods. ‘His-Mag’ magnetic beads (Novagen) 
provided a far superior purification option with a 2-fold increase in the activity 
when compared with the next best method, represented by the talon beads, with a 
lower error when considered in the context of total enzyme.  
This leads to the identification of His-Mag beads as the most practical method for 
micro-scale purification. 
3.5.5 Robotic 96 well assay trial 
Ultimately, the identification of improved variants is via the detection of an 
increased steady-state reaction rate. Therefore, the 96 well plate assay method 
must be optimised to detect both fast and very weak activities. The latter is 
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necessary when looking for activity with very poor substrates of the wild-type 
enzyme. To ensure this, a relatively long reaction time was employed. Activity was 
determined by monitoring NADPH oxidation at 340 nm in the presence of an 
oxidising substrate. 
3.5.5.1 Microplate apparent path length calculation 
Due to the requirement to calculate accurate rates for assay, it was necessary to 
derive an accurate value for the apparent path length used in enzyme assays. The 
absorbance of known concentrations of NADPH in a constant volume (300 µl) were 
recorded to determine the apparent path length (lapp) of solution in microplate 
wells (Figure 3.27).  
 
Figure 3.27. Standard curve of known NADPH concentrations and the absorbance given in the plate 
reader.  
Analysis of the linear fit to the data and applying beers law (A = ε c l) yielded a lapp 
of 0.84 cm, which was used in all subsequent analyses. 
3.5.5.2 PETNRHis concentration dependence of reaction rate  
In order to allow estimation of the concentration of PETNR present in purifications, 
a standard curve was recorded (Figure 3.28) of the steady-state rates as a function 
of enzyme concentration. This graph should allow the estimation of the enzyme 
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concentration from purifications by performing standard assays with NADPH and 
CH. 
 
Figure 3.28. Calibration curve used to estimate the concentration of PETNRHis. Rates were 
determined using 0.1 mM NADPH, 6.5 mM CH in 50 mM pH 7 KH2PO4/K2HPO4 buffer for 10 min at 25 
˚C. 
Results indicated a strong linear correlation between the amount of enzyme 
present in the reaction and the steady-state reaction rates from the turnover of 
NADPH and CH and will be used in later sections to extrapolate and estimate of the 
protein concentration. 
3.5.5.3 Steady-state rate as a function of CH concentration of PETNRHis recorded in a 
96 well format on a microplate reader.  
To assess the accuracy and reproducibility of microtitre plate assays, data were 
recorded for the steady-state reaction rates as a function of CH concentration 
under identical conditions to the initial characterisation conditions described in 
Figures 3.4 and 3.14. Calculations were adjusted to account for the differences in 
path length between conventional spectrophotometric assays and microplate 
assays. 
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Figure 3.29. The steady-state rate as a function of CH concentration of PETNRHis recorded using an 
anaerobic plate reader. Data were recorded by monitoring the rate of NADPH oxidation at 340 nm 
over a maximum period of 120 s. Data were recorded at 0.1 μM PETNR, 150 µM NADPH, 25 °C in 50 
mM KH2PO4/K2HPO4 pH 7. Panel A, non-linear least squares fit to the Michalis-Menten equation 
incorporating substrate inhibition (Section 2.2.3.2, Equation 2.3) and kinetic parameters were 
estimated; Panel B, example trace obtained for an assay performed with 6 mM CH. 
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From the above data, the apparent kinetic parameters associated with the steady-
state reaction of PETNRHis were estimated as kcat = 4.9 ± 0.7 s
-1, KM
CH = 5.4 ± 1.1 mM 
for the steady-state turnover at fixed NADPH concentration (150 µM). Substrate 
inhibition was again observed and the value of Ki
CH = 10.5 ± 2.4  mM, which bears 
reasonable similarity to the previously recorded data from Section 3.3.4. There are 
however some significant differences to note, most obviously the maximum 
recorded rate and kcat are lower than those recorded using the conventional 
spectrophotometric method. This is most likely due to an increase in the time taken 
to begin reading reactions. In the spectrophotometric methods reaction initiation, 
mixing and initial measurements occur in very close order. However, in the plate 
reader there are several steps which contribute to an increased delay. First there 
are several steps in the initiation of reaction that are limited by the speed of the 
plate readers mechanical parts, such as moving the plate into the reader. Second, 
mixing using the plate reader is less efficient, hence takes longer to complete, than 
mixing by inversion. 
This additional delay results in an increase in the time between initiation of reaction 
and observation of first data points. This results in the underestimation of the true 
reaction rate. This underestimation results in the underestimation of v/E0 and as a 
result the underestimation of kcat. Those data points with a faster rate are 
particularly sensitive to this phenomenon.   
Lowering the concentration of enzyme or decreasing the mixing time could 
potentially minimise these problems however generate further problems of their 
own including too small a change in absorbance to be reliable or poorly mixed 
reactions respectively. 
3.5.6 Control robotic method trials with PETNRHis 
In order to validate the approach and assess the accuracy and reproducibility of the 
robotics protocols, PETNRHis colonies were tested and protein levels, degree of 
purification and kinetic activity were detected and statistically analysed. 
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3.5.6.1 Expression trial 
Highly consistent protein expression was detected in cultures grown after robotic 
colony picking and expression in TB AIM (Figure 3.30) 
 
Figure 3.30. Expression trial gel showing the cell pellet of 1 ml cultures PETNRHis WT grown in a 96 
well format. Lane M, Pageruler plus prestained protein ladder (Fermentas; 10 (not visible), 17, 28, 
36, 55, 72, 95, 130, 250); Lane S, PETNRWT standard; other labels, well from which each sample was 
taken. SDS PAGE was performed on a 12 % SDS PAGE gel electrophoresed at 180 V for 45 min. The 
gel was stained. The gel was stained with Coomassie Brilliant Blue R250. 
3.5.6.2 Purification trial 
Robotic lysis and purification were performed, as described in the protocols 
discussed in Section 2.2.4.10, for PETNRHis clones. Eluates from the purification 
were subjected to analysis by SDS PAGE, protein quantitation and standard assay 
with the NADPH/CH couple. 
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Figure 3.31. Eluate gel from the purification of 1 ml cultures PETNRHis WT grown in a 96 well format. 
Lane M, Pageruler plus prestained protein ladder (Fermentas; 10, 17, 28, 36, 55, 72, 95, 130, 250); 
Lane S, PETNRWT standard; other labels, well from which each sample was taken. SDS PAGE was 
performed on a 12 % SDS PAGE gel electrophoresed at 180 V for 45 min. The gel was stained. The gel 
was stained with Coomassie Brilliant Blue R250. 
SDS PAGE analysis indicated an approximately constant level of pure protein in the 
eluates, which following quantitation was found to be 148 ± 20 µg ml-1. This 
represents an error associated with the protein concentration of ~14 %. This value 
is thought to account for errors in the protocol, attributed to growth and 
purification, and to some extent protein expression. 
Protein eluates were assayed using a standard 96 well protocol using NADPH/CH to 
assess the intra block variability (Figure 3.32). The results demonstrated an average 
rate of 207 ± 55 nM s-1 overall representing a total error of 27 %. A large proportion 
of this error has been accounted for in the purification error. However, this 
experiment also suggests that an approximately equal contribution comes from 
variations within the assay. 
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Figure 3.32. Panel A shows the initial rates for screening reactions in individual wells of the 96 well 
plate. Panel B shows the initial rate for screening reactions grouped by row. Panel C shows the initial 
rate for screening reactions grouped by column. 
An important conclusion from this experiment is to demonstrate the minimisation 
of a source of systematic error inherent in the purification protocol. Early 
purification trials with magnetic beads demonstrated a large bias, resulting in wells 
pipetted later received a larger amount of magnetic beads attributable to them 
settling during distribution. Bead settling was counteracted by the addition of 
sucrose to the magnetic bead buffer However, as is demonstrated in Figure 3.32, 
panels B and C, whilst this effect has been minimised it has not been completely 
eliminated with a maximal variation of up to 22 % in the average across the 
columns of the plate; no trend in variation was observed when classified by row. 
Ideally, this type of error would be best classified by assessment of the protein 
concentration but insufficient data were available from protein qubit concentration 
determination to analyse in this way.  
Potential sources of error associated with the growth, purification and assay in 96 
well format include; i) the accuracy of robotic colony picking, ensuring that the best 
growing colonies are picked and that no bubbles or marks in the agar are mistaken 
for colonies; ii) the uniformity of growth rate between individual wells, variation in 
the rate of growth of individual cultures leads to variety in the volume of the pellet 
harvested, this includes the potential loss of pellets during removal of growth 
media; iii) the uniformity of purification conditions, this includes variation in the 
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amount of magnetic beads, the volume of individual buffers and the volume of final 
eluate associated with errors in pipetting on the robotics platform; iv) the 
uniformity of assay conditions, largely consisting of error in pipetting, errors in 
timing of reaction initiation and reading, errors associated with spectrophotometer 
reading. Given the number of potential sources of error in these experiments the 
level of constancy in the wild type assay is remarkable.   
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3.6 Summary 
In summary, PETNRWT was purified and characterised to provide baseline values 
with which to compare data of the tagged enzymes. A poly-histidine tagged version 
(PETNRHis) was generated which expressed extremely well with simple IPTG 
induction, purified simply in a one step protocol and was kinetically almost 
indistinguishable from PETNRWT. A biotin tagged variant of PETNR was generated 
(PETNRBio), which required complex induction conditions and was demonstrated to 
be expressed to a low level and was characterised no further because of this 
difficulty.  
Following generation and characterisation of PETNRHis of the next step was to 
develop a consistent 96 well purification and assay for the high throughput growth 
purification and screening of mutant libraries. This chapter has outlined preliminary 
experiments which enabled the finalisation of a protocol for the library colony 
picking, growth, lysis, purification, and assay using a Hamilton robotics platform. 
The rationale and optimisation of the methods of colony picking, AIM growth, lysis, 
purification, assay and E. coli strain selection have been demonstrated. Initial full 
scale trials of the robotics procedures with PETNRHis enabled an estimation of the 
accuracy and reproducibility of the procedures and a discussion of potential sources 
of error. 
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4 Generation and initial characterisation of PETNRHis libraries 
Following the development of a repeatable, reliable library generation, growth, 
purification and assay protocol as discussed in Chapter 3. The first stage of the 
experimental outline (Figure 3.1) involved the generation of diversity in the gene 
encoding the protein of interest. Following library generation, it is important to 
ensure that; libraries have been sufficiently randomised, that libraries encode 
proteins which are expressed, that the purification protocol performs correctly and 
to characterise the baseline activity with a model substrate couple. Following 
satisfactory verification of these libraries they can then be included in reactions 
screening for acceptance of a range of novel substrates which will be described in 
Chapter 5. 
The design of a series of mutant libraries must include consideration of a number of 
issues including, the method of library generation and the residue position targeted 
for mutagenesis.  
First, one needs to consider a number of options available regarding mutation 
strategy to employ. This ranges from error prone PCR methods (Section 1.6.2.2, [85, 
87, 90]), covering large amounts of sequence space, to small targeted single site 
saturation methods (Section 1.6.2.3, [92, 96, 98]), which can be screened with a 
high degree of coverage.  
In the case of OYE homologues, in particular PETNR, a large amount of information 
is available concerning the mechanism in the active site and the residues which 
contribute to catalysis (Section 1.5, [38, 40, 73, 75]). In the studies reported in this 
thesis, single site saturation mutagenesis has been used which allows generation of 
small focussed libraries [92]. This approach, however, relies heavily on knowledge 
of structure-function relationships.  
In single site saturation libraries single residue positions are randomly mutated by 
utilisation of degenerate oligonucleotides to perform PCR-based replication of 
plasmid DNA incorporating the desired mutated codons [92, 96]. One critical factor 
in the generation of these libraries is the types of nucleotides included in the 
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degenerate oligonucleotides [94, 95]. A range of options can be considered to 
restrict the number of degenerate combinations at a defined position. For example, 
one can incorporate only a single or subset of nucleotides at a defined position in 
the DNA sequence, this limits the number of combinations represented in the 
screen therefore limiting the required screening effort [95]. This leads to maximum 
representation of amino acids with minimal DNA variation [94]. If the variation in 
DNA sequence is constrained too much the library will not contain all amino acid 
residues types at the target position, and under some circumstances this is 
desirable [94]. There is clearly a trade off between variation in sequence and amino 
acid coverage in the library. The degeneracy option selected for this experiment 
was use the bases NNK for target residue codons in the mutagenesis 
oligonucleotides [95]. This enables coverage of all 20 amino acid residues at the 
defined location whilst limiting the number of individual clones to be screened [94]. 
Consequently, for 95 % coverage of the library one needs to screen 94 colonies 
(calculated from equation given in Section 1.5.2.4 [95, 102]), which can be achieved 
in a single deep well block. 
This approach should allow for rapid saturation mutagenesis of a number of 
positions in the active site of PETNR whilst maintaining reasonable library sizes, 
thereby allowing rapid screening of a number of target compounds.  
A further important factor for the generation and screening of single site saturation 
libraries is the residue position selected for mutagenesis. As described previously 
(Section 1.4), a wide range of structure-function data is available for PETNR and 
other OYE homologues and these structural data were used to inform the selection 
of target residues for mutagenesis experiments. These residues were selected on 
the basis of their involvement in catalysis (as defined by literature reports) [38, 73, 
75], by analogy with residues involved in catalysis in other OYE homologue 
(references within Section 1.4 and [169]), or by their proximity to the active site in 
the PETNR crystal structure [40]. Residues such as H181 and H184 (Section 1.5.3.4, 
[38, 73]), Y351 (Section 1.5.3.6, [15, 40]) are known to have a clear role in substrate 
binding. Residue Y186 (Section 1.5.3.5) was targeted following identification as the 
proton donor in OYE [77], however having a more obscure role in the remainder of 
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the family [41, 73]. Residues T26 (Section 1.5.3.1, [66, 73, 78]), Y68 (Section 1.5.3.2, 
[40, 78]), W102 (Section 1.5.3.3, [38, 75, 78]) and Q241 (Section 1.5.3.7, [15, 40, 
41]) were targeted following implication in influencing reactivity from a 
combination of structural data and past studies. 
  
Results 2 
155 | P a g e  
4.1 Single site saturation mutagenesis library generation 
Single site saturation libraries were generated by PCR amplification of PETNRHis 
using single site degenerate oligonucleotides at a range of positions using Kod DNA 
polymerase according to the standard PCR protocol (Section 2.2.1.8). 
Oligonucleotide sequences are given in Appendix 1 (Page 236). Following DpnI 
digestion (Section 2.2.1.9), PCR products were analysed by agarose gel 
electrophoresis (Section 2.2.1.1) and gel purified (Section 2.2.1.3).  
 
Figure 4.1. Agarose gels showing the results from PCRs to generate single site NNK libraries. Lane 
M1, 1 kbp ladder (NEB; 0.5, 1, 1.5, 2, 3, 4, 5, 6, 8, 10 kbp); Lanes M2, Generuler 1 kbp ladder 
(Fermentas; 250, 500, 750 bp, 1, 1.5, 2, 2.5, 3, 3.5, 4, 5, 6, 8, 10 kbp); Lane A, H181X; Lane B, H184X; 
Lane C, T26X; Lane D, Y68X; Lane E, W102X; Lane F, Y186X; Lane G, Q241X; Lane H, Y351X. The band 
marked on the gel is consistent with the 4 kb plasmid (pBluescript SK+) containing the PETNR insert. 
Electrophoresis was performed in a 0.6 % agarose gel at 100 V for 45 min. 
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All PCRs generated the expected ~4 kbp plasmid product in sufficient quantities 
(Figure 4.1). These products were purified from the agarose gel and transformed 
into E. coli strain JM109 (Section 2.2.1.8) for library generation. The 
transformations were plated onto selective LB agar plates following serial dilution. 
Libraries of mutants were generated by selecting individual colonies using the 
robotic colony picker, transferred to a 96 well plate containing TB medium, grown 
(overnight at 37 °C, according to the standard protocol, Section 2.2.4.10.2) and 
stored at -80 ˚C in 96 well PCR plates plate following addition of glycerol (Section 
2.2.4.10.1). These glycerol stocks were used as the inocula for all library screening 
experiments (Section 2.2.4.10.2-3). 
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4.2 Random sequencing of colonies 
In order to determine the degree of randomisation of the amino acid residue at 
each targeted position, a number of individual clones were selected for growth 
amplification, these cells were used to prepare DNA for sequencing. Consequently, 
a sample of 10 clones from each library (selected randomly) were grown and used 
for DNA sequence analysis (Section 2.2.1.2; Section 2.2.1.5); replicate cultures were 
also grown in 96 well format for quantification of protein expression, enzyme 
purification and assay. The randomly selected wells were replicated for all libraries 
and the same experiments were performed.  
In the results described below, where large insertions/deletions were observed, 
these insertions/deletions are omitted from the alignment figures (Figure 4.2-9) for 
the sake of clarity. However, all results are detailed in the tabulated results (Tables 
4.1-8). Labels adopt a standard format maintained throughout where the first block 
of numerals indicates the mutant library and the second alpha-numeric entry 
indicates the well sampled from that library (e.g. 26 A3 indicates well A3 from the 
T26X library). 
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WT             CCCCAAACCGCGTGTTTATGGCCCCACTTACCCGTCTGCGCAGCATCGAGCCGGGCGATA  
26 A3          CCCCAAACCGCGTGTTTATGGCCCCACTTGTGCGTCTGCGCAGCATCGAGCCGGGCGATA  
26 B11         CCCCAAACCGCGTGTTTATGGCCCCACTTGTGCGTCTGCGCAGCATCGAGCCGGGCGATA  
26 C6          CCCCAAACCGCGTGTTTATGGCCCCACTTCGTCGTCTGCGCAGCATCGAGCCGGGCGATA  
26 C10         CCCCAAACCGCGTGTTTATGGCCCCACTTAAGCGTCTGCGCAGCATCGAGCCGGGCGATA  
26 D2          CCCCAAACCGCGTGTTTATGGCCCCACTTGGTCGT-TGCGCAGCATCGAGCCGGGCGATA  
26 E7          CCCCAAACCGCGTGTTTATGGCCCCACTTCCTCGTCTGCGCAGCATCGAGCCGGGCGATA  
26 F8          CCCCAAACCGCGTGTTTATGGCCCCACTTGAGCGTCTGCGCAGCATCGAGCCGGGCGATA  
26 F12         CCCCAAACCGCGTGTTTATGGCCCCACTTTTTCGTCTGCGCAGCATCGAGCCGGGCGATA  
26 G9          CCCCAAACCGCGTGTTTATGGCCCCACTTTAGCGTCTGCGCAGCATCGAGCCGGGCGATA  
               *****************************   *** ************************ 
Figure 4.2. Alignment of 10 random selected colonies from the PETNR T26X library. Plasmid DNA was 
extracted from 5 ml cultures and sequenced in the region of the randomised position. The alignment 
was performed using the Clustal online tool [164]. 
Clone Codon Amino Acid 
WT ACC Thr 
A3 GTG Val 
B11 GTG Val 
C6 CGT Arg 
C10 AAG Lys 
D2 GGT Gly 
E7 CCT Pro 
F8 GAG Glu 
F12 TTT Phe 
G9 TAG Stop 
H4 Insertion  
 Table 4.1. Identification of residue 26 in randomly sequenced clones from the T26X library. 
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WT             AAGCCACGCAGATTTCTGCTCAGGCAAAAGGCTACGCCGGTGCACCGGGTCTGCACAGCC  
68 A3          AAGCCACGCAGATTTCTGCTCAGGCAAAAGGCGTTGCCGGTGCACCGGGTCTGCACAGCC  
68 B11         AAGCCACGCAGATTTCTGCTCAGGCAAAAGGCAATGCCGGTGCACCGGGTCTGCACAGCC  
68 C6          AAGCCACGCAGATTTCTGCTCAGGCAAAAGGCGGGGCCGGTGCACCGGGTCTGCACAGCC  
68 C10         AAGCCACGCAGATTTCTGCTCAGGCAAAAGGCCTGGCCGGTGCACCGGGTCTGCACAGCC  
68 D2          AAGCCACGCAGATTTCTGCTCAGGCAAAAGGCAAGGCCGGTGCACCGGGTCTGCACAGCC  
68 E7          AAGCCACGCAGATTTCTGCTCAGGCAAAAGGCAGGGCCGGTGCACCGGGTCTGCACAGCC  
68 F8          AAGCCACGCAGATTTCTGCTCAGGCAAAAGGCCAGGCCGGTGCACCGGGTCTGCACAGCC  
68 F12         AAGCCACGCAGATTTCTGCTCAGGCAAAAGGCGTGGCCGGTGCACCGGGTCTGCACAGCC  
68 G9          AAGCCACGCAGATTTCTGCTCAGGCAAAAGGCCATGCCGGTGCACCGGGTCTGCACAGCC  
               ********************************   ************************* 
Figure 4.3. Alignment of 10 random selected colonies from the PETNR T68X library. Plasmid DNA was 
extracted from 5 ml cultures and sequenced in the region of the randomised position. The alignment 
was performed using the Clustal online tool [164]. 
Clone Codon Amino Acid 
WT TAC Tyr 
A3 GTT Val 
B11 AAT Asn 
C6 GGG Gly 
C10 CTG Leu 
D2 AAG Lys 
E7 AGG Arg 
F8 CAG Gln 
F12 GTG Val 
G9 CAT His 
H4 Deletion  
Table 4.2. Identification of residue 68 in randomly sequenced clones from the Y68X library.  
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WT             TTCAGCTGTGGCACACCGGTCGTATCTCACACAGCAGCATCCAGCCTGGCGGTCAGGCGC  
102 A3         TTCAGCTGTAGCACACCGGTCGTATCTCACACAGCAGCATCCAGCCTGGCGGTCAGGCGC  
102 B11        TTCAGCTGCTGCACACCGGTCGTATCTCACACAGCAGCATCCAGCCTGGCGGTCAGGCGC  
102 C6         TTCAGCTGTCTCACACCGGTCGTATCTCACACAGCAGCATCCAGCCTGGCGGTCAGGCGC  
102 C10        TTCAGCTGTCTCACACCGGTCGTATCTCACACAGCAGCATCCAGCCTGGCGGTCAGGCGC  
102 D2         TTCAGCTGTTTCACACCGGTCGTATCTCACACAGCAGCATCCAGCCTGGCGGTCAGGCGC  
102 E7         TTCAGCTGAGGCACACCGGTCGTATCTCACACAGCAGCATCCAGCCTGGCGGTCAGGCGC  
102 F8         TTCAGCTGGGGCACACCGGTCGTATCTCACACAGCAGCATCCAGCCTGGCGGTCAGGCGC  
102 F12        TTCAGCTGCCGCACACCGGTCGTATCTCACACAGCAGCATCCAGCCTGGCGGTCAGGCGC  
102 G9         TTCAGCTGATTCACACCGGTCGTATCTCACACAGCAGCATCCAGCCTGGCGGTCAGGCGC  
102 H4         TTCAGCTGGGGCACACCGGTCGTATCTCACACAGCAGCATCCAGCCTGGCGGTCAGGCGC 
               ********   ************************************************* 
Figure 4.4. Alignment of 10 random selected colonies from the PETNR W102X library. Plasmid DNA 
was extracted from 5 ml cultures and sequenced in the region of the randomised position. The 
alignment was performed using the Clustal online tool [164]. 
Clone Codon Amino Acid 
WT TGG Trp 
A3 TAG Stop 
B11 CTG Leu 
C6 TCT Ser 
C10 TCT Ser 
D2 TTT Phe 
E7 AGG Arg 
F8 GGG Gly 
F12 CCG Pro 
G9 ATT Ile 
H4 GGG Gly 
Table 4.3. Identification of residue 102 in randomly sequenced clones from the W102X library. 
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WT             GCTTCACTCTGCGCACGGTTACCTGCTGCATCAGTTCCTGTCCCCGTCTTCCAACCAGCG  
181 A3         GCTTAGGTCTGCGCACGGTTACCTGCTGCATCAGTTCCTGTCCCCGTCTTCCAACCAGCG  
181 B6         GCTTGCTTCTGCGCACGGTTACCTGCTGCATCAGTTCCTGTCCCCGTCTTCCAACCAGCG  
181 D1         GCTTGATTCTGCGCACGGTTACCTGCTGCATCAGTTCCTGTCCCCGTCTTCCAACCAGCG  
181 E7         GCTTTCTTCTGCGCACGGTTACCTGCTGCATCAGTTCCTGTCCCCGTCTTCCAACCAGCG  
181 F2         GCTTCGGTCTGCGCACGGTTACCTGCTGCATCAGTTCCTGTCCCCGTCTTCCAACCAGCG  
181 F10        -CTTAGTTCTGCGCACGGTTACCTGCTGCATCAGTTCCTGTCCCCGTCTTCCAACCAGCG  
181 G11        GCTTCTTTCTGCGCACGGTTACCTGCTGCATCAGTTCCTGTCCCCGTCTTCCAACCAGCG  
181 H2         GCTTTCGTCTGCGCACGGTTACCTGCTGCATCAGTTCCTGTCCCCGTCTTCCAACCAGCG  
181 H5         GCTTACGTCTGCGCACGGTTACCTGCTGCATCAGTTCCTGTCCCCGTCTTCCAACCAGCG  
                ***   ***************************************************** 
Figure 4.5. Alignment of 10 random selected colonies from the PETNR H181X library. Plasmid DNA 
was extracted from 5 ml cultures and sequenced in the region of the randomised position. The 
alignment was performed using the Clustal online tool [164]. 
Clone Codon Amino Acid 
WT CAC His 
A3 AGG Arg 
B6 GCT Ala 
C10 Insertion  
D1 GAT Asp 
E7 TCT Ser 
F2 CGG Arg 
F10 AGT Ser 
G11 CTT Leu 
H2 TCG Ser 
H5 ACG Thr 
Table 4.4. Identification of residue 181 in randomly sequenced clones from the H181X library.  
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WT             GCTTCACTCTGCGCACGGTTACCTGCTGCATCAGTTCCTGTCCCCGTCTTCCAACCAGCG  
184 A3         GCTTCACTCTGCGGAGGGTTACCTGCTGCATCAGTTCCTGTCCCCGTCTTCCAACCAGCG  
184 B6         GCTTCACTCTGCGATTGGTTACCTGCTGCATCAGTTCCTGTCCCCGTCTTCCAACCAGCG  
184 C10        GCTTCACTCTGCGAAGGGTTACCTGCTGCATCAGTTCCTGTCCCCGTCTTCCAACCAGCG  
184 D1         GCTTCACTCTGCGGTTGGTTACCTGCTGCATCAGTTCCTGTCCCCGTCTTCCAACCAGCG  
184 E7         GCTTCACTCTGCGGTGGGTTACCTGCTGCATCAGTTCCTGTCCCCGTCTTCCAACCAGCG  
184 F2         GCTTCACTCTGCGGATGGTTACCTGCTGCATCAGTTCCTGTCCCCGTCTTCCAACCAGCG  
184 F10        GCTTCACTCTGCGTCGGGTTACCTGCTGCATCAGTTCCTGTCCCCGTCTTCCAACCAGCG  
184 G11        GCTTCACTCTGCGCATGGTTACCTGCTGCATCAGTTCCTGTCCCCGTCTTCCAACCAGCG  
184 H2         GCTTCACTCTGCGATTGGTTACCTGCTGCATCAGTTCCTGTCCCCGTCTTCCAACCAGCG  
184 H5         GCTTCACTCTGCGTAGGGTTACCTGCTGCATCAGTTCCTGTCCCCGTCTTCCAACCAGCG 
               *************   ******************************************** 
Figure 4.6. Alignment of 10 random selected colonies from the PETNR H184X library. Plasmid DNA 
was extracted from 5 ml cultures and sequenced in the region of the randomised position. The 
alignment was performed using the Clustal online tool [164]. 
Clone Codon Amino Acid 
WT CAC His 
A3 GAG Glu 
B6 ATT Ile 
C10 AAG Lys 
D1 GTT Val 
E7 GTG Val 
F2 GAT Asp 
F10 TCG Ser 
G11 CAT His 
H2 ATT Ile 
H5 TAG STOP 
Table 4.5. Identification of residue 184 in randomly sequenced clones from the H184X library. 
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WT             GGTACCCTGCTGCATCAGTTCCTGTCCCCGTCTTCCAACCAGCGTACCGACCAGTACGGC  
186 A3         GGTCGTCTGCTGCATCAGTTCCTGTCCCCGTCTTCCAACCAGCGTACCGACCAGTACGGC  
186 B11        GGTGGTCTGCTGCATCAGTTCCTGTCCCCGTCTTCCAACCAGCGTACCGACCAGTACGGC  
186 C6         GGTCGGCTGCTGCATCAGTTCCTGTCCCCGTCTTCCAACCAGCGTACCGACCAGTACGGC  
186 F12        GGTAATCTGCTGCATCAGTTCCTGTCCCCGTCTTCCAACCAGCGTACCGACCAGTACGGC  
186 G9         GGTGATCTGCTGCATCAGTTCCTGTCCCCGTCTTCCAACCAGCGTACCGACCAGTACGGC  
186 H4         GGTAGGCTGCTGCATCAGTTCCTGTCCCCGTCTTCCAACCAGCGTACCGACCAGTACGGC  
               ***   ****************************************************** 
Figure 4.7. Alignment of 10 random selected colonies from the PETNR Y186X library. Plasmid DNA 
was extracted from 5 ml cultures and sequenced in the region of the randomised position. The 
alignment was performed using the Clustal online tool [164]. 
Clone Codon Amino Acid 
WT TAC Tyr 
A3 CGT Arg 
B11 GGT Gly 
C6 CGG Arg 
C10 Insertion  
D2 Insertion  
E7 Insertion  
F8 Insertion  
F12 AAT Asn 
G9 GAT Asp 
H4 AGG Arg 
Table 4.6. Identification of residue 186 in randomly sequenced clones from the Y186X library. 
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WT             TTCCAGAACGTCGACAACGGTCCGAACGAAGAAGCAGACGCGCTGTATCTGATTGAAGAG  
241 A3         TTCTAGAACGTCGACAACGGTCCGAACGAAGAAGCAGACGCGCTGTATCTGATTGAAGAG  
241 B11        TTCCCTAACGTCGACAACGGTCCGAACGAAGAAGCAGACGCGCTGTATCTGATTGAAGAG  
241 C6         TTCAAGAACGTCGACAACGGTCCGAACGAAGAAGCAGACGCGCTGTATCTGATTGAAGAG  
241 C11        TTCTAGAACGTCGACAACGGTCCGAACGAAGAAGCAGACGCGCTGTATCTGATTGAAGAG  
241 D2         TTCATGAACGTCGACAACGGTCCGAACGAAGAAGCAGACGCGCTGTATCTGATTGAAGAG  
241 E7         TTCAAGAACGTCGACAACGGTCCGAACGAAGAAGCAGACGCGCTGTATCTGATTGAAGAG  
241 F8         TTCTAGAACGTCGACAACGGTCCGAACGAAGAAGCAGACGCGCTGTATCTGATTGAAGAG  
241 F12        TTCATGAACGTCGACAACGGTCCGAACGAAGAAGCAGACGCGCTGTATCTGATTGAAGAG  
241 G9         TTCGATAACGTCGACAACGGTCCGAACGAAGAAGCAGACGTGCTGTATCTGATTGAAGAG  
241 H4         TTCTAGAACGTCGACAACGGTCCGAACGAAGAAGCAGACGCGCTGTATCTGATTGAAGAG 
               ***   ********************************** ******************* 
Figure 4.8. Alignment of 10 random selected colonies from the PETNR Q241X library. Plasmid DNA 
was extracted from 5 ml cultures and sequenced in the region of the randomised position. The 
alignment was performed using the Clustal online tool [164]. 
Clone Codon Amino Acid 
WT CAG Gln 
A7 TAG Stop 
B11 CCT Pro 
C6 AAG Lys 
C10 TAG Stop 
D2 ATG Met 
E7 AAG Lys 
F8 TAG Stop 
F12 ATG Met 
G9 GAT Asp 
H4 TAG Stop 
Table 4.7. Identification of residue 241 in randomly sequenced clones from the Q241X library. 
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WT             GTTGCCCGTTTGCAGAAAAAAGCCGAACTGAACCCGCAGCGTCCTGAAAGCTTCTATGGC  
351 A7         GTTGCCCGTTTGCAGAAAAAAGCCGAACTGAACCCGCAGCGTCCTGAAAGCTTCGCTGGC  
351 B11        GTTGCCCGTTTGCAGAAAAAAGCCGAACTGAACCCGCAGCGTCCTGAAAGCTTCTCGGGC  
351 C6         GTTGCCCGTTTGCAGAAAAAAGCCGAACTGAACCCGCAGCGTCCTGAAAGCTTCAATGGC  
351 C10        GTTGCCCGTTTGCAGAAAAAAGCCGAACTGAACCCGCAGCGTCCTGAAAGCTTCCTGGGC  
351 D2         GTTGCCCGTTTGCAGAAAAAAGCCGAACTGAACCCGCAGCGTCCTGAAAGCTTCTATGGC  
351 E7         GTTGCCCGTTTGCAGAAAAAAGCCGAACTGAACCCGCAGCGTCCTGAAAGCTTCTGGGGC  
351 F8         GTTGCCCGTTTGCAGAAAAAAGCCGAACTGAACCCGCAGCGTCCTGAAAGCTTCACTGGC  
351 F12        GTTGCCCGTTTGCAGAAAAAAGCCGAACTGAACCCGCAGCGTCCTGAAAGCTTCCTTGGC  
351 G9         GTTGCCCGTTTGCAGAAAAAAGCCGAACTGAACCCGCAGCGTCCTGAAAGCTTCTTTGGC  
351 H4         GTTGCCCGTTTGCAGAAAAAAGCCGAACTGAACCCGCAGCGTCCTGAAAGCTTCTTGGGC  
               ******************************************************   *** 
Figure 4.9. Alignment of 10 random selected colonies from the PETNR Y351X library. Plasmid DNA 
was extracted from 5 ml cultures and sequenced in the region of the randomised position. The 
alignment was performed using the Clustal online tool [164]. 
Clone Codon Amino Acid 
WT TAT Tyr 
A7 GCT Ala 
B11 TCG Ser 
C6 AAT Asn 
C10 CTG Leu 
D2 TAT Tyr 
E7 TGG Trp 
F8 ACT Thr 
F12 CTT Leu 
G9 TTT Phe 
H4 TTG Leu 
Table 4.8. Identification of residue 351 in randomly sequenced clones from the Y351X library. 
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Library 
Unique 
mutants 
Duplicate 
amino 
acids[a] 
Ins/Del 
Wild-
type 
Stop 
codons 
Usable 
clones[b] 
(%) 
Calculated 
actual 
screening 
effort 
(clones) 
T26X 6 1 1 0 1 80 76 
Y68X 8 1 1 0 0 90 86 
W102X 7 2 0 0 1 90 86 
H181X 6 2 1 0 0 80 76 
H184X 6 2 0 1 1 100 96 
Y186X 4 2 4 0 0 60 57 
Q241X 3 2 0 0 4 90 86[c] 
Y351X 8 1 0 1 0 100 96 
[a] Number of mutant amino acids present at least twice within the 10 library 
members sequenced. 
[b] Percentage of clones that did not contain an insertion/deletion/additional 
mutation. Wild-type/STOP codons were included in the calculation. 
[c] Likely to be an overestimate due to over-representation of STOP codons 
Table 4.9. Statistics for the random sequencing of PETNR libraries. 
Statistics summarising the library sampling are given in Table 4.9. It is important to 
point out that 10 out of 96 colonies were sampled representing ~10 % of wells. 
Statistical analysis would be improved if a wider sample number was chosen. 
However, for the purpose of confirming randomisation at the target codon the 
sample size was considered to be sufficient. 
There are several important points to note when analysing the random sequencing 
results from the constructed libraries. First, there is an occasional occurrence of 
internal STOP codons at the randomised position, as seen in the libraries T26X, 
W102X and H184X. This is expected as the degeneracy used for the construction of 
the libraries (NNK) includes the termination codon TAG. In some cases, such as the 
Q241X library, the frequency of an internal stop codon seems to be greatly 
enhanced compared with that expected by probability alone. This might indicate 
some bias towards clones containing the STOP codons at this position (although 
one needs to consider the low sample number used in the analysis). An interesting 
point to note is the similarity between the wild type CAG codon of this library and 
the STOP TAG codon. This suggests that the STOP codon might bind preferentially 
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to the template DNA compared with other oligonucleotides. However, the same 
over-representation should also be present for wild type, but this does not appear 
to be the case. From the available evidence it is impossible to determine if this is 
mechanism based or a statistical artefact. 
Other unexpected mutations were present in the libraries, such as, point mutations 
outside the targeted region and larger insertion and deletions of DNA sequence. 
This phenomenon is potentially problematic since clones with additional mutations 
could be misfolded, missing parts of the protein essential for activity, may be 
targeted for proteolysis in vivo, or have compromised activity. In some cases, large 
numbers of the same unintended mutant in a library can be traced back to a single 
mutation (e.g. insertions in Y186X). This change, thought to occur early in the PCR 
reaction, is then propagated further in subsequent PCR amplifications so that it is 
present in a large subset of the library. In the majority of cases, however, mutations 
outside the target region occur only once and are located close to the randomised 
codon. This often occurs in PCR-based mutagenesis protocols and might be 
explained by errors in the solid phase synthesis of oligonucleotide sequences. An 
alternate explanation where errors are further from the randomised codon is that 
polymerase enzymes used for PCR have an intrinsic error rate and as such naturally 
make occasional errors. 
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4.3 Expression trials of mutant libraries 
Each site-saturated library was grown in TB AIM from the glycerol stocks (Section 
2.2.4.10.2), harvested (2.2.4.10.3) and frozen at -20 ˚C. Samples of cell pellets were 
analysed by SDS PAGE to determine the levels and consistency of PETNR expression 
in each of the mutant libraries.  
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Figure 4.10. SDS PAGE analysis of expression of PETNR mutants in whole cell pellets of the T26X 
library. Lanes M Pageruler plus prestained protein ladder (Fermentas; 10 (not visible), 17 (not 
visible), 28, 36, 55, 72, 95, 130, 250 kDa); Lane A, PETNR standard; Lane B, 26 A3 – T26V-1; Lane C, 
26 B11 – T26V-2; Lane D, 26 C6 – T26R; Lane E, 26 C10 – T26K; Lane F, 26 D2 – T26G; Lane G, 26 E7 – 
T26P; Lane H, 26 F8 – T26E; Lane I, T26 F12 – T26F; Lane J, 26 G9 – STOP; Lane K, Insertion. Analysis 
was performed on a 12 % SDS PAGE gel at 180 V for 45 min, gels were stained with Coomassie 
Brilliant Blue R250. 
 
Figure 4.11. SDS PAGE analysis of expression of PETNR mutants in whole cell pellets of the Y68X 
library. Lanes M Pageruler plus prestained protein ladder (Fermentas; 10 (not visible), 17 (not 
visible), 28, 36, 55, 72, 95, 130, 250 kDa); Lane A,PETNR standard; Lane B, 68 A3 – Y68V; Lane C, 68 
B11 – Y68N; Lane D, 68 C6 – Y68G; Lane E, 68 C10 – Y68L; Lane F, 68 D2 – Y68K; Lane G, 68 E7 Y68R; 
Lane H, 68 F8 - Y68Q; Lane I, 68 F12 – Y68V; Lane J, 68 G9 – Y68H; Lane K, 68 H4 – Deletion. Analysis 
was performed on a 12 % SDS PAGE gel at 180 V for 45 min, gels were stained with Coomassie 
Brilliant Blue R250. 
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Figure 4.12. SDS PAGE analysis of expression of PETNR mutants in whole cell pellets of the W102X 
library. Lanes M Pageruler plus prestained protein ladder (Fermentas; 10 (not visible), 17 (not 
visible), 28, 36, 55, 72, 95, 130, 250 kDa); Lane A,PETNR standard; Lane B, 102 A3 – STOP; Lane C, 
102 B11 – W102L; Lane D, 102 C6 – W102S; Lane E, 102 C10 – W102S; Lane F, 102 D2 – W102F; Lane 
G, 102 E7 W102R; Lane H, 102 F8 – W102G; Lane I, 102 F12 – W102P; Lane J, 102 G9 – W102I; Lane 
K, 102 H4 – W102G. Analysis was performed on a 12 % SDS PAGE gel at 180 V for 45 min, gels were 
stained with Coomassie Brilliant Blue R250. 
  
Figure 4.13. SDS PAGE analysis of expression of PETNR mutants in whole cell pellets of the H181X 
library. Lanes M Pageruler plus prestained protein ladder (Fermentas; 10 (not visible), 17, 28, 36, 55, 
72, 95, 130, 250 kDa) including PETNR standard (40 kDa); Lane A, 181 A11; Lane B,181 B2; Lane C, 
181 C6; Lane D, 181 E9; Lane E, 181 G2; Lane F, 181 H7. Analysis was performed on a 12 % SDS PAGE 
gel at 180 V for 45 min, gels were stained with Coomassie Brilliant Blue R250. 
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Figure 4.14. SDS PAGE analysis of expression of PETNR mutants in whole cell pellets of the H184X 
library. Lanes M Pageruler plus prestained protein ladder (Fermentas; 10 (not visible), 17, 28, 36 , 55, 
72, 95, 130, 250 kDa) including PETNR standard (40 kDa); Lane A, 184 A11; Lane B, 184 B2; Lane C, 
184 C6; Lane D, 184 E9; Lane E, 184 G2; Lane F, 184 H7. Analysis was performed on a 12 % SDS PAGE 
gel at 180 V for 45 min, gels were stained with Coomassie Brilliant Blue R250. 
 
Figure 4.15. SDS PAGE analysis of expression of PETNR mutants in whole cell pellets of the Y186X 
library. Lanes M Pageruler plus prestained protein ladder (Fermentas; 10 (not visible), 17 (not 
visible), 28, 36, 55, 72, 95, 130, 250 kDa); Lane A, PETNR standard; Lane B, 186 A3 – Y186R-1; Lane C, 
186 B11 – Y186G; Lane D, 186 C6 – Y186R-2; Lane E, 186 C10 – Y186M; Lane F, 186 D2 – Y186M; 
Lane G, 186 E7 – Y186I; Lane H, 186 F8 – Deletion; Lane I, 186 F12 – Y186N; Lane J, 186 G9 – Y186D; 
Lane K, 186 H4 – Y186R-3.Analysis was performed on a 12 % SDS PAGE gel at 180 V for 45 min, gels 
were stained with Coomassie Brilliant Blue R250. 
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Figure 4.16. SDS PAGE analysis of expression of PETNR mutants in whole cell pellets of the Q241X 
library. Lanes M Pageruler plus prestained protein ladder (Fermentas; 10 (not visible), 17 (not 
visible), 28, 36, 55, 72, 95, 130, 250 kDa); Lane A, PETNR standard; Lane B, 241 A3 – STOP; Lane C, 
241 B11 – Q241P; Lane D, 241 C6 – Q241K-1; Lane E, 241 C10 – STOP; Lane F, 241 D2 – Q241M-1; 
Lane G, 241 E7 – Q241K-2; Lane H, 241 F8 – STOP; Lane I, 241 F12 – Q241M-2; Lane J, 241 G9 – 
Q241D; Lane K, 241 H4 – STOP. Analysis was performed on a 12 % SDS PAGE gel at 180 V for 45 min, 
gels were stained with Coomassie Brilliant Blue R250. 
 
Figure 4.17. SDS PAGE analysis of expression of PETNR mutants in whole cell pellets of the Y351X 
library. Lanes M Pageruler plus prestained protein ladder (Fermentas; 10 (not visible), 17 (not 
visible), 28, 36, 55, 72, 95, 130, 250 kDa); Lane A, PETNR Standard; Lane B, 351 A3 – Y351A; Lane C, 
351 B11 – Y351S; Lane D, 351 C6 – Y351N; Lane E, 351 C10 – Y351L-1; Lane F, 351 D2 – WT; Lane G, 
351 E7 – Y351W;Lane H, 351 F8 – Y351T; Lane I, 351 F12 – Y351L-2; Lane J, 351 G9 – Y351F; Lane K, 
351 H4 – Y351L-3. Analysis was performed on a 12 % SDS PAGE gel at 180 V for 45 min, gels were 
stained with Coomassie Brilliant Blue R250.  
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The majority of clones from the libraries are capable of expressing PETNR, although 
not all at the same level. However, the Y186X library failed to over express PETNR 
mutant protein (Figure 4.15). A possibility to be considered is that mutations at this 
residue lead to misfolded proteins that are then targeted for proteolysis by the cell. 
However, this is inconsistent with published reports that have demonstrated 
expression and purification of folded enzyme following directed mutagenesis at this 
position (Section 1.5.3.5, [73]). Localised sequence analysis around the site of 
mutagenesis indicated randomisation of the target codon (Figure 4.15 legend). 
However, sequence analysis of the whole gene was not performed and the 
possibility remains that errors in sequence distant from the mutagenesis site were 
generated in the PCR protocol. Analysis of mutants at this position in PETNR will 
likely require re-construction of the library. The expression problem in the Y186X 
library was not characterised any further.   
Some libraries (e.g. T26X, Figure 4.10) demonstrated remarkable consistency in the 
amount of over-expression in the sample clones, suggesting mutations at this 
position had little effect on protein expression. However, libraries such as Y68X and 
Y351X (Figure 4.11 and 4.17 respectively) show greater variability in the levels of 
expression seen. 
SDS PAGE analysis of clones containing internal STOP codons showed that in the 
majority of cases (wells 241 A3, C10, F8; Figure 4.16), the inferred smaller over-
expression product is observed. However, the identity of these products was not 
confirmed. As the truncated products do not contain the C terminal His tag, these 
clones should not be purified by the robotics protocol to be used in library 
screening. Well H4 also coding for STOP has a substantial amount of product of the 
expected size for full length PETNR as well as the truncated product. The most likely 
explanation for this is that multiple colony forming units (cfu) were closely 
positioned on the plate. The robotic colony picker would see this as a single colony. 
In order to limit this occurrence in subsequent screening, the colony picking 
programme was modified so that only circular colonies were picked, thereby 
minimising recovery of ‘mixed’ colonies from the plate. 
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Given the large degree of variation in protein expression, lysed cell assays 
performed with these libraries are not comparable because the enzyme 
concentration in each sample is unknown. To overcome this problem, a micro-scale 
purification of enzyme from the library clones was designed. The aim was to 
recover similar quantities of protein from each culture sample amplified from a 
picked colony. Since recovery of purified protein is similar in each well of the 96 
well plate, normalisation is achieved by using the same protein concentration in 
each assay well. Consequently, only very poorly expressing clones will be 
problematic in achieving normalisation in the automated activity assays. 
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4.4 Robotic purification of mutant libraries 
As well as normalising enzyme concentrations, robotics purification protocols were 
designed to eliminate competing activity from other cellular NADPH utilising 
enzymes. Another complicating factor is that PETNR also has an intrinsic NADPH 
oxidase activity in the presence of oxygen. Consequently, experiments were 
performed in an anaerobic environment (Section 2.2.3.1). Following harvesting of 
cells from the bacterial cultures (Section 2.2.4.10.3), enzyme was purified from 
cultures contained in the 96 well plates using the purification protocol (Section 
2.2.4.10.4). Eluted protein samples were analysed by SDS PAGE and quantified 
using the protein qubit concentration determination method (Section 2.2.1.4).  
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Figure 4.18. SDS PAGE analysis of robotically purified T26X library clones. Lanes M Pageruler plus 
prestained protein ladder (Fermentas; 10 (not visible), 17, 28, 36, 55, 72, 95, 130, 250 kDa); Lane A, 
PETNR standard; Lane B, 26 A3 – T26V-1; Lane C, 26 B11 – T26V-2; Lane D, 26 C6 – T26R; Lane E, 26 
C10 – T26K; Lane F, 26 D2 – T26G; Lane G, 26 E7 – T26P; Lane H, 26 F8 – T26E; Lane I, T26 F12 – 
T26F; Lane J, 26 G9 – STOP; Lane K, Insertion. Analysis was performed on a 12 % SDS PAGE gel at 180 
V for 45 min, gels were stained with Coomassie Brilliant Blue R250. 
 
Figure 4.19. SDS PAGE analysis of robotically purified Y68X library clones. Lanes M Pageruler plus 
prestained protein ladder (Fermentas; 10 (not visible), 17, 28, 36, 55, 72, 95, 130, 250 kDa); Lane 
A,PETNR standard; Lane B, 68 A3 – Y68V; Lane C, 68 B11 – Y68N; Lane D, 68 C6 – Y68G; Lane E, 68 
C10 – Y68L; Lane F, 68 D2 – Y68K; Lane G, 68 E7 Y68R; Lane H, 68 F8 - Y68Q; Lane I, 68 F12 – Y68V; 
Lane J, 68 G9 – Y68H; Lane K, 68 H4 – Deletion. Analysis was performed on a 12 % SDS PAGE gel at 
180 V for 45 min, gels were stained with Coomassie Brilliant Blue R250.  
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Figure 4.20. SDS PAGE analysis of robotically purified W102X library clones. Lanes M Pageruler plus 
prestained protein ladder (Fermentas; 10 (not visible), 17, 28, 36, 55, 72, 95, 130, 250 kDa); Lane 
A,PETNR standard; Lane B, 102 A3 – STOP; Lane C, 102 B11 – W102L; Lane D, 102 C6 – W102S; Lane 
E, 102 C10 – W102S; Lane F, 102 D2 – W102F; Lane G, 102 E7 W102R; Lane H, 102 F8 – W102G; Lane 
I, 102 F12 – W102P; Lane J, 102 G9 – W102I; Lane K, 102 H4 – W102G. Analysis was performed on a 
12 % SDS PAGE gel at 180 V for 45 min, gels were stained with Coomassie Brilliant Blue R250.  
 
Figure 4.21. SDS PAGE analysis of robotically purified H181X library clones. Lanes M Pageruler plus 
prestained protein ladder (Fermentas; 10 (not visible), 17, 28, 36, 55, 72, 95, 130, 250 kDa) including 
PETNR standard (40 kDa); Lane A, 181 A11; Lane B,181 B2; Lane C, 181 C6; Lane D, 181 E9; Lane E, 
181 G2; Lane F, 181 H7. Analysis was performed on a 12 % SDS PAGE gel at 180 V for 45 min, gels 
were stained with Coomassie Brilliant Blue R250. 
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Figure 4.22. SDS PAGE analysis of robotically purified H184X library clones. Lanes M Pageruler plus 
prestained protein ladder (Fermentas; 10 (not visible), 17, 28, 36, 55, 72, 95, 130, 250 kDa) including 
PETNR standard (40 kDa); Lane A, 184 A11; Lane B, 184 B2; Lane C, 184 C6; Lane D, 184 E9; Lane E, 
184 G2; Lane F, 184 H7. Analysis was performed on a 12 % SDS PAGE gel at 180 V for 45 min, gels 
were stained with Coomassie Brilliant Blue R250. 
 
Figure 4.23. SDS PAGE analysis of robotically purified Q241X library clones. Lanes M Pageruler plus 
prestained protein ladder (Fermentas; 10 (not visible), 17, 28, 36, 55, 72, 95, 130, 250 kDa); Lane A, 
241 A3 – STOP; Lane B, 241 B11 – Q241P; Lane C, 241 C6 – Q241K-1; Lane D, 241 C10 – STOP; Lane 
E, 241 D2 – Q241M-1; Lane F, 241 E7 – Q241K-2; Lane G, 241 F8 – STOP; Lane H, 241 F12 – Q241M-
2; Lane I, 241 G9 – Q241D; Lane J, 241 H4 – STOP. Analysis was performed on a 12 % SDS PAGE gel at 
180 V for 45 min, gels were stained with Coomassie Brilliant Blue R250. 
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Figure 4.24. SDS PAGE analysis of robotically purified Y351X library clones. Lanes M Pageruler plus 
prestained protein ladder (Fermentas; 10 (not visible), 17, 28, 36, 55, 72, 95, 130, 250 kDa); Lane A, 
PETNR Standard; Lane B, 351 A3 – Y351A; Lane C, 351 B11 – Y351S; Lane D, 351 C6 – Y351N; Lane E, 
351 C10 – Y351L-1; Lane F, 351 D2 – WT; Lane G, 351 E7 – Y351W;Lane H, 351 F8 – Y351T; Lane I, 
351 F12 – Y351L-2; Lane J, 351 G9 – Y351F; Lane K, 351 H4 – Y351L-3. Analysis was performed on a 
12 % SDS PAGE gel at 180 V for 45 min, gels were stained with Coomassie Brilliant Blue R250. 
Alongside evidence obtained from SDS PAGE, which provides a visual assessment of 
protein recovery from the purification protocol, protein concentration was 
estimated for selected clones using the protein qubit quantification method (Table 
4.10). 
Library 
Average Protein Concentration 
(µg ml-1) 
Standard deviation 
(µg ml-1) 
T26X 127 20 
Y68X 144 18 
W102X 146 15 
H181X nd nd 
H184X nd nd 
Y186X n/a n/a 
Q241X 122 13 
Y351X 126 42 
Table 4.10. Protein concentration determination for PETNR samples taken from wells of the 96 well 
plate for selected libraries.  
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Both SDS PAGE analysis and protein quantitation methods showed a high level of 
consistency in the quantity of purified protein obtained from robotic purification 
protocols (Figures 4.18 - 24, Table 4.10). This was the case even within libraries that 
showed a large degree of variation in PETNR expression (e.g Y351X, Figure 4.17). 
This finding is important for future screening experiments as it ensures that any 
differences in activity in the library eluates are not influenced substantially by 
variation in enzyme concentration. Excellent examples of this can be seen by 
comparing the growth and purification gels for libraries 68 and 102 (particularly 68 
B11 vs 68 C10, and 102 C10 vs. 102 D2, See Figure 4.11/4.19, 4.12/4.20). These 
findings eliminate the need to determine the protein concentration of each eluate 
following protein purification since each well contains similar quantities of 
expressed protein. This is a significant advantage since incorporation of protein 
assays alongside activity assays would severely limit the high throughput nature of 
the procedure. 
SDS PAGE analysis indicated that PETNR eluates were remarkably pure following a 
single purification step (Figures 4.18 - 24). This reduces considerably the likelihood 
of detecting activity due to the presence of contaminating E. coli NADPH oxidising 
enzymes. Cross contamination has been observed (e.g. with E. coli keto-reductase) 
in other reported experiments with OYE homologues [61]. 
There were no examples where an over-expressed protein detected by SDS PAGE in 
expression trials, resulted in no enzyme recovery following robotic purification.  
This indicates that the purification steps are reliable and reproducible, again a key 
requirement for the automated activity assays being developed.  
Occasionally, some clones with premature STOP codons (e.g. 241 A3, C10, F8, H4), 
yielded small quantities of purified protein product (Figure 4.23). This is unexpected 
as, when expressed, these mutants do not contain a His tag and so should not be 
purified. A likely explanation is that these clones represent a mixture of two 
mutants, with one minor species capable of producing full length protein. However, 
no such erroneous purification was seen in other clones with premature STOP 
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codons (e.g. T26X G9, Y68X H8 and W102X A3, see Figures 4.18 - 20) suggesting this 
observation is limited to this specific library.  
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4.5 Library screening assays using the model substrate couple NADPH/2CH  
Trial experiments for robotics-based purification and enzyme assays were first 
conducted with PETNR libraries using the known substrates NADPH and CH. The 
purpose of this experiment was to measure the range of activity in the libraries 
following mutagenesis using a series of substrates (NADPH/CH) that are known to 
operate well with PETNRWT. The second aim of these assays was to identify wild-
type PETNR clones from the libraries to use as an internal standard/control (internal 
wild type control) for activity screening within a single 96 plate. Controls for this 
experiment were performed by separately assaying known wild-type clones 
propagated and purified within the 96 well format (external wild type controls) for 
comparison with activity measured from the library plates. For the external 
controls, data for activity assays are presented as the average, standard deviation 
and maximum activity recorded from a 96 well PETNRWT plate (as discussed in 
Section 3.5.6). This is shown as the first data column in Figures (4.25 - 31). Activity 
assays from the library plates are single measurements and are shown ranked 
according to activity, determined spectroscopically as δC/δt (nM s-1). The 5 results 
with the highest activity were sequenced to determine which mutation was 
present.  
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Figure 4.25. Activity of T26X library eluates. Reactions comprised 50 µl PETNR library eluate, 0.1 mM 
NADPH, 1 mM CH in 50 mM potassium phosphate buffer pH7 containing 5 % ethanol. Reaction rates 
were calculated by monitoring A340 over the first 126 s of the reaction (δC/δt (nM s
-1)). WT 
represents the average (grey), standard deviation (error bars) and maximum (black) of a separate 
PETNRWT block. 
 
Figure 4.26. Activity of Y68X library eluates. Reactions comprised 50 µl PETNR library eluate, 0.1 mM 
NADPH, 1 mM CH in 50 mM potassium phosphate buffer pH7 containing 5 % ethanol. Reaction rates 
were calculated by monitoring A340 over the first 126 s of the reaction (δC/δt (nM s
-1)). WT 
represents the average (grey), standard deviation (error bars) and maximum (black) of a separate 
PETNRWT block. 
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Figure 4.27. Activity of W102X library eluates. Reactions comprised 50 µl PETNR library eluate, 0.1 
mM NADPH, 1 mM CH in 50 mM potassium phosphate buffer pH7 containing 5 % ethanol. Reaction 
rates were calculated by monitoring A340 over the first 126 s of the reaction (δC/δt (nM s
-1)). WT 
represents the average (grey), standard deviation (error bars) and maximum (black) of a separate 
PETNRWT block. 
 
Figure 4.28. Activity of H181X library eluates. Reactions comprised 50 µl PETNR library eluate, 0.1 
mM NADPH, 1 mM CH in 50 mM potassium phosphate buffer pH7 containing 5 % ethanol. Reaction 
rates were calculated by monitoring A340 over the first 126 s of the reaction (δC/δt (nM s
-1)). WT 
represents the average (grey), standard deviation (error bars) and maximum (black) of a separate 
PETNRWT block. 
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Figure 4.29. Activity of H184X library eluates. Reactions comprised 50 µl PETNR library eluate, 0.1 
mM NADPH, 1 mM CH in 50 mM potassium phosphate buffer pH7 containing 5 % ethanol. Reaction 
rates were calculated by monitoring A340 over the first 126 s of the reaction (δC/δt (nM s
-1)). WT 
represents the average (grey), standard deviation (error bars) and maximum (black) of a separate 
PETNRWT block. 
 
Figure 4.30. Activity of Q241X library eluates. Reactions comprised 50 µl PETNR library eluate, 0.1 
mM NADPH, 1 mM CH in 50 mM potassium phosphate buffer pH7 containing 5 % ethanol. Reaction 
rates were calculated by monitoring A340 over the first 126 s of the reaction (δC/δt (nM s
-1)). WT 
represents the average (grey), standard deviation (error bars) and maximum (black) of a separate 
PETNRWT block. 
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Figure 4.31. Activity of Y351X library eluates. Reactions comprised 50 µl PETNR library eluate, 0.1 
mM NADPH, 1 mM CH in 50 mM potassium phosphate buffer pH7 containing 5 % ethanol. Reaction 
rates were calculated by monitoring A340 over the first 126 s of the reaction (δC/δt (nM s
-1)). WT 
represents the average (grey), standard deviation (error bars) and maximum (black) of a separate 
PETNRWT block. 
 
Figure 4.32. Comparative activities of 96 well purified enzyme blocks. Assays were performed 
according to the robotic protocol with 0.1 mM NADPH, 1 mM CH, 50 µl purified enzyme extract; 
activities were calculated over the first 126 s following insertion of the plate into the reader. 
Average of all wells on the plate (grey), standard deviation (error bars) and maximal rate (black) are 
provided.  
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An important point to note is that the majority of mutants identified from libraries 
had activities far lower than that obtained for PETNRWT, whilst the maximal rate 
was generally comparable to that of wild type enzyme. The majority of clones in the 
library are seriously catalytically impaired (Figure 4.32). 
Those clones which maintain high levels of activity in the individual screens (Figures 
4.25 - 4.31) were sequenced and the majority were identified as PETNRWT clones. 
These clones are not thought to represent the entire wild type population of the 
block due to the fact that only the top 5 ranked clones (i.e. those clones which are 
most active with the NADPH/CH couple as monitored by the δA340/δt (s
-1)) were 
sequenced. This observation supports the hypothesis that the majority of mutations 
compromise rather than improve activity. 
The extent to which the activity is compromised, however, is not uniform. A 
number of libraries such as Y68X, W102X and Q241X (Figures 4.26/27/30/31) have 
retained a large fraction of the wild type levels of activity. However libraries such as 
H181X, H184X and Y351X (Figures 4.28/29/31/32) have poor residual activity. In 
particular, for libraries H181X and H184X (Figures 4.28/28/32) an explanation can 
be advanced that these residues, which are conserved in OYE homologues, have 
been implicated in binding the carbonyl group of the cyclohexenone substrate 
(Section 1.4.3.4, [40]). Mutation of these residues is therefore likely to affect 
substrate binding. Sequencing confirmed that after PETNRWT the next most active 
mutant was H184N. This substitution of histidine to asparagine is seen in some 
natural OYE homologue enzymes (e.g. OYE1 and 2 and MR [14, 16, 18]). 
In the case of the Y351X library clones were characterised by a far lower level of 
activity than the other libraries (Figures 4.31/32), including the wild type clones 
present. This could potentially indicate a reduced concentration in this individual 96 
well purification experiment, and may not necessarily represent a library with a 
lower level of wild type activity. 
The library altered in the identity of Q241 (PETNRWT) was found to have variable 
activity and was the only library for which wild type was not included in the most 
active enzymes (Figures 4.30/32). Also, within the library most enzymes retain high 
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levels of activity compared to PETNRWT. This suggests many of the generated 
mutants are viable proteins and retain catalytic competence, this implies that this 
library could yield improved enzyme variants. 
The top ranked enzyme from each library that was not PETNRWT was carried 
forward for further characterisation in Chapter 6. The aim of this characterisation 
was confirm these mutant enzymes were impaired compared to PETNRWT by 
determining specific activity and biotransformation profiles.  
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4.6 Summary 
The results from this chapter have described the generation of library DNA by 
mutagenic PCR methods at a range of positions which are implicated as being 
important in catalysis and substrate binding on the basis of structural and 
mechanistic studies. These libraries were archived as glycerol stocks within a 96 
well format and analysed using a robotics platform. Libraries were sequenced to 
determine the degree of randomisation. The libraries were then subjected to 
inductive growth and characterised with respect to protein expression. Libraries 
were then micro-scale purified in a 96 well format. A method was developed that 
enabled approximately equal recovery of target protein in each sample well of the 
plate and comparative assay across wells without the need for protein 
quantification. Purified protein libraries were demonstrated to display a variety of 
activities defined by the function of the targeted residue or experimental 
parameters. Where possible, wild type clones were identified from the reactions to 
act as internal controls for future screening experiments. 
In summary this chapter has established a number of DNA libraries for use in the 
rapid screening of variants using the robust high throughput robotics methods 
described in chapter 3 under anaerobic conditions. These libraries were generated 
and their randomisation was validated by random sequencing of clones. Libraries 
were then expressed and purified according to the protocols derived from work in 
chapter 3. Libraries were subjected to initial characterisation assays with the model 
substrates NADPH/CH and demonstrated a variety of activities. Following this in-
depth assessment of library quality these libraries can be used for screening with a 
panel of novel substrates, which will be discussed in Chapter 6, with the intention 
of isolating novel variants capable of accommodating non-natural substrates. 
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5 Screening of PETNRHis libraries against a panel of novel substrates 
5.1 Screening of H181X and H184X libraries to accommodate novel activating 
groups 
Initial experiments focussed on trying to modify the PETNR active site to accept 
novel functionalities in the position occupied by the carbonyl in the model 
substrate cyclohexenone. A range of functionalities have been shown to be 
accommodated in this position in PETNR including keto, nitro, di-keto and di-acid 
(Section 1.3.2; [54, 59, 63]).  
While some enone derivatives are reduced by PETNR and other OYE homologues 
others are not, for example nitrocyclohex-1-ene (NCH) has been demonstrated to 
act as a substrate whilst the respective acid and nitrile compounds were trialled and 
demonstrated no activity (Section 1.3.2; [54, 59, 63]). Similarly (E)-1-nitro-2-
phenylethene has been demonstrated to be a substrate for PETNR, however the 
acid and nitrile derivatives are not (Section 1.3.2). Interestingly, di-acid compounds 
have been demonstrated to be substrates for PETNR suggesting the acid 
functionality can be accommodated (Section 1.3.2), however a literature search has 
found no evidence of nitrile reduction by OYE’s. 
Structural studies of OYE homologues complexed with oxidative substrates and 
inhibitors (Section 1.5.3.4; [40]) have highlighted a key role for residues H181 and 
H184 in binding the electron withdrawing or activating groups of these substrates. 
Thus, these libraries were the first target for mutagenesis to see if different 
residues at positions 181 / 184 could accommodate different activating groups. 
However, it is important to note that these residues are also implicated in FMN 
binding and NADPH reduction (Section 1.4.1.3 and 1.4.2; [69] and [38]) suggesting a 
subset of the library could be catalytically compromised.  
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Figure 5.1. Schematic representation of screening substrates, compounds on the left are known 
substrates of PETNR whereas compounds on the right are non substrates with which to screen 
mutagenic libraries. Panel 1, nitrocyclohex-1-ene; Panel 2, (E)-1-Nitro-2-phenylethene; Panel 3, 
cyclohexene-1-carboxylic acid; Panel 4, cyclohexene-1-carbonitrile; Panel 5, trans-cinnamic acid; 
Panel 6, cinnamonitrile; 
In order to attempt to widen the substrate specificity of PETNR, libraries were 
generated at H181 and H184 as discussed previously (Section 4.1). These libraries 
were expressed and purified (Section 4.3, 4.4) before being assayed with novel 
substrates (Section 2.2.4.10.6). Following assay, Z factors were calculated from 
screening results (Section 2.2.4.10.7). Hits were defined by a Z factor of 2 or above 
(up to a maximum of 2 per library per substrate). If no hits were present according 
to these criteria the top ranked clone was considered a hit. In these experiments, 
clones previously identified as PETNRHis WT (Section 4.5), were used as internal 
controls in the assay reactions. DNA from positive hits was purified (Section 2.2.1.2) 
and sequenced (Section 2.2.1.5). 
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Figure 5.2. Screening of H181X and H184X library eluates against trans-cinnamic acid. Panel A, trans-
cinnamic acid structure; Panel B, H181X screen; Panel C, H184X screen. Reactions comprised 50 µl 
PETNR library eluate, 0.1 mM NADPH, 1 mM CH in 50 mM potassium phosphate buffer pH7 
containing 5 % ethanol. Reaction rates were calculated by monitoring A340 over the first 126 s of the 
reaction (δC/δt (nM s-1)). WT represents the average (grey), standard deviation (error bars) and 
maximum (black) of internal WT controls. 
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Clone δC(NADPH)/δt (nM s
-1) Z score 
H181S (E11) 4.6 4.2 
H181I (B1) 3.4 2.9 
H181- (C8) 3.1 2.4 
H181- (F10) 3.0 2.4 
H181- (D9) 2.5 1.8 
Del (F8) 3.6 2.9 
STOP (H5) 2.3 2.0 
H184- (E1) 1.9 1.7 
H184- (A3) 1.7 1.6 
H184- (C4) 1.5 1.4 
Table 5.1. Summary table showing data from H181X and H184X screening with trans-cinnamic acid. 
Potential hits are highlighted; where data were available well and clone details are given. 
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Figure 5.3. Screening of H181X and H184X library eluates against cinnamonitrile. Panel A, 
cinnamonitrile structure; Panel B, H181X screen; Panel C, H184X screen. Reactions were composed 
of 50 µl PETNR library eluate, 0.1 mM NADPH, 1 mM CH in potassium phosphate buffer containing 5 
% ethanol. Rates were calculated by monitoring A340 over the first 126 s of the reaction (δC/δt (nM s
-
1)). WT represents the average (grey), standard deviation (error bars) and maximum (black) of 
internal WT controls. 
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Clone δC(NADPH)/δt (nM s
-1) Z score 
STOP (H10) 2.6 2.7 
H181S (E10) 2.2 2.3 
H181- (C10) 1.7 1.8 
WT  (A11) 1.7 1.8 
H181- (F10) 1.5 1.5 
H184Y (A1) 2.1 2.4 
H184K (H11) 1.8 2.2 
STOP (H5) 1.8 2.2 
WT  (G12) 1.6 2.0 
H184- (A9) 1.5 1.9 
Table 5.2. Summary table showing data from H181X and H184X screening with cinnamonitrile acid. 
Potential hits are highlighted, where data were available well and clone details are given. 
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Figure 5.4. Screening of H181X and H184X library eluates against cyclohexene-1-carboxylic acid. 
Panel A, cyclohexene-1-carboxylic acid structure; Panel B, H181X screen; Panel C, H184X screen. 
Reactions were composed of 50 µl PETNR library eluate, 0.1 mM NADPH, 1 mM CH in potassium 
phosphate buffer containing 5 % ethanol. Rates were calculated by monitoring A340 over the first 126 
s of the reaction (δC/δt (nM s-1)). WT represents the average (grey), standard deviation (error bars) 
and maximum (black) of Internal WT controls. 
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Clone δC(NADPH)/δt (nM s
-1) Z score 
H181Y (F4) 7.6 2.1 
H181- (D7) 6.7 1.8 
H181- (F9) 6.1 1.5 
H181- (F7) 5.8 1.4 
H181- (G5) 5.6 1.2 
H184F (F11) 7.0 2.5 
WT  (G11) 7.0 2.5 
H184- (F7) 6.7 2.4 
H184- (G2) 5.9 2.0 
H184- (G5) 5.5 1.8 
Table 5.3. Summary table showing data from H181X and H184X screening with 1-cyclohexene-1-
carboxylic acid. Potential hits are highlighted, where data were available well and clone details are 
given.  
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Figure 5.5. Screening of H181X and H184X library eluates against cyclohexene-1-carbonitrile. Panel 
A, cyclohexene-1-carbonitrile structure; Panel B, H181X screen; Panel C, H184X screen. Reactions 
were composed of 50 µl PETNR library eluate, 0.1 mM NADPH, 1 mM CH in potassium phosphate 
buffer containing 5 % ethanol. Rates were calculated by monitoring A340 over the first 126 s of the 
reaction (δC/δt (nM s-1)). WT represents the average (grey), standard deviation (error bars) and 
maximum (black) of Internal WT controls. 
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Clone δC(NADPH)/δt (nM s
-1) Z score 
H181L (E2) 6.6 1.9 
H181- (D5) 6.5 1.9 
H181- (D11) 6.5 1.8 
H181- (F7) 6.4 1.8 
H181- (D8) 6.0 1.6 
H184K (C5) 8.4 1.9 
H184F (C3) 8.2 1.9 
H184F (F11) 8.1 1.8 
H184- (G3) 7.4 1.6 
H184- (B2) 7.4 1.5 
Table 5.4. Summary table showing data from H181X and H184X screening with cyclohexene-1-
carbonitrile. Potential hits are highlighted, where data were available well and clone details are 
given 
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The results indicate that all mutants and WT clones showed poor activity against 
these substrates. In the case of trans-cinnamic acid potential hits were obtained for 
the H181X library, however the same screen for the H184X library highlighted 
clones with significant mutations not conducive with improved catalysis (internal 
STOP and deletion).  
These data suggest that the rates highlighted as hits in the experiment may not be 
genuine hits but outliers of a normal distribution around a low mean. As a 
consequence of this the errors inherent in the purification and assay are far larger 
than variation attributable to any activity improved or not so. This can be seen 
frequently throughout the screening data for the first experiment.  
Despite the low likelihood of these results being genuine hits any clones matching 
the selection criteria discussed previously were purified on a small scale and taken 
forward to the next stage of experimentation. Hits taken forward for further 
experimentation are outlined in Table 5.5.  
Substrate H181X H184X 
Trans-cinnamic acid H181S, H181I n/a 
Cinnamonitrile H181S, H184Y, H184L 
1-Cyclohexene-1-carboxylic acid H181Y H184F 
Cyclohexene-1-carbonitrile H181L H184L 
Table 5.5. Hits taken forward for further characterisation from screening of H181X, H184X single site 
saturation libraries for novel functionality. 
Also, the use of internal control reactions has proved problematic in these cases 
often providing large error values because variation due to noise represents a far 
higher fraction of total activity in smaller rates, hence experimental ‘noise’ makes a 
more significant contribution to error. For future screening reactions an external 
control block of PETNRHis WT will be recorded for all reactions.   
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5.2 Screening of T26X, Y68X, W102X, Q241X and Y351X libraries for expanded 
substrate acceptance. 
In addition to studies attempting to modify binding interactions a number of 
variations of known PETNR substrates with much lower activity were identified as 
outlined in figure 5.6. These substrates involve the substitution of methyl groups at 
various positions on the known substrates cyclohexenone, cyclopentanone and in 
the case of OYE cinnamaldehyde (Section 1.3.2.4, [59, 62, 63]) and the methyl 
substituents have largely been shown to be poor substrates. In these experiments 
WT blocks were used in preference to internal controls in order to improve the 
accuracy of the estimate used for PETNRWT by minimising the effect of outliers. 
 
Figure 5.6. Table showing the screening substrates used to widen the substrate acceptance of PETNR 
along with the respective substrates which are active with WT. Panel 1, 3-methylcyclohex-2-enone; 
Panel 2, 2-methylcyclopent-2-enone; Panel 3, 3-methylcyclopent-2-enone; Panel 4, α-Methyl-trans-
cinnamaldehyde; Panel 5, methyl-trans-cinnamate.  
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Figure 5.7. Screening of a range of PETNRHis libraries against trans-cinnamaldehyde. Panel A, trans-
cinnamaldehyde structure; Panel B, T26X screen; Panel C, Y68X screen; Panel D, W102X screen; 
Panel E, Q241X screen; Panel F, Y351X screen. Reactions were composed of 50 µl PETNR library 
eluate, 0.1 mM NADPH, 1 mM substrate in potassium phosphate buffer containing 5 % ethanol. 
Rates were calculated by monitoring A340 over the first 126 s of the reaction (δC/δt (nM s
-1)). WT 
represents the average (grey), standard deviation (error bars) and maximum (black) of an external 
PETNRWT control block.  
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Clone δC(NADPH)/δt (nM s
-1) Z score 
WT (B9) 257 4.4 
WT (B12) 249 4.3 
WT (G6) 236 4.0 
WT (H2) 204 3.4 
T26S (G11) 171 2.8 
WT (C12) 220 2.5 
WT (B4) 204 2.2 
Y68S (F6) 185 1.9 
Y68- (H6) 181 1.9 
Y68- (E11) 173 1.7 
WT (G5) 247 5.5 
WT (D3) 226 5.0 
WT (G8) 222 4.9 
W102L (D12) 78 1.4 
W102Y (C4) 43 0.5 
Q241L (A10) 277 2.0 
Q241V (A7) 249 1.6 
Q241M (D7) 245 1.6 
Q241V (A9) 243 1.6 
Q241T (H7) 239 1.5 
WT (E3) 180 6.3 
WT (H10) 173 6.1 
WT (D2) 103 3.5 
Y351F (A6) 25 0.6 
Y351- (B10) 21 0.4 
Table 5.6. Summary table showing data from a range of libraries screened with trans-
cinnamaldehyde. Potential hits are highlighted, where data were available well and clone details are 
given.  
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Figure 5.8. Screening of a range of PETNRHis libraries against α-methyl-trans-cinnamaldehyde. Panel 
A, α-methyl-trans-cinnamaldehyde structure; Panel B, T26X screen; Panel C, Y68X screen; Panel D, 
W102X screen; Panel E, Q241X screen; Panel F, Y351X screen. Reactions were composed of 50 µl 
PETNR library eluate, 0.1 mM NADPH, 1 mM substrate in potassium phosphate buffer containing 5 % 
ethanol. Rates were calculated by monitoring A340 over the first 126 s of the reaction (δC/δt (nM s
-
1)). WT represents the average (grey), standard deviation (error bars) and maximum (black) of an 
external PETNRWT control block.  
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Clone δC(NADPH)/δt (nM s
-1) Z score 
WT (H2) 115 5.4 
WT (G6) 96 4.4 
WT (B12) 90 4.1 
WT (B9) 83 3.8 
T26A (H11) 25 0.9 
Y68S (F6) 171 2.8 
Y68S (C7) 156 2.5 
Y68- (D1) 144 2.2 
Y68- (G2) 131 1.9 
Y68- (F11) 128 1.9 
W102F (C11) 206 2.3 
W102Q (G3) 194 2.1 
W102F (D2) 185 1.9 
WT (D7) 176 1.8 
W102Q (G6) 174 1.8 
Q241L (A10) 166 2.0 
Q241P (H12) 150 1.6 
Q241G (H3) 147 1.6 
Q241V (A9) 147 1.6 
Q241V (B3) 144 1.5 
WT (E3) 64 5.8 
WT (H10) 61 5.5 
WT (D2) 33 2.9 
Ins (B12) 23 2.0 
Y351F (A6) 9 0.7 
Table 5.7. Summary table showing data from a range of libraries screened with α-methyl-trans-
cinnamaldehyde. Potential hits are highlighted, where data were available well and clone details are 
given.  
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Figure 5.9. Screening of a range of PETNRHis libraries against methyl-trans-cinnamate. Panel A, α- 
methyl-trans-cinnamate structure; Panel B, T26X screen; Panel C, Y68X screen; Panel D, W102X 
screen; Panel E, Q241X screen; Panel F, Y351X screen. Reactions were composed of 50 µl PETNR 
library eluate, 0.1 mM NADPH, 1 mM substrate in potassium phosphate buffer containing 5 % 
ethanol. Rates were calculated by monitoring A340 over the first 126 s of the reaction (δC/δt (nM s
-
1)). WT represents the average (grey), standard deviation (error bars) and maximum (black) of an 
external PETNRWT control block.  
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Clone δC(NADPH)/δt (nM s
-1) Z score 
T26H (E8) 6.5 1.8 
Del (H7) 6.1 1.7 
T26A (C12) 5.2 1.5 
T26R (A8) 4.9 1.4 
STOP (G7) 4.3 1.2 
Y68- (F5) 6.1 2.1 
Y68M (D8) 5.2 1.8 
Y68I (F2) 4.4 1.6 
Y68- (H4) 4.1 1.5 
Y68- (F4) 3.6 1.4 
WT (A8) 17.4 2.8 
W102V (A11) 12.5 2.0 
W102Y (H11) 7.4 1.3 
W102F (G10) 6.6 1.1 
W102I (G2) 5.5 1.0 
Q241H (E12) 10.2 3.1 
Ins (F9) 6.9 2.2 
Ins (D11) 6.4 2.0 
Ins (H9) 5.6 1.8 
Q241W (G12) 5.5 1.8 
Del (B12) 29 3.0 
Ins (A12) 12 1.3 
Ins (C12) 11 1.3 
STOP (A2) 11 1.2 
Y351H (E1) 9 1.1 
Table 5.8. Summary table showing data from a range of libraries screened with methyl-trans-
cinnamate. Potential hits are highlighted, where data were available well and clone details are given.   
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Figure 5.10. Screening of a range of PETNRHis libraries against 3-Methyl-2-cyclohexen-1-one. Panel A, 
3-methyl-2-cyclohexen-1-one structure; Panel B, T26X screen; Panel C, Y68X screen; Panel D, W102X 
screen; Panel E, Q241X screen; Panel F, Y351X screen. Reactions were composed of 50 µl PETNR 
library eluate, 0.1 mM NADPH, 1 mM substrate in potassium phosphate buffer containing 5 % 
ethanol. Rates were calculated by monitoring A340 over the first 126 s of the reaction (δC/δt (nM s
-
1)). WT represents the average (grey), standard deviation (error bars) and maximum (black) of an 
external PETNRWT control block..  
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Clone δC(NADPH)/δt (nM s
-1) Z score 
Ins (D4) 8.4 3.5 
T26A (H11) 5.4 2.1 
T26H (E8) 4.7 1.7 
T26A (C11) 4.4 1.5 
T26A (C12) 4.0 1.4 
Y68L (E5) 5.1 0.8 
Y68M (H10) 4.4 0.7 
Y68I (F2) 3.9 0.6 
Y68- (H8) 3.3 0.5 
Y68- (A4) 3.0 0.4 
W102I (E8) 12 4.0 
W102D (H5) 7 2.0 
W102Y (H11) 5 1.3 
W102S (D10) 4 1.2 
W102D (A10) 4 1.0 
Q241W (G12) 8.4 2.6 
Q241- (C1) 7.2 2.2 
Q241- (C12) 6.6 2.0 
Ins (G4) 6.3 1.9 
Ins (B1) 6.3 1.9 
Ins (C12) 8.6 2.2 
Y351E (A8) 5.8 1.5 
Y351L (F12) 5.8 1.5 
Ins (A12) 4.2 1.1 
Y351A (A9) 3.8 0.9 
Table 5.9. Summary table showing data from a range of libraries screened with 3-methyl-2-
cyclohexenone. Potential hits are highlighted, where data were available well and clone details are 
given.   
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Figure 5.11. Screening of a range of PETNRHis libraries against 2-methyl-2-cyclopenten-1-one. Panel 
A, 2-methyl-2-cyclopenten-1-one structure; Panel B, T26X screen; Panel C, Y68X screen; Panel D, 
W102X screen; Panel E, Q241X screen; Panel F, Y351X screen. Reactions were composed of 50 µl 
PETNR library eluate, 0.1 mM NADPH, 1 mM substrate in potassium phosphate buffer containing 5 % 
ethanol. Rates were calculated by monitoring A340 over the first 126 s of the reaction (δC/δt (nM s
-
1)). WT represents the average (grey), standard deviation (error bars) and maximum (black) of an 
external PETNRWT control block.  
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Clone δC(NADPH)/δt (nM s
-1) Z score 
WT (B12) 20 3.5 
WT (B9) 19 3.3 
WT (H2) 18 3.0 
T26A (C11) 17 2.9 
T26A (H11) 17 2.9 
Y68- (A4) 30 4.0 
Y68- (E8) 19 2.2 
Y68F (B3) 17 1.9 
Y68Y (C12) 16 1.7 
Y68A (A12) 15 1.5 
W102I (A7) 51 3.3 
W102F (C11) 50 3.2 
W102I (C3) 45 2.8 
W102F (D2) 39 2.3 
W102L (A12) 34 1.9 
Q241W (A11) 19 2.7 
Q241V (A9) 18 2.6 
Q241M (C8) 17 2.4 
Q241- (B8) 17 2.3 
Q241P (H5) 16 2.2 
Y351M (F5) 13 2.6 
Y351P (C8) 12 2.4 
Y351M (A10) 11 2.3 
Y351M (H7) 11 2.3 
Y351T (E3) 11 2.3 
Table 5.10. Summary table showing data from a range of libraries screened with 2-methyl-2-
cyclopentenone. Potential hits are highlighted, where data were available well and clone details are 
given.   
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Figure 5.12. Screening of a range of PETNRHis libraries against 3-methyl-2-cyclopenten-1-one. Panel 
A, 3-methyl-2-cyclopenten-1-one structure; Panel B, T26X screen; Panel C, Y68X screen; Panel D, 
W102X screen; Panel E, Q241X screen; Panel F, Y351X screen. Reactions were composed of 50 µl 
PETNR library eluate, 0.1 mM NADPH, 1 mM substrate in potassium phosphate buffer containing 5 % 
ethanol. Rates were calculated by monitoring A340 over the first 126 s of the reaction (δC/δt (nM s
-
1)). WT represents the average (grey), standard deviation (error bars) and maximum (black) of an 
external PETNRWT control block.  
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Clone δC(NADPH)/δt (nM s
-1) Z score 
T26- (B6) 3.5 1.3 
T26L (A5) 3.5 1.3 
T26A (F2) 3.4 1.2 
T26R (D4) 3.3 1.2 
T26- (A4) 2.9 1.0 
Y68M (H10) 5.8 1.9 
Y68A (E7) 3.4 1.0 
Y68V (F1) 3.3 1.0 
Y68M (D8) 3.2 0.9 
Y68P (A6) 3.0 0.9 
WT (A8) 14 4.7 
W102Y (H11) 7 1.9 
W102I (E8) 6 1.9 
W102V (H1) 5 1.5 
W102S (D10) 4 1.1 
Q241D (A5) 11.2 3.2 
Q241- (C12) 9.4 2.7 
Q241V (A7) 8.4 2.4 
Q241T (G12) 6.9 2.0 
Q241A (E6) 6.5 1.9 
Del (B12) 10.4 2.9 
Ins (A12) 5.1 1.4 
Y351M (G3) 5.1 1.4 
Y351A (A7) 4.9 1.4 
Y351E (A8) 3.9 1.1 
Table 5.11. Summary table showing data from a range of libraries screened with 3-methyl-2-
cyclopentenone. Potential hits are highlighted, where data were available well and clone details are 
given.
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A large number of mutants with possibly improved activity were identified in the 
screening protocols and were selected for further characterisation. A wide range of 
activities were observed from the good substrate trans-cinnamaldehyde to the 
poorer substrates including the methyl substituted cyclic derivatives. These 
potential hits are detailed in the table below (Table 5.12). 
Substrate T26X Y68X W102X Q241X Y351X 
Trans-cinnamaldehyde T26S Y68S W102L Q241L Y351F 
α-Methyl-trans-
cinnamaldehyde 
T26A Y68S 
W102F, 
W102Q 
Q241L Y351F 
methyl trans-cinnamate T26H Y68M W102V Q241H Y351H 
3-Methyl-2-cyclohexenone T26A Y68L 
W102I, 
W102D 
Q241W Y351E 
2-Methyl-2-cyclopentenone T26A Y68F 
W102I, 
W102F 
Q241W, 
Q241V 
Y351M, 
Y351P 
3-Methyl-2-cyclopentenone T26L Y68M W102Y 
Q241D, 
Q241V 
Y351M 
Table 5.12. Potential hits taken forward for further characterisation from screening of T26X, Y68X, 
W102X, Q241X and Y351X single site saturation libraries for expanded substrate acceptance.  
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5.3 Discussion 
Overall 38 deep well blocks were screened against 10 novel substrates, 
corresponding to over 3,600 individual screening reactions. The application of strict 
selection criteria yielded a total of 45 possible hits representing ~1% of the total 
number of reactions screened. Without further characterisation of library hits 
(Chapter 6) discussion of potential hits at this juncture is difficult. However a 
number of points of interest can be raised from the screening data alone. 
The first conclusion from this experiment is an understanding of the relative 
activities of the substrates which are screened with WT enzyme as derived from 
control reactions. This indicates the range of native activities to be improved upon 
ranging from effectively no activity, including trans-cinnamic acid, to much more 
active substrates, including trans-cinnamaldehyde. Few of these activities however 
come close to the activity achieved with the NADPH / CH couple (Table 5.13). 
Substrate 
Activity 
(nM s-1) 
Standard deviation 
(nM s-1) 
2-Cyclohexen-1-one 207 55 
Trans-cinnamic acid nd n/a 
Cinnamonitrile nd n/a 
1-Cyclohexene-1-carboxylic acid nd n/a 
Cyclohexene-1-carbonitrile nd n/a 
Trans-cinnamaldehyde 186 49 
α-Methyl-trans-cinnamaldehyde 75 22 
Methyl trans-cinnamate 0.688 3.38 
3-Methyl-2-cyclohexenone 20.8 6.9 
2-Methyl-2-cyclopentenone 1.67 7.77 
3-Methyl-2-cyclopentenone 0.419 2.01 
Figure 5.13. Summary of WT activity derived from single PETNRHis block purifications, used as control 
for screening reactions; nd, none detected. 
A number of false positives were also identified at this point, which do not encode 
functional proteins. In this case, false positives represent a population of hits which 
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when sequenced reveal serious mutations such as large deletions / insertions and 
internal STOP codons. Notably, these false positives occur mainly in reactions with a 
lower activity. It is likely that these hits are due either to outliers around a low 
mean (Section 5.1.5) or mixing artefacts affecting a very low mean since the fitting 
method is insensitive to such phenomena. Under such conditions in order to be 
confident of a hit being genuine a far larger increase in activity is required. 
A number of assays above have highlighted a number of WT codons, particularly 
with substrates with a reasonable level of WT activity. This phenomenon is due to 
the fact that the majority of generated mutants have compromised activity, hence 
WT clones are the only ones with activity remaining. This also serves to 
demonstrate the efficacy of the assay, for example if wild type clones were not 
highlighted from experiments with known WT active substrate couples (e.g. NADPH 
/ CH) it would suggest problems were present with the assay. In these cases “the 
next best” clone was analysed. 
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6 Characterisation of identified variants from library screening  
The screening of 3600 clones from 8 libraries with 11 substrates generated a large 
number of potentially improved variants (as described in Chapter 5). However, 
because of the high incidence of false positives [e.g. i) outliers surrounding a low 
mean or ii) mixing artefacts as described in Chapter 5], it was necessary to confirm 
that positive hits were actually improved catalysts. Each mutant was characterised 
by investigating its steady state reaction with CH and carrying out 
biotransformation reactions to positively identify the product(s).  
Variants of interest were grown and purified on an intermediate growth scale (1L 
media) according to the standard PETNRHis purification protocol (Section 2.2.4.5). 
Variants were purified in order to minimise potential competing reactions either 
modifying substrate / product, or utilising NADPH. It is important to consider that 
previous attempts to engineer OYE homologues have been hampered by the 
presence of E. coli keto-reductase enzymes which were not eliminated by other 
workers [61]. 
Following purification, mutants were analysed by determination of the specific 
activity towards the substrate of interest (the substrate used in the screen which 
identified that particular mutant) with NADPH as reductant, using 
spectrophotometric methods (Section 2.2.3.2). The assay monitors the oxidation of 
NADPH associated with the turnover of the alkene substrate to the alkane product, 
however implicit in this method are a number of assumptions including that the 
NADPH is turned over only by PETNR and only in response to the desired oxidative 
half reaction. Therefore, the reaction of substrate and the formation of product was 
monitored directly by using GC to determine the concentration of substrate and 
product following 24 hr biotransformation reactions (Section 2.2.3.5). 
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6.1 Characterisation of identified variants from screens performed with 
cyclohexenone as substrate. 
Screening with CH as the oxidative substrate was performed as part of the initial 
characterisation of the PETNR libraries (Section 4.5). These experiments were 
performed in order to assess the degree to which mutant libraries were 
compromised with respect to diagnostic wild type activity. The specific activity data 
for all the variant enzymes (Table 6.1) demonstrate a considerably lower steady 
state turnover rate when compared with the wild type control data. When the 
activity retained by variants isolated from CH screens is contrasted with the WT 
controls for other substrates used for screening it is clear that a substantial amount 
of activity is still retained (see Section 6.2 and 6.3). All library screening reactions 
with CH, with the exception of Q241X, showed that the majority of the top ranked 
hits were in fact WT clones. Interestingly, the only library that produced a clone 
with an elevated level of activity over other library variants was Q241X. This library 
had the most variety in the top ranked hits, suggesting that a number of variants 
from this library retain wild-type-like catalytic competence.  
In contrast, all the biotransformation reactions were shown to have proceeded to 
near completion with the CH substrate, irrespective of their lower steady state 
rates (Table 6.1). This is most likely due to the length of the biotransformation 
reactions. The most active variants react to completion in a short period of time; 
however despite the less active variants reacting slower there is still sufficient time 
available to react to completion. Hence, at the endpoint of the reaction where data 
are recorded, differences in the rate of product formation are impossible to 
determine. This “catching up” phenomenon is also observed for other reactions 
discussed in this chapter. 
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Enzyme 
Specific 
Activity (µmol 
min-1 mg-1) 
Standard 
deviation (µmol 
min-1 mg-1) 
Conversion (%) Yield (%) 
WT 5.82 0.68 100 100 
T26S 0.84 0.17 100 96 
Y68L 1.21 0.11 100 82 
W102Y 0.84 0.14 100 90 
Q241T 1.81 0.03 100 88 
Y351F 1.21 0.03 100 85 
Table 6.1. Specific activity and GC analysis of reactions with PETNRHis variants identified from screens 
with CH as substrate. Specific activity reactions were composed of 50 nM PETNRHis variant, 0.1 mM 
NADPH, 1 mM CH in 50mM KH2PO4/K2HPO4 buffer, pH 7 containing 5 % ethanol in a total volume of 
1 ml. GC Reactions were composed of 5 mM CH, 6 mM NADPH and 2 µM enzyme in 50mM 
KH2PO4/K2HPO4 buffer pH 7 containing 5 % ethanol in a total volume of 1 ml. 
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6.2 Characterisation of identified variants from screens performed with 
substrates differing in their activating group located next to the unsaturated C=C 
bond. 
Previous studies with PETNRHis showed no activity towards substrates trans-
cinnamic acid, cinnamonitrile, 1-cyclohexene-1-carboxylic acid or cyclohexene-1-
carbonitrile [59]. The screening of libraries H181X and H184X generated a few 
possible hits with these substrates.  
Specific activity data indicated no significantly improved variants, a conclusion 
which was supported by the absence of a detectable product in the analysis of the 
biotransformation reactions. Data from the screening reactions are thought to 
represent false positives [e.g. i) outliers surrounding a low mean or ii) mixing 
artefacts; outlined in Chapter 5]. This idea is supported by the observation of low 
rates in the specific activity assays for the variant enzymes (Table 6.2). Due to the 
low levels of activity consistent experimental rates were difficult to obtain.  
GC analysis of biotransformation reactions indicated the complete lack of 
conversion of substrate to product consistent with the specific activity data. 
Therefore, no mutants isolated from the H181X and H184X libraries showed 
significant activity towards these substrates. This is not unexpected since H181 and 
H184 have previously been demonstrated to be critical to substrate binding in OYEs 
[38, 69]. 
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Substrate Enzyme 
Specific Activity 
(µmol min-1 mg-1) 
Standard deviation 
(µmol min-1 mg-1) 
Trans-cinnamic 
acid 
WT 0.0047 0.00042 
H181I 0.0085 0.0049 
H181S 0.01 0.007 
Cinnamonitrile 
WT 0.016 0.0035 
H181S 0.020 0.0036 
H181L 0.016 0.0045 
H184K 0.022 0.0077 
H184Y 0.021 0.0073 
1-Cyclohexene-1-
carboxylic acid 
WT 0.0074 0.0030 
H181Y 0.0060 0.0021 
H184F 0.0096 0.0043 
Cyclohexene-1-
carbonitrile 
WT 0.0096 0.0030 
H181L 0.0055 0.0018 
H184L 0.0033 0.0007 
H184F 0.0055 0.0021 
H184K 0.0085 0.0023 
Table 6.2. Specific activity of PETNRHis variants assayed with a range of substrates differing in their 
activating group located next to the unsaturated C=C bond. Reactions were composed of 2 µM 
PETNRHis variant, 0.1 mM NADPH, 1 mM substrate in 50mM KH2PO4/K2HPO4 buffer, pH 7 containing 
5 % ethanol in a total volume of 1 ml. WT represents the average and standard deviation of PETNRHis 
control reactions. 
It is important to note that there are two possible conclusions which explain the 
experimental data; i) there are no mutations at H181 and H184 which lead to 
improvements with respect to these substrates (i.e. the library is said to be empty) 
or ii) there are mutations at H181 and H184 which lead to improvements, but the 
conditions of the screening reaction are not suitable to identify them. In the case of 
this experiment the most likely conclusion is that the H181 and H184 libraries do 
contain improved variants but the screen was insufficient to identify them. 
Previously published data supports this conclusion. A number of mutants at 
position 181 and 184 have been demonstrated to yield improved catalysts with a 
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range of other substrates. These variants have been demonstrated to yield catalysts 
with improved stereochemical control [170]. Interestingly however the majority of 
these clones had compromised turnover [170] as has been observed in the initial 
library characterisation with CH (Section 4.5). 
There are no known examples of PETNR reacting with alkenes containing a nitrile 
activating group, however a few rare examples of other OYEs reducing nitrile 
containing compounds are known [169]. This could be attributable to the poor 
activating properties of the nitrile group. In addition, a number of di-carboxylic 
acids are known substrates of PETNR [62], but there are no known examples of 
mono-acid substrates.  
As described in Table 6.2 there were no improvements in the specific activity or GC 
from any of the variants isolated from screening reactions. Potential reasons for the 
lack of improved variants with nitrile and mono acid substrates include; i) the 
change in amino acid identity at these positions was not sufficient, at least in 
isolation, to improve activity against these substrates ii) the active site of PETNR 
may not be capable of catalysing reactions with these substrates due to the poor 
activating properties of the groups adjacent to the unsaturated C=C bond. 
In addition to the reasons discussed above, a number of other factors may impact 
on the inability to detect improved mutants against these substrates including; i) 
poor expression leading to a reduced concentration of enzyme in the screening 
assay, as observed with the OYE1 N194 variant [69] ii) variation in FMN binding 
leading to a reduced subset of the purified PETNR being catalytically active iii) 
variation in the binding of NADPH as observed with the MR H186A and N189A 
variants [171].  
Steps were included to hopefully compensate for some of these effects, such as the 
inclusion of FMN in the purification buffers to try and ensure complete flavination 
and the micro scale purification of variants ensuring protein concentration is limited 
by the binding capacity of the beads rather than the expression levels. Such steps 
are only capable of correcting some errors, for example additional FMN can occupy 
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an active site capable of accepting FMN, but not an active site unflavinated due to 
the mutation preventing binding.  
Previous work has suggested that a large number of variants at residues H181 and 
H184 both maintain activity and in some cases provide improved biocatalysts [170] 
suggesting that these residues can be successfully varied. The studies reported in 
this section detected no variants with improved specific activity and no variants 
with improved biotransformation reactions. This could be explained either by no 
improved variants being present in the library or by the improved variants which 
are present in the library being undetectable using the current screening protocol. 
Due to the lack of success in detecting mutants in the H181X and H184X using the 
current assay these libraries were not screened against other substrate classes. 
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6.3 Characterisation of identified variants from screens performed with a 
range of methyl substituted substrates at both the  α and β position of the alkene 
group.  
6.3.1 Trans-cinnamaldehyde 
WT control reactions demonstrated cinnamaldehyde to be an effective oxidative 
substrate of PETNR (Chapter 5). The activity of WT PETNR with cinnamaldehyde (2.8 
± 0.2 µmol min-1 mg-1) is approximately half of the specific activity of model 
substrate CH (5.8 ± 0.7 µmol min-1 mg-1). From these data it is clear that 
cinnamaldehyde is capable of binding PETNR in a conformation compatible with 
catalysis. However, the slight increases in activity in the variants isolated from the 
library screens suggest that there are more favourable binding geometries 
restricted in the wild type enzymes.  
Specific activity data with trans-cinnamaldehyde as substrate (Table 6.2) indicate 
small increases in the rate of NADPH turnover for the T26S and Q241L enzymes (3 ± 
0.2 and 3.3 ± 0.1 µmol min-1 mg-1 respectively). The remainder of the variants 
demonstrated compromised activity.  
The analysis of GC results is complicated by the presence of an additional peak. This 
peak was identified as the alcohol product derived from the further reduction of 
the PETNR derived product aldehyde (Scheme 6.1), in this case 3-phenylpropan-1-
ol. Mass spectrophotometric analysis of purified protein indicates the presence of a 
minor contaminant identified as YahK (an alcohol dehydrogenase like protein; 
results not shown). Similar side product formation has been detected previously in 
whole cell biotransformations with YqjM mutants [61]. This reaction is likely to 
proceed only from the reduced aldehyde (Scheme 6.1) [61] hence any alcohol 
present was most likely derived from the PETNR variant product and can be 
considered as a biotransformation product. In order to remove this impurity further 
purification steps could be incorporated. 
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Scheme 6.1. Generallised reaction scheme showing alkene reduction of PETNR followed by the 
action of an unidentified E. coli keto-reductase. 
In the case of the W102L variant the enzyme appears kinetically compromised from 
the specific activity data. However this variant demonstrated superior 
biotransformation characteristics. This effect is likely due to the enzyme’s inhibition 
characteristics at a range of substrate concentrations. In the case of PETNRHis 
substrate inhibition is observed (Chapter 3). This substrate inhibition has been 
demonstrated previously to vary in response to mutation at a single amino acid 
position where the effect was practically abolished by the mutation of H184N [170]. 
It is possible that under some inhibition conditions relative reaction rates at 1 mM 
and 5 mM can vary.   
There was a slight increase in both the specific activity and substrate conversion of 
T26S mutant with trans-cinnamaldehyde. However, the product yield was similar to 
wild-type enzyme (Table 6.3). The remaining 13 % of product(s) was not due to the 
formation of the alcohol by-product. Possible explanations for the unaccounted 
product(s) include i) substrate/product degradation and/or volatility over extended 
reaction times, ii) the action of enzymatic contaminants on substrate/product and 
iii) the conversion of substrate/product to a novel compound not detected by our 
analytical techniques. A similar effect is seen in the Y68S reaction. Like the T26S 
mutant, both the specific activity and substrate conversion was moderately higher 
for the Q241L mutant.  
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Enzyme 
Specific 
Activity 
(µmol min-1 
mg-1) 
Standard 
deviation 
(µmol min-1 
mg-1) 
Conversion 
(%) 
Yield (%) 
Alcohol 
product 
yield (%) 
WT 2.83 0.21 72 72 nd 
T26S 3.01 0.15 82 69 nd 
Y68S 1.39 0.03 92 68 nd 
W102L 0.94 0.02 88 87 nd 
Q241L 3.29 0.11 100 57 43 
Y351F 0.35 0.03 100 32 nd 
Table 6.3. Specific activity and GC analysis of reactions with PETNRHis variants identified from screens 
with trans-cinnamaldehyde as substrate. Specific activity reactions were composed of 1 - 2 µM 
PETNRHis variant, 0.1 mM NADPH, 1 mM trans-cinnamaldehyde in 50 mM KH2PO4/K2HPO4 buffer, pH 
7 containing 5 % ethanol in a total volume of 1 ml. GC reactions were composed of 5 mM trans-
cinnamaldehyde, 6 mM NADPH and 2 µM enzyme in 50mM KH2PO4/K2HPO4 buffer pH 7 containing 5 
% ethanol in a total volume of 1 ml. nd signifies that no product was detected. 
Position 241 was randomised due to its location, on a flexible loop close to the 
substrate in the active site, inferred from crystal structure data for PETNR [40] and 
other OYEs [15, 41]. Q241L represents only a minor change in size, but the mutation 
does represent the conversion from a hydrophilic to a hydrophobic side chain. The 
effect on activity may be mediated by movement in the flexible loop to 
accommodate the slightly bulkier leucine residue. This movement could have 
indirect effects on neighbouring residues. Any effect present has been 
demonstrated, from the specific activity data, to be minor and without further 
studies determination of the molecular mechanism underlying the change is 
impossible. 
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6.3.2 α-Methyl-trans-cinnamaldehyde 
α-Methyl-trans-cinnamaldehyde has been demonstrated to be a quite poor 
substrate for PETNR (0.6 ± 0.001 µmol min-1mg-1). Analogy with the previously 
studied substrate cinnamaldehyde (2.8 ± 0.2 µmol min-1 mg-1) indicates the methyl 
substituent located on the α carbon is responsible for the compromised activity 
with this substrate. The most likely reason for this is the methyl substituent 
sterically interfering with binding in an optimal conformation for catalysis, which 
are accessible in the case of trans-cinnamaldehyde. 
The specific activity of a range of enzyme variants isolated from screening with α-
methyl-trans-cinnamaldehyde (Table 6.3) suggests that a number of enzymes have 
shown a substantial improvement activity with α-methyl-trans-cinnamaldehyde as 
substrate. Mutants W102F and W102Q were shown to have dramatically improved 
specific activity when compared to PETNRWT (5.9 ± 0.2 and 1.9 ± 0.06 µmol min
-1 
mg-1, respectively). Mutant Q241L also demonstrated a modest improvement (0.8 ± 
0.02 µmol min-1 mg-1), however the other variants screened demonstrate reduced 
specific activity. 
Biotransformation data with α-methyl-trans-cinnamaldehyde (Table 6.4) support 
the observations derived from specific activity data, which indicated that WT, 
W102F, W102Q, and Q241L all demonstrated complete depletion of substrate with 
subsequent detection of the desired aldehyde product (2-methyl-3-phenylpropanal) 
or the alcohol side-product (2-methyl-3-phenylpropan-1-ol) discussed previously 
(Chapter 6.3.1). The magnitude of the activity increase is not quantified by GC due 
to all the active samples reacting to completion under the assay conditions.  
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Enzyme 
Specific 
Activity 
(µmol min-
1 mg-1) 
Standard 
deviation 
(µmol min-
1 mg-1) 
Conversio
n (%) 
Yield (%) 
Alcohol 
product 
yield (%) 
e.e. (%) 
WT 0.65 0.001 99 99 1 13 (S) 
T26A 0.21 0.008 10 0 6 0 (S) 
Y68S 0.10 0.004 81 77 8 6 (R) 
W102F 5.93 0.22 100 97 3 62 (R) 
W102Q 1.90 0.068 100 1 99 ND 
Q241L 0.82 0.022 99 77 22 5 (S) 
Y351F 0.18 0.002 99 98 1 38 (S) 
Table 6.4. Specific activity and GC analysis of biotransformation reactions with PETNRHis variants 
identified from screens with α-methyl-trans-cinnamaldehyde as substrate. Specific activity Reactions 
were composed of 0.1 - 2 µM PETNRHis variant, 0.1 mM NADPH, 1 mM α-methyl-trans-
cinnamaldehyde in 50 mM KH2PO4/K2HPO4 buffer, pH 7 containing 5 % ethanol in a total volume of 1 
ml. GC Reactions were composed of 5 mM α-methyl-trans-cinnamaldehyde, 6 mM NADPH and 2 µM 
enzyme in 50mM KH2PO4/K2HPO4 buffer pH 7 containing 5 % ethanol in a total volume of 1 ml for 4 
hours. 
The increased specific activity of W102F, W102Q and Q241L mutants towards α-
methyl-trans-cinnamaldehyde suggests the substrate binds to the enzyme in a 
more optimal conformation for catalysis. W102 has already been demonstrated to 
move in response to substrate binding [75], has been demonstrated to have an 
effect in discrimination between oxidative substrate mechanisms [75] and the 
W102Y/F mutants have been demonstrated to relieve a steric clash with substrate 
(Section 1.4.3.3; [75]). The specific mutations above represent the removal of a 
bulky intermediate side-chain, and its replacement by either a slightly smaller polar 
side-chain (W102Q) or a slightly smaller hydrophobic side-chain (W102F). This 
suggests that size is the important factor.  
Residue 241 was selected for mutagenesis studies due to the possibility of opening 
up the active site on the basis of the crystal structure (Section 1.4.3.7). The Q241L 
substitution involves the substitution of a long polar side-chain with the shorter 
non-polar side-chain, the mechanism of this marginal improvement is unclear. 
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In addition, the comparison of PETNRHis with W102F highlights a reversal in 
stereochemistry. This effect implies that the angles of hydride transfer from the 
FMN prosthetic group (N5) to the substrate (Cβ) are changed. Such stereochemical 
variation is explained by the existence of multiple substrate binding modes each 
with a characteristic angle of hydride transfer resulting in the various resultant 
stereochemistries. These multiple binding modes are evident in any reaction which 
does not yield an enantiopure product. The suggestion in this case is that the 
distribution of binding mode in the W102F variant is different to that of PETNRHis.  
The variation of activity level and stereochemistry in response to mutation of W102 
has been demonstrated previously in other OYEs [61, 148]. In the case of OYE1 
screening of W116X libraries with α and β substituted cyclohexenone identified a 
range of mutants at this position including the W116F mutant (analogous to the 
PETNR W102F mutant) [148]. In contrast with the data described above, all W116X 
variants were demonstrated to have inferior specific activates with the β 
substituted substrate [148], whereas both the W102F and Q variants in our study 
were shown to have enhanced kinetic properties (albeit with an α substituted 
substrate in this case). The W116X variants were trialled with α substituted carvone 
as substrate and W116I demonstrated a reversal of stereochemistry at the α carbon 
[148] similar to that described in this study for the W102F variant. Additional data 
suggest that the addition to the unsaturated bond still occurs as a trans addition 
mechanism. However the reversal in stereochemistry is attributed to binding in an 
alternate ‘flipped’ geometry [148]. Interestingly, in the case of carvone, the C4 
substituent was identified as being critical for this binding geometry [148], 
however, this substituent is replaced by a phenyl substituent in the β position in our 
substrate. The screening of additional substrates also demonstrated the reversal of 
stereochemistry associated with an improvement in catalytic efficacy with the 
aliphatic substrate neral by W102F [148] which is directly analogous to the reaction 
we have demonstrated. Interestingly, the variant equivalent to W102Q was not 
observed under the screening conditions of this experiment [148]. 
The respective residue in YqjM is A104 [27] and was studied by the generation of 
ISM libraries [61]. The exchange of a bulky tryptophan for the minimal alanine in 
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thermophillic-like OYEs does suggest that the residue may not perform the same 
function. A number of variants at this position were demonstrated to improve 
catalysis including an approximate 15 fold increase in the percent conversion 
associated with the A104W variant [61]. 
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6.3.3 Methyl-trans-cinnamate 
The data from the specific activity determination of a range of variants with methyl-
trans-cinnamate (Figure 6.5) suggest a minimal improvement in activity with Y351H. 
However, as the specific activity is very low for all enzymes, these small variations in 
activity are within the experimental error and therefore may not be representative 
of a genuine improvement in activity with methyl-trans-cinnamate (Figure 6.5).  
Analysis of the biotransformation demonstrated the complete absence of substrate 
conversion or product yield with all variants including PETNRHis WT (data not 
shown). This indicates that the variants isolated from screening are all false 
positives, and the variation is due to error in conjunction to a low signal: noise ratio. 
Enzyme 
Specific Activity (µmol 
min-1 mg-1) 
Standard deviation (µmol 
min-1 mg-1) 
WT 0.013 0.002 
T26H ND ND 
Y68M ND ND 
W102V 0.013 0.006 
Q241H 0.005 0.0006 
Y351H 0.016 0.002 
Table 6.5. Specific activity of PETNRHis variants assayed with methyl-trans-cinnamate as substrate. 
Reactions were composed of 2 µM PETNRHis variant, 0.1 mM NADPH, 1 mM methyl-trans-cinnamate 
in 50 mM KH2PO4/K2HPO4 buffer, pH 7 containing 5 % ethanol in a total volume of 1 ml. WT 
represents the average and standard deviation of PETNRHis control reactions. 
The lack of activity of PETNR variants with methyl-trans-cinnamate is not 
completely unexpected since mono-esters have been demonstrated to be 
substrates for OYEs rarely [2, 28, 59]. This observation suggests that either; i) there 
are no improved mutants in the libraries screened, representing a range of 
conditions as discussed previously in section 6.2; or ii) that any improved variants 
present in the library are not detected under the conditions by which the assay is 
limited (false negatives). This again represents a large subset of conditions which 
are detailed in Section 6.2.  
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6.3.4 3-Methyl-2-cyclohexen-1-one 
The compound 3-methyl-2-cyclohexen-1-one has been demonstrated to be a poor 
substrate for PETNR (0.009 ± 0.0002 µmol min-1 mg-1). This contrast is particularly 
stark when compared with CH (5.8 ± 0.7 µmol min-1 mg-1) which is often used as a 
model substrate for OYEs. The addition of a methyl substituent on the β carbon 
results in an almost total loss of activity. This difference in activity is thought to be 
due to steric hindrance between the substrate methyl substituent and residue T26 
CG2 atom, preventing access to catalytically competent conformations, as has been 
described previously for the inhibitor progesterone [73]. 
The specific activity with 3-methyl-2-cyclohexen-1-one as substrate (Table 6.5) 
suggests that T26A has acquired a substantial increase in activity (0.024 ± 0.0008 
µmol min-1 mg-1) and Q241W has improved to a far smaller extent (0.015 ± 0.002 
µmol min-1 mg-1). The remainder of the clones demonstrated no improvement in 
activity.  
Biotransformation data with 3-methyl-2-cyclohexen-1-one as substrate (Table 6.6) 
demonstrated that only the T26A variant had a significant improvement in 
substrate conversion (%) and product yield (%) with no by-products detected. The 
remainder of the mutants demonstrated compromised biotransformation, 
including the Q241W variant which demonstrated improved specific activity. Such 
inconsistencies are probably attributable to either i) the mutation having an effect 
on protein stability, so that biotransformations carried over extended periods of 
time showed a reduction in overall product formation or ii) the difference in 
conditions in each experiment, particularly the increased concentration of oxidative 
substrate (1 mM in specific activity assays and 5 mM in biotransformation 
reactions). Previous experiments with PETNRWT have indicated the presence of 
substrate inhibition at elevated CH concentrations (Section 3.2.2). The Ki associated 
with this phenomenon has been demonstrated to vary in response to mutations in 
PETNR [170].  
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Enzyme 
Specific 
Activity (µmol 
min-1 mg-1) 
Standard 
deviation (µmol 
min-1 mg-1) 
Conversion (%) Yield (%) 
WT 0.010 0.0002 21 21 
T26A 0.024 0.0008 41 41 
Y68L 0.009 0.0018 8 8 
W102D 0.005 0.0008 0 0 
W102I 0.007 0.0005 0 0 
Q241W 0.015 0.0024 8 8 
Y351E 0.006 0.0007 8 8 
Table 6.6. Specific activity and GC analysis of biotransformation reactions with PETNRHis variants 
identified from screens with 3-methyl-2-cyclohexen-1-one as substrate. Specific activity reactions 
were composed of 2 µM PETNRHis variant, 0.1 mM NADPH, 1 mM 3-methyl-2-cyclohexen-1-one in 
50mM KH2PO4/K2HPO4 buffer, pH 7 containing 5 % ethanol in a total volume of 1 ml. GC Reactions 
were composed of 5 mM 3-methyl-2-cyclohexen-1-one, 6 mM NADPH and 2 µM enzyme in 50mM 
KH2PO4/K2HPO4 buffer pH 7 containing 5 % ethanol in a total volume of 1 ml. 
Residue 26 has previously been demonstrated to play a role in preventing the 
inhibitor, progesterone, binding in a catalytically competent conformation (Section 
1.4.3.1.; [73]). These interactions are possibly responsible for the decrease in 
activity associated with the methyl substitution at the Cβ of CH. It is likely that the 
mutation of T26 to the smaller alanine residue removes a steric clash associated 
with either the methyl or hydroxyl group of the T26 residue. This reduction in size 
of residue 26 increases the size of the substrate binding pocket allowing the 
accommodation of the substrate in a conformation more conducive with catalysis. 
Residue 26 is conserved within the thermophilic-like OYEs subclass as a cysteine 
residue (C26). A range of variants at this position have been screened and 
demonstrated to improve activity and to affect stereochemistry with a wide range 
of β substituted substrates [61].    
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6.3.5 2-Methyl-2-cyclopenten-1-one 
2-Methyl-2-cyclopenten-1-one (0.17 ± 0.02 µmol min-1 mg-1) has been 
demonstrated to be a poor substrate for PETNR, particularly when compared with 
2-cyclopentenone (data not shown). The addition of a methyl substituent on the α 
carbon results in a substantial decrease in activity. This difference in activity is 
thought to be due to steric hindrance between the substrate methyl group and a 
number of active site residues identified from the crystal structure, including T26, 
Y68, W102, Q241 or Y351, preventing access to catalytically superior 
conformations. 
The specific activity of a number of variants with 2-methyl-2-cyclopenten-1-one as 
substrate (Table 6.7) suggests a wide range of enzymes appear to have improved 
activities. The specific activity data demonstrate improvement for almost all the 
enzymes tested. Variants including W102F and W102I have a substantial increase in 
activity (0.83 ± 0.02 and 1.00 ± 0.04 µmol min-1 mg-1 respectively), the best 
representing an almost 6 fold improvement. Additionally a number of variants 
including T26A, Y68F, Q241W, Q241V and Y351P have specific activities improved 
but to a far lesser extent. 
Biotransformation reactions with 2-methyl-2-cyclopenten-1-one as substrate (Table 
6.7) demonstrated that W102F and W102I had marginally improved substrate 
conversions (%) with slightly poorer product yields (%) than wild-type. Mutant 
Y351P also has improved substrate conversion and product yield however the 
magnitude of the specific activity change and the increase in conversion is small. 
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Enzyme 
Specific 
Activity 
(µmol min-1 
mg-1) 
Standard 
deviation 
(µmol min-1 
mg-1) 
Conversion 
(%) 
Yield (%) e.e. (%) 
WT 0.17 0.02 89 89 69 (S) 
T26A 0.30 0.02 59 59 56 (S) 
Y68F 0.43 0.01 59 53 49 (S) 
W102F 0.83 0.02 93 81 46 (S) 
W102I 1.00 0.04 93 82 72 (S) 
Q241W 0.31 0.06 89 89 66 (S) 
Q241V 0.31 0.01 72 72 62 (S) 
Y351M 0.16 0.01 84 84 66 (S) 
Y351P 0.23 0.01 94 94 70 (S) 
Table 6.7. Specific activity and GC analysis of biotransformation reactions with PETNRHis variants 
identified from screens with 2-methyl-2-cyclopenten-1-one as substrate. Specific activity reactions 
were composed of 2 µM PETNRHis variant, 0.1 mM NADPH, 1 mM 2-methyl-2-cyclopenten-1-one in 
50 mM KH2PO4/K2HPO4 buffer, pH 7 containing 5 % ethanol in a total volume of 1 ml. GC reactions 
were composed of 5 mM 2-methyl-2-cyclopenten-1-one, 6 mM NADPH and 2 µM enzyme in 50 mM 
KH2PO4/K2HPO4 buffer pH 7 containing 5 % ethanol in a total volume of 1 ml. 
None of the observed variants have an inversion in stereochemistry as observed 
with the substrate α-methyl-trans-cinnamaldehyde (Section 6.3.2). However, the 
W102X library screening provides an interesting case study as mutants W102I and 
W102F produce higher and lower e.e. Considering the rationale described 
previously, that changes in stereochemistry were attributable to substrate binding 
to the active site in various conformations, allowing the trans addition across the 
double bond to give alternate results. This suggests that W102F and W102I favour a 
different distribution of binding modes.  
These variants whilst not providing an inversion in stereochemistry potentially 
represent an intermediate from which to engineer such an enzyme. The W102F 
variant has also been demonstrated to lead to a complete reversal in 
stereochemistry with α-methyl-trans-cinnamaldehyde as substrate and a decrease 
(partial reversal) in ee with 2-methyl-2-cyclopenten-1-one which is thought to be 
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the first step in evolving alternate stereochemistry. The less pronounced inversion 
with 2-methyl-2-cyclopenten-1-one may be due to the reduced size of this 
substrate associated with the lack of an aromatic substituent at the β carbon. 
The molecular basis of this improvement is most likely that mutagenesis of W102 to 
smaller side chains removes steric clashes upon substrate binding. W102 has 
previously been demonstrated to move to perform a range of functions in substrate 
binding including; i) discrimination between oxidative mechanisms, by removal of a 
steric clash with TNT [75] and ii) movement to accommodate substrate binding.  
These effects are discussed in detail in Section 6.3.2.   
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6.3.6 3-Methyl-2-cyclopenten-1-one 
3-Methyl-2-cyclopenten-1-one (0.010 ± 0.001 µmol min-1 mg-1) has been 
demonstrated to be an exceptionally poor substrate, particularly when compared 
with cyclopentanone (data not shown) and to 2-Methyl-2-cyclopenten-1-one (0.17 
± 0.02 µmol min-1 mg-1). This loss of activity is thought to be attributable to the 
same steric clash involving the methyl substituent on the Cβ and residue T26 
discussed previously in reference to 3-Methyl-2-cyclohexen-1-one (Section 6.3.4) 
Notably a comparison between 2-cyclohexen-1-one, 3-methyl-2-cyclohexen-1-one 
and 2-methyl-2-cyclopenten-1-one suggests that substituents at the β carbon 
appear to have a more substantial effect on the specific activity than those at the α 
carbon. 
The specific activity of a number of variants with 3-methyl-2-cyclopenten-1-one 
(Table 6.8) suggest a number of enzymes with slightly improved activity towards 3-
methyl-2-cyclopenten-1-one, such as T26L and Y351M (0.015 ± 0.003 µmol min-1 
mg-1 and 0.019 ± 0.006 µmol min-1 mg-1 respectively). However the remainder of 
the mutants showed no improvement in specific activity. Biotransformation 
reactions with 3-methyl-2-cyclopenten-1-one as substrate (Table 6.8) demonstrated 
that the only mutant with improved activity was Y351M, showing a modest increase 
in both yield and conversion. 
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Enzyme 
Specific 
Activity (µmol 
min-1 mg-1) 
Standard 
deviation (µmol 
min-1 mg-1) 
Conversion (%) Yield (%) 
WT 0.010 0.001 9 9 
T26L 0.016 0.004 1 0 
W102Y 0.012 0.005 1 1 
Q241D 0.007 0.001 1 1 
Q241V 0.005 0.002 4 4 
Y351M 0.020 0.006 11 11 
Table 6.8. Specific activity and GC analysis of biotransformation reactions with PETNRHis variants 
identified from screens with 3-methyl-2-cyclopenten-1-one as substrate. Specific activity reactions 
were composed of 2 µM PETNRHis variant, 0.1 mM NADPH, 1 mM 3-methyl-2-cyclopenten-1-one in 
50 mM KH2PO4/K2HPO4 buffer, pH 7 containing 5 % ethanol in a total volume of 1 ml. GC reactions 
were composed of 5 mM 3-methyl-2-cyclopenten-1-one, 6 mM NADPH and 2 µM enzyme in 50 mM 
KH2PO4/K2HPO4 buffer pH 7 containing 5 % ethanol in a total volume of 1 ml. 
The molecular basis of the slight improvement of Y351M in both the specific activity 
and the biotransformation reaction is probably due to the removal of a steric clash 
between the tyrosine side chain and the β methyl substituent. In the Y351M variant 
the bulky, polar tyrosine is replaced by the smaller and hydrophobic methionine 
residue Y351 has been demonstrated to have a role in the binding of PETNR to 
some compounds for example in the binding of the binding of substrate analogue p-
hydroxybenzaldehyde in the active site of OYE1 [15]. This effect is unlikely to be the 
case for 3-methyl-2-cyclopenten-1-one due to lack of the appropriate functionality 
para to the carbonyl functionality.  
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6.4 Discussion 
The screening of mutant libraries against a range of substrates containing either a 
ketone or an aldehyde-activating group (Table 6.9) yielded a total of 35 potential 
hits. Kinetic characterisation of these variants confirmed improvements in the 
specific activity of 14 enzymes (2 enzymes were not fully characterised). This 
suggests a true positive rate of 40 % for our sample. Of those variants with 
confirmed specific activity increases only 8 demonstrated improvements in 
substrate conversion under conditions of biotransformation reactions and 
represent potentially improved synthetic enzymes (Table 6.9). 
Substrate Enzyme 
Improvement in specific 
activity (fold) 
Trans-cinnamaldehyde T26S 1.1 
α-methyl-trans-
cinnamaldehyde 
W102F 9.1 
3-Methyl-2-cyclohexen-1-one T26A 2.5 
2-Methyl-2-cyclopenten-1-one 
Y68F 2.5 
W102F 4.9 
W102I 5.9 
Y351P 1.4 
3-Methyl-2-cyclopenten-1-one Y351M 1.9 
Table 6.9. Summary table detailing confirmed improved variants isolated from the screening of 
PETNR mutagenic libraries. 
The summary data (Table 6.9) suggests a general relationship between the 
positioning of substituents and the probability of a significant increase in specific 
activity. In general α-substituted compounds e.g. α methylcinnamaldehyde, 2-
methyl-2-cyclopenten-1-one are much better substrates for WT PETNRHis than the β 
substituted compounds 3-methyl-2-cyclohexen-1-one and 3-methyl-2-cyclopenten-
1-one (specific activity data described in this chapter). These α-substituted 
substrates have also been shown to yield far greater increases in specific activity, 
suggesting acceptance of novel substituents at this position is easier to achieve. 
This suggests that the protein environment surrounding the β carbon is far more 
restrictive which is most likely attributable to the T26 residue as discussed 
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previously. This implies that the improvement of acceptance at the β carbon 
requires the randomisation of further single site positions, iterative rounds of 
mutagenesis or the randomisation of multiple sites at the same time.   
These results suggest possible mutation hotspots associated with the methyl 
substituents at the α and β positions (Figure 6.1). Variants isolated from screening 
with α and β substituted unsaturated carbonyls have highlighted variation in the 
tyrosine pair (Y68/Y351) which has been suggested to regulate access to the active 
site (Section 1.4.3.2, Section 1.4.3.6 [40]). These variants involve the substitution of 
the large, polar tyrosine side chain with a variety of residues including 
phenylalanine, proline and methionine. The largest improvement in specific activity 
comes from the substitution of the polar hydroxyl at position 68 with a similar sized 
non-polar side-chain (Y68F). Smaller improvements are observed by replacement of 
Y351 with the smaller, non-polar proline and methionine residues. Due to the 
variation in size of the substituted residues this suggests that size may not be the 
determining factor. All substitutions change a polar residue for a non-polar residue 
which suggests that electrostatic interactions between the substrate and the polar 
tyrosine side-chain could influence substrate binding. 
The variant with the largest increase in specific activity for both the 2-methyl-
substituted substrates is the substitution of W102 to the smaller non-polar 
phenylalanine and isoleucine residues. These transformations involve the 
substitution of a large non polar side-chain with smaller aromatic and aliphatic non-
polar side-chains, which suggests that steric constraints between the W102 side-
chain and the α substituent are likely to dominate this interaction.  
The variant with the largest increase in specific activity for both the 3-methyl-
substituted substrates is the substitution of T26 to the smaller non polar residue 
alanine. This transformation involves the removal of a medium sized polar side-
chain and replaced by a small non-polar side chain, whilst the change in polarity is 
possibly an influencing factor, steric constraints between the β substituent and the 
additional methyl or the hydroxyl group on the T residue. Interestingly mutations at 
this residue were also observed to increase activity slightly with trans-
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cinnamaldehyde, suggesting a similar interaction could be present in non-
substituted substrates. 
 
Fig 6.1. Location of residues identified from hits in libraries screened containing with methyl 
substituted substrates. Panel A α substituted substrates including α-methyl-trans-cinnamaldehyde 
and 2-methyl-2-cyclopenten-1-one, red, W102; blue, Y68; yellow, Y351; panel B β substituted 
substrates including 3-methyl-2-cyclopenten-1-one and 3-Methyl-2-cyclohexen-1-one, red, T26; 
blue, Y351. Other active site residues are shown as atom coloured sticks with the substituted carbon 
shown as a sphere.  
Despite the successes demonstrated for screening PETNR libraries against 
substrates with novel α/β substituents, the experiments to vary the activating 
group were much less successful. These substrates were screened only against the 
H181X and H184X libraries due to their observed role in binding the activating 
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group (Section 1.4.3.4), it was thought that modification of these residues could 
lead to binding of other activating groups. These residues are largely conserved as 
His/Asn or His/His pairs in other OYEs and homologues. This outcome is not wholly 
unexpected due to the conserved nature of the H181 and H184 residues, and the 
potential roles discussed in other aspects of the PETNR catalytic cycle, such as 
NAD(P)H binding (Section 1.4.1.3; [69]) and FMN binding (Section 1.4.2; [73]). 
Possible reasons for this negative outcome include; (i) that there are no 
improvements present in this library or (ii) the possibility that there are variants 
which improve the oxidative half reaction however have such compromised 
reductive half reactions that these effects are masked. 
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7 Discussion 
7.1 Generation of tagged PETNR and initial robotic trials (Chapter 3) 
Chapter 3 describes the generation and characterisation of tagged PETNR variants. 
The best variant was incorporated into a protocol for the growth, extraction, 
purification and assay of enzyme libraries. Following finalisation of the protocols 
initial trials on a PETNRWT control block were performed to assess the 
reproducibility of the experimental protocol.  
Variants of PETNR incorporating either histidine or biotin tag nucleotide sequences 
were generated using a range of molecular biology methods. Initial expression and 
purification studies showed that the histidine tagged PETNR (PETNRHis) was 
expressed to a higher level and easier to purify than the biotin tagged variant 
(PETNRBio). Due to the problematic expression and purification conditions 
associated with the PETNRBio variant, only the PETNRHis variant was taken forward 
to thorough characterisation and multi-well trials. Various aspects of the PETNRHis 
robotic protocols were optimised such as the growth, purification and assay 
conditions in a 96 well format. Finalised procedures were trialled using a control 
block containing 96 PETNRHis WT clones. This initial trial enabled the quantitation of 
the sources of error in the protocols. These were estimated to be 14 % and 13 % for 
errors associated with the growth and purification of the clones, respectively. A 
proportion of this error has been identified as systematic with a variation of up to 
22 % across the block. 
A number of potential sources of error associated with the growth, purification and 
assay in 96 well format were identified. Firstly, the accuracy of robotic colony 
picking varied, which was dependent on the evenness of the distribution and size of 
the individual colonies as well as the presence of imperfections in the agar plate 
(e.g. agar bubbles or particulates in the agar which may be mistaken for colonies). 
Secondly, a variation in the growth rate of individual clones was dependent on the 
inoculum size from glycerol stocks combined with the effect the mutation has on E. 
coli growth. Thirdly, mutants can often vary in the degree of protein expression, an 
effect that was minimised by only performing micro-scale protein purification. 
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Protein purification conditions are likely to contribute significantly to the overall 
experimental error including; i) the potential loss of all or part of the cell pellets 
during removal of growth media ii) variation in the amount of magnetic beads 
dispensed iii) variation in the volume of individual buffers dispensed and iv) 
variation in the volume of final eluate. The final potential source of error is the 
assay conditions including factors such as i) pipetting errors ii) timing of reaction 
initiation and iii) error in absorbance readings. Whilst a subset of these sources of 
error is apparent in PETNRWT experiments, there are some sources of error, such as 
the variation of expression due to mutations, which cannot be characterised. 
Consequently, the total error associated from the screening reactions cannot be 
estimated.  
7.2 Library generation and initial characterisation (Chapter 4) 
Chapter 4 outlines the generation of single site saturation mutagenic libraries at a 
number of positions in the active site of PETNRHis. This involves the generation of 
library DNA by mutagenic PCR, the sequencing of a number of colonies to ensure 
randomisation, the trial high throughput expression and purification of libraries in a 
96 well format, followed by 96 well format activity assays with standard wild type 
substrates. 
When generating genetic diversity there are a number of sources of bias which 
would increase the proportion of some variants over others, such as the use of 
degenerate oligos in PCR. Oligos with a greater degree of complementarity to the 
template are more likely to anneal and hence mutations changing fewer bases will 
be slightly overrepresented in libraries. An example of this can be seen in the 
apparent over representation of WT codons (seen in the sequencing results) which 
result from the completely complementary oligonucleotide binding.  
Another source of bias is cellular toxicity, where some mutations generated may be 
toxic to the cell and hence either do not grow or lead to small colonies that are not 
picked by the colony picker. This acts as a type of unintended selection pressure as 
the colony picking software preferentially selects colonies deemed closest to ideal 
standards of colony size, shape and separation from its neighbours. 
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It is also important to note that sequencing 10 colonies per 96-well deep well block 
represents just over 10 % of the library members, and is therefore not a true 
reflection of the overall randomness of the site-saturation mutagenesis. In the case 
of the H181X and H184X libraries further sequencing, by co-workers, revealed a 
highly randomised library with the majority of library clones represented [170].  
In addition to DNA level bias attributable to the individual variants, there are a 
number of factors, involved in the growth, purification and assay which affect the 
activity demonstrated by each well. Other effects, separate from the property of 
interest, which are likely to manifest themselves in screening reactions include; i) 
effect of the mutation on expression; ii) effect of the mutation on stability/folding, 
leading to increased cellular degradation; iii) effect of the mutation on 
flavination/FMN binding; iv) effect of the mutation on NADPH activity; v) effect of 
the mutation on substrate inhibition properties. All of which could possibly serve to 
mask the true property of interest, that is variation in the steady state reaction rate 
with the oxidative substrate. 
There are a vast number of potential sources of error attributable to the generation 
of mutagenic libraries. A number of these sources of error come under the control 
of the experimenter, to some degree, however the majority do not. From the data 
in this chapter it is clear that reasonable steps have been taken to ensure the 
quality of the libraries about to be investigated and all but one of these libraries 
have been demonstrated to be of high quality. Control data were then recorded for 
these libraries, and they demonstrated a wide range of residual activity with NADPH 
and CH.  
Single site saturation libraries generated in the future could potentially be improved 
by ensuring all possible variants are represented in the library. The experiments in 
this chapter indicate that all potential variants at each position have probably not 
been sampled in all cases. Most obvious of these is the non-random construction of 
libraries using oligos designed to incorporate specific amino acids at each position.. 
Alternate methods including the use of MAX libraries [93] and codon mutagenesis 
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[172] could also yield improved quality libraries. These methods could enable the 
construction of extremely high quality libraries. 
7.3 Summary of screening PETNR libraries against a panel of novel substrates 
(Chapter 5) 
Chapter 5 provides a summary of the screening reactions conducted in an attempt 
to isolate improved clones from the generated libraries. A number of types of 
problematic data are detailed in this chapter.  
Firstly, there is the occurrence of false negatives. These data represent enzyme 
variants which have an improved property of interest but appear negative 
according to the screen employed. Due to their nature these errors are difficult to 
quantify since they appear negative and are not highlighted by the screen. At a 
molecular level these results are explained either by; i) positive mutations which 
are not represented in the library due to bias or probability (as discussed in Section 
7.2); ii) positive variants which are not identified due to experimental error (as 
discussed in Section 7.1); iii) positive variants with improved oxidative half reactions 
but compromised in other aspects of the catalytic cycle (as discussed in Section 
7.2); viii) variants which are not carried further due to the hit identification criteria. 
It is usually accepted in screening experiments that a lot of positive variants are 
missed and present as false negatives. Due to the nature of these data they are 
difficult to quantify. Experimental conditions are, where possible, tailored to avoid 
these sources of error, for example, the micro scale purification to avoid variation 
due to expression levels. Where this is not possible steps are taken to assess their 
contribution, for example sequencing reactions to assess variability attributable to 
DNA bias. 
Another problematic type of data identified is the occurrence of false positives. 
These data represent variants which do not have an improved property of interest 
but appear positive according to the screen and selection criteria employed. As 
opposed to false negatives discussed previously, false positives can be identified 
and quantified but this identification generally requires further unproductive work. 
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At a molecular level these results are explained either by; i) the observation of 
experimental outliers, for example even in the case of an experiment with no 
improved variants experimental variation means there is always a top ranked hit; ii) 
the effect of mixing errors on an assay with a low signal : noise. These type of data 
are indistinguishable from the true positive data and characterised further using 
kinetic and analytical chemistry techniques (Chapter 6). 
7.4 Confirmation of suspected hits (Chapter 6) 
Chapter 6 discussed the further characterisation of potential improved variants. 
Intermediate scale purifications were used for the spectrophotometric specific 
activity determination and biotransformation reactions were analysed to determine 
the percent substrate conversion and the percent product yield.  
It was clear from the data that a number of positive variants isolated from the 
screen were not improved biocatalysts in these subsequent analyses. These false 
positive results can be explained by consideration of the reasons discussed in 
Section 6.3, and are particularly prevalent in reaction with poor PETNR substrates, 
suggesting that low signal : noise can be a problem in some cases. 
In order to minimise this problem the Z-factor method of non controls based 
normalisation was used, but in the circumstance of low signal significant variation 
due to experimental error can lead to artificially inflated values. However, the 
alternatives, such as arbitrarily setting a cut-off value, also have their problems.  All 
normalisation and hit definition methods suffer from their own characteristic 
fallibilities and any single method is unlikely to be completely effective.  
A number of variants were identified with improved activity against a range of α 
and β substituted enones identified as poor substrates for PETNRWT, including the 9-
fold improvement of the W102F variant with α-methyl-trans-cinnamaldehyde. This 
effectively increases the activity of the enzyme with a poor substrate to a value 
comparable with the model substrate CH. In addition, mutants W102I and W102F 
showed a 6 and 5 fold improvement, respectively, with substrate 2-methyl-2-
cyclopenten-1-one. A number of other modest improvements; such as T26S with 
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trans-cinnamaldehyde, Y68F and Y351P with 2-methyl-2-cyclopenten-1-one, and 
Y351M with 3-methyl-2-cyclopenten-1-one and T26A with 3-methyl-2-cyclohexen-
1-one were also found. 
These changes in catalytic rate were changes in the property used as a reporter in 
the screen. However, a number of interesting coincidental changes in the 
stereochemistry of the reaction were also demonstrated. These include a reversal 
in stereochemistry associated with the reaction of α-methyl-trans-cinnamaldehyde 
with the W102F enzyme and a diversion in stereochemistry reported for the 
reactions of 2-methyl-2-cyclopenten-1-one with W102F/I variants. 
A number of experiments described above (Chapter 6) demonstrated no improved 
variants for a particular substrate (e.g. Section 6.2). This lack of positive results is 
attributable to a number of possible circumstances including; i) the residues 
targeted could be the wrong residues to affect the acceptance of the substrate; ii) 
improved variants could be present but show as false negatives for any of the 
reasons discussed previously (Section 7.1.3); iii) randomisation at a single position 
may not be insufficient in isolation to affect the acceptance of the substrate, and 
further iterative or synergistic substitutions may be required. 
7.5 Future work 
In order to further characterise the effects of these amino acid changes on catalysis, 
further detailed kinetic and structural studies could be carried out of the variants 
generated from these experiments to investigate the molecular nature of 
interactions leading to changes in activity. These studies could provide further 
insight into the substrate-binding conformations of PETNR, whilst also providing 
structural information to aid further directed evolution studies.  
The obvious extension to the studies reported in this thesis is to continue by 
generating libraries at further positions around the active site. This allows the 
extension of the sequence space to be screened. In some cases rationally designing 
novel variants by combining multiple hits from different libraries could also result in 
improved variants. Additionally, the variation of multiple positions in the same 
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library, such as the CASTing and multiple mutagenesis reactions described 
previously, could allow access to enzyme variants in which some degree of synergy 
is required for improved function. Randomising the residues identified in this study 
(such as Y68, W102 and Y351 for α substituted substrates, and T26 and Y351 for β 
substituted substrates) would represent an excellent starting point for these 
studies. 
These novel libraries, along with those described in this study, could be screened 
against other potential substrates. The activity of the mutants generated in this 
report could also be tested against further analogous substrates, for example the 
W102F mutant could be trialled against a range of α substituted trans-
cinnamaldehyde substrates. The improved variants generated in these studies 
could be subjected to further rounds of iterative site directed mutagenesis. This 
approach might be particularly useful where a number of amino acids have been 
demonstrated to yield improved variants from the first round of mutagenesis, for 
example screening using Y68F as a template for randomising W102. All the 
experiments discussed above could be performed rapidly using the same 
experimental protocols and equipment as outlined in Chapters 3 and 4 and 
demonstrated to be effective in Chapters 5 and 6. Works in these directions are 
essentially inexhaustible and could yield a large number of novel variants with 
desirable properties. 
Further mutagenic libraries could be generated and screened using alternate library 
generation techniques. These include gene shuffling approaches, multiple 
mutagenesis reactions or a whole range of the techniques discussed in Section 
1.5.2.  
There is also potential to vary the screening method to use different properties of 
the chemical reaction to report on the reaction progress, for example measuring 
substrate conversion (%) or product yield (%). In particular the incorporation of a 
chiral analytical chromatography method, similar to that described previously [61], 
would enable the screening for stereospecific enzymes and potentially lead to an 
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incredibly powerful platform for the identification of industrially relevant 
biocatalysts.
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Oligonucleotide table 
Oligonucleotide 
identification 
Oligonucleotide sequence 
Tm 
(˚C) 
2˚ 
Tm 
(˚C) 
His3T 
F CATCACCATTAATCCCGCTTTGTACATTGATAGCG 56 44 
R GTGATGATGCAGTGAAGGGTAGTCGGTATAAGGTTC 60 42 
His6T 
F CATCATCACCATCACCATTAATCCCGCTTTGTACATTG 59 8 
R ATGGTGATGGTGATGATGCAGTGAAGGGTAGTCGG 61 6 
Bio3 
F CAGAAAATTGAATGGCATGAATAATCCC 56 17 
R CGCTTCAAAAATATCGTTCAGGCCCTGG 61 30 
Bio5 
F AGGGCCTGAACGATATTTTTGAAGCG 58 21 
R GATTARRCATGCCATTCAATTTTTTG 52 11 
Biorep 
F GAAGCGCAGAAAATTGAATGGCATGAATAATCCCGC 
78 
26 
R GCGGGATTATTCATGCCATTCAATTTTCTGCGCTTC 36 
TagFind 
F CGGGTGCGTATACGGCAGAAAAAGC 61 38.4 
R GCGCATAATTTCCTCATTAACCAGTCGAATG 60 26 
T26X 
F GTTTATGGCCCCACTTNNKCGTCTGCGCAGCATCG 
75.9 
58.8 
R CGATGCTGCGCAGACGMNNAAGTGGGGCCATAAAC 35 
Y68X 
F GCTCAGGCAAAAGGCNNKGCCGGTGCACCGGG 
78.2 
52.9 
R CCCGGTGCACCGGCMNNGCCTTTTGCCTGAGC 51.3 
W102X 
F CGTATTGCGGTTCAGCTGNNKCACACCGGTCGTATC 
76.1 
45.4 
R GATACGACCGGTGTGMNNCAGCTGAACCGCAATACG 44.9 
H181X 
F CGACCTGGTTGAGCTTNNKTCTGCGCACGGTTACC 
70 
41 
R GGTAACCGTGCGCAGAMNNAAGCTCAACCAGGTCG 43 
H184X 
F GTTGAGCTTCACTCTGCGNNKGGTTACCTGCTGCATCAG 
71 
34.2 
R CTGATGCAGCAGGTAACCMNNCGCAGAGTGAAGCTCAAC 35.3 
Y186X 
F CACTCTGCGCACGGTNNKCTGCTGCATCAGTTCCTG 
76.1 
32.3 
R CAGGAACTGATGCAGCAGMNNACCGTGCGCAGAGTG 40.7 
Q241W 
F CCCCGATCGGTACTTTCNNKAACGTCGACAACGGTC 
76.1 
40.8 
R GACCGTTGTCGACGTTMNNGAAAGTACCGATCGGGG 41.7 
Y351X 
F GTCCTGAAAGCTTCNNKGGCGGCGGCGCGG 
76.3 
51.7 
R CCGCGCCGCCGCCMNNGAAGCTTTCAGGAC 49 
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